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ABSTRACT
Homologous recombination (HR) serves critical roles in DNA repair to maintain
genome stability, and the malfunction of HR contributes to carcinogenesis and cancer
development. Current research focuses on the regulation against deleterious
recombination between imperfectly matching sequences, which has been documented in
certain myeloid leukemias, hereditary nonpolyposis colorectal cancers and other genetic
diseases. Homology dependency of recombination was examined in cultured thymidine
kinase-deficient mouse fibroblasts. Cells have chromosomal integration of DNA
constructs harboring a herpes tk gene (the “recipient”) and a closely linked truncated
“donor” tk sequence. The recipient was rendered non-functional by insertion of the
recognition site for endonuclease I-SceI, and the donor sequence could restore the
function of the recipient through spontaneous gene conversion or via recombinational
repair provoked by a double-strand break (DSB) at the I-SceI site. Recombination events
were recoverable by HAT selection for tk-positive clones. Three different donor
sequences contained 16, 25, or 33 mismatches relative to the recipient, and these
mismatches were clustered within these “homeologous” sequences surrounded by region
of high homology. Previous work indicated that mammalian cells fastidiously avoid
recombination between homeologous sequences, while our results revealed that when
homeologous sequences are surrounded by high homology, mismatches are frequently
included in gene conversion events. Knock-down of DNA mismatch repair provided
evidence that incorporation of mismatches into gene conversion tracts involved repair
iv

of mismatched heteroduplex intermediates. Our results demonstrate that mismatch repair
of multiple mispaired bases does not function to impede exchange between homeologous
sequences. Moreover, gene conversion tracts from spontaneous recombination showed
that either all or none of the mismatches were transferred from donor to recipient,
suggesting that recombination must begin and end in high homology. But this
requirement was somewhat relaxed in DSB-induced events with recombination ending in
homeology. Further experiments with a rearranged construct were attempted to
investigate the relaxed homology requirement during DSB repair. In addition to the study
on homology requirement of recombination, research works were also carried out to
characterize the roles of RecQ4 helicases in DSB repair. It is the first demonstration that
RecQ4 deficiency reduces the fraction of crossover events in DSB-induced
recombination. Moreover, BLM deficiency failed to boost crossover events in RecQ4
deficient cells. It is postulated that these two helicases act agonistically to determine the
generation of crossover events.
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CHAPTER 1 INTRODUCTION TO HOMOLOGOUS RECOMBINATION
AND DNA DOUBLE STRAND BREAK REPAIR IN MAMMALIAN
CELLS
Cells are facing numerous attacks on chromosomal DNA throughout their life
cycles, such as reactive oxygen species, genotoxic chemicals or radiations. These attacks
from endogenous or exogenous sources may damage nitrogenous base, break
deoxyribose, introduce single-strand nick, interstrand crosslink or even double-strand
break into the genomic DNA. To counteract these DNA lesions, cells maintain several
repair pathways to protect genome integrity (1, 2). Base excision repair (BER) and
nucleotide excision repair (NER) recognize the damaged nucleotides on one strand of
DNA, cleave and resynthesize them according to the remaining, complementary DNA
strand. But when DNA damages affect both strands of a DNA sequence, for example,
DNA double-strand break (DSB) or interstrand crosslink (ICL), homologous
recombination (HR) is needed for faithful repair (3, 4). HR relies on RecA helicase to
perform homology search and strand invasion in bacteria while in eukaryotes, Rad51
(homolog of E.coli RecA) serves the same function of RecA (5–7). Besides HR, there are
other homology independent, error prone pathways to repair DSB, for example,
nonhomologous end joining (NHEJ), single strand annealing (SSA) and alternative NHEJ
(8, 9).
The pivotal roles of HR in maintaining genome stability are well demonstrated in
several rare genetic diseases characterized with genome instability and cancer
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predispositions. Patients with Fanconi anemia may have congenital birth defects, short
stature, high incidence of acute myeloid leukemia, and bone marrow failure at an early
age (10). These syndromes are caused by mutants within a group of genes, the Fanconi
anemia complementation group (FANC) gene family. Cells deficient in FANC genes
barely respond to replication stress caused by DNA ICLs and fail to repair them through
HR, therefore these cells are not able to maintain the genome stability especially when
facing crosslinking agents like cisplatin and mitomycin C. RecQ helicase BLM
participates in HR and inhibits Holliday junction resolution toward crossover (CO)
events. BLM deficient cells have high rate of sister chromatid exchange (SCE) as well as
elevated recombination between homologous chromosomes (11–13). As a result, the
patients with BLM deficiency (Bloom syndrome) are characterized with genome
instability, short stature and predisposition to cancer within multiple tissues. Genetic
studies also revealed that deficiencies of other HR mediators, such as BRCA1, BRCA2,
RAD54B, RAD51B, RAD51C and RAD51D, endanger the genome stability and
contribute to the susceptibility to several cancers including breast cancer, ovarian cancer
and colon cancer (14). Specifically, mutations in BRCA1 and BRCA2 significantly
increase the carrier’s risk in breast cancer and ovarian cancer, and also contribute to other
types of cancer. These two genes mainly assist in RAD51 nucleoprotein filament
formation, homology search and strand invasion during HR (4). As described above, HR
pathway is so tightly connected to genome stability that discoveries of remaining HR
components, functions of these participating proteins, and regulation within this
complicate process would broaden our knowledge of the genome maintenance in somatic
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cells, and help elucidating the genomic alterations in carcinogenesis and cancer
development.
Two working models of HR are briefly illustrated in Figure 1.1. The
recombination starts from a DNA damage event breaking both strands of a DNA
molecule. Then, 5' exonuclease resects the broken DNA ends to produce 3’ single-strand
overhangs for homologous pairing (4, 15). Rad51 coats the single-strand overhang,
directs it to invade a DNA sequence with high homology, and pairs it with the
complementary strand (4). Following the strand invasion, DNA synthesis elongates the
invading strand under the guide of the homologous template, therefore restoring the
broken region as well as nearby nucleotide sequences. After strand invasion and DNA
synthesis, HR may diverge into two ways.
In synthesis dependent strand annealing (SDSA) pathway, the nascent DNA
strand aborts DNA synthesis, detaches from the homologous template and anneals to the
other resected broken end. Through cooperation of DNA polymerase, exonuclease and
DNA ligase, the broken DNA molecule is finally rejoined through base pairing of the
complementary DNA ends. SDSA will repair the DSB-damaged DNA sequence
according to the chosen homologous template, and leave gene conversion tract in the
restored DNA molecule (16–19) .
In the double strand break repair (DSBR) model, the initial strand invasion and
DNA synthesis peels off the non-template strand of the template to form a bubble shaped
D-loop, and then the extended D-loop anneals to the other resected broken end starting
the DNA synthesis of the second strand (7, 20). Later on, the temporary “synaptonemal”
intermediate matures into two stable Holliday junctions (double Holliday junctions,
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Figure 1.1 Double strand break repair model (DSBR) and synthesis dependent strand
annealing model (SDSA).
Two models describing the procedure to repair DNA DSB through HR are demonstrated
in above Figure. Black lines represent the strands of the broken DNA molecule while the
gray lines represent the strands of the template DNA molecule. The grey arrowheads
show the 3’ end of the DNA strand and the direction of DNA synthesis. The dashed lines
indicate they are the newly synthesized DNA strands. Black or white arrowheads point to
the sites for cleavage and re-ligation in Holliday junction resolution. Adapted from San
Filippo et al. 2008 (4).
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dHJs) bridging these two participating DNA molecules. Finally, the Holliday junctions
(HJs) are resolved by coordinated endonuclease cleavage and strand ligation. Holliday
junction resolution has two competing outcomes: gene conversion (GC), which restores
the broken DNA molecule using genetic information from its homologous template, or
crossover (CO), which not only restores the broken DNA molecule, but also splices these
two DNA molecules around the repair region.
Supplementary to the DSBR model, Holliday junction dissolution describes a subpathway to separate the dHJs connected DNA molecules. RecQ helicase BLM,
Topoisomerase IIIα and RMI1 (RecQ mediated genome instability 1 or BLAP75)-RMI2
(BLAP18) propel the convergent branch migration of dHJs to form hemicatenated DNA
molecules, then cut and re-ligate one DNA strand to eliminate the topological link
between these two molecules (21, 22). The Holliday junction dissolution only restores the
broken DNA molecule with gene conversion product indistinguishable from that of
SDSA pathway.
Without exogenous stress or disturbance, HR happens at an extremely low rate
during cell proliferation, and it is called spontaneous recombination. The origin of
spontaneous recombination is debatable and probably different causes mentioned below
all contribute to the spontaneous recombination events. HR may start from a
spontaneously occurring DSB, and generate gene conversion or crossover events as
described above (Figure 1.1). Secondly, a stalled replication fork may cause spontaneous
recombination as well (23). When a replication fork meets obstacle, and pauses, it may
regress, unwinding the newly synthesized DNA strands from the parental DNA (Figure
1.2, right panel). These two complementary strands then anneal and turn the replication
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fork into a chicken foot structure. The newly synthesized leading strand within the
structure would invade the parental DNA to reestablish the replication fork. DNA
recombination restoring stalled replication fork usually does not cause strand splicing
between sister chromatids. Thirdly, collapsed replication forks spark spontaneous
recombination (24). When leading strand encounters a nick on its complementary,
parental DNA strand, it will run off the ongoing replication fork as a one-ended DSB. The
broken end would invade the parental DNA molecule and reconstruct a new replication
fork with the help of RAD51 (Figure 1.2, left panel). Unlike stalled replication fork,
restoration of the collapsed replication fork tends to generate SCE. Spontaneous
recombination is needed to resolve other DNA lesions during replication as well, which
involves HJs and associated resolution, similar to previous two described pathways (25).
Lastly, the newly synthesized DNA strand may simply unwind from the original parental
strand, and anneal to a nearby homologous strand to continue DNA replication (4). The
template switching allows daughter DNA molecule to copy from a homologous partner
and overcome the lesions on its parental DNA molecule.
In recombination studies, fluctuation test has been used to collect spontaneous
recombination events as well as to estimate the rate of the recombination events (26). The
fluctuation test was first introduced to delineate the origin of the bacteria’s immunity
against virus, from spontaneous mutation or acquired immunity (27). Proportion of
resistant bacteria were monitored in a growing culture and subsequent cultures, and the
great variation across the subcultures confirmed the mutation hypothesis. The occurrence
of HR events fits the mathematical description in aforementioned paper, which implies
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Figure 1.2 DNA recombination restores problematic replication forks.
The collapsed and stalled replication fork are rescued by HR, as shown above. Parental
DNA strands are drawn with black line while the daughter strands are drawn with gray
line. Newly synthesized DNA strands are drawn with dash line and the arrowheads
indicate the 3’ end of the DNA strand. Adapted from Helleday 2003 (28).
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that the recombination events arise during cell proliferation similar to the spontaneous
mutations.
HR participates in DSB repair to maintain genome stability, as stated earlier in
this chapter and the recombination frequency is dramatically boosted by DNA DSB.
Ionizing radiation, reactive oxygen species, and other chemicals produce DNA DSBs
directly or indirectly (29). Approximately 50 endogenous DNA DSBs happen per cell
cycle, and the number will double if the cells are facing 1 Gyt ionizing radiation (9).
Timely repair of DSBs is vital for cells to overcome these intracellular or extracellular
stresses, while the failure would lead to cell cycle arrest and even cell death (8). As
illustrated in Figure 1.1, during HR, broken DNA ends are resected to generate 3’ singlestrand overhangs and then directed to a homologous template for restorative DNA
synthesis. HR faithfully repairs the broken DNA molecule, while sometimes produces
crossover events splicing the broken DNA molecule and the template DNA molecule. HR
is also critical to repair other DNA lesions. DNA ICLs may be cleaved to produce DSB,
and then HR takes the turn to complete the late stage of repair (10). Conceivably HR can
fix DSBs generated by other repair pathways, and accurately restore the broken sequence
based on a homologous template.
HR provides faithful repair even if the broken DNA molecule loses a significant
amount of DNA sequence after DNA damage. The benefits of the HR are obvious unless
the chosen homologous template has a mutation within region needed for repair. In this
rare circumstance, loss of heterozygosity (LOH) will severely affect the normal gene
function in the host cell (9, 13).
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Cells also utilize other pathways to repair DSBs, especially non-dividing cells
lacking in HR activity. Non-homologous end joining (NHEJ), single strand annealing
(SSA), precise ligation (PL) and other alternative pathways can repair DNA DSBs
(Figure 1.3). NHEJ is a prominent pathway to repair DSB, especially when the damaged
DNA does not have homologous sequence available nearby. NHEJ shares protein
components with HR initially: MRN (MRE11-RAD50-NBS1) complex trims broken
DNA ends and cleaves obstructive adducts for both pathways. NHEJ employs Ku70
(XRCC6, Lupus Ku autoantigen protein p70 or X-ray repair cross complementing 6),
Ku80 to tether the broken ends and uses DNA ligase IV to reestablish the linkage (30–
32).
NHEJ events keep the structure and continuity of the damaged chromosome,
though produce sequence deletions ranging from several base pairs to thousands of base
pairs. These events would affect normal gene function if the coding sequence or
regulatory element get changed after repair. Available evidence also shows that NHEJ
events are capable of efficient and accurate DSB repair when compatible DNA ends exist
for direct ligation, which was called PL previously.
When the two-ended DSBs somehow still have complementary ends, PL directly
ligates them, and preserves the original DNA sequence without any alteration (33, 34).
Limited number of studies in DNA repair addressed PL since most recombination
systems are designed to select events with sequence changes after repair. However, PL is
likely the most time-and energy-efficient way of accurate repair if compatible ends
remain after DSB. Using mutant I-SceI sites to recover re-ligation events, a recent study
revealed that PL is the predominant way to repair DSBs with complementary ends, while
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Figure 1.3 NHEJ and SSA pathways to fix DNA DSBs.
Overview of NHEJ and SSA pathway. Critical proteins in NHEJ are drawn on the left,
while re-ligation procedure of SSA is drawn on the right. Adapted from Lazzerini-Denchi
et al. 2016 (35) and Schubert et al. 2011 (36).
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only 5% of the repair events are NHEJ with nucleotide deletions (37). Moreover, PL
relies on NHEJ components, for example, Ku70, XRCC3 and ligase IV. It is conceivable
that before the generation of NHEJ events with sequence deletion, the compatible ends
were tethered together, and PL ligated them successfully multiple times (37, 38).
NHEJ efficiently repairs DSB without using a DNA template across cell cycles,
and it may bring minor or moderate deletions to the DNA sequence. When NHEJ is
delayed or damaged, cells may take an alternative pathway: alternative NHEJ (A-NHEJ)
(31, 34, 38, 39). For example, NHEJ relies on ligase IV, Ku70 and DNA-PKcs. If cells
have deficiency in these proteins, the broken ends may get extensive resection before
ligation, therefore, repair events with long deletions become commonly observed.
Sometimes, the broken end may be ligated with a broken ends from other breakages,
producing chromosomal translocation or fusion (31, 40). In A-NHEJ, re-ligation of the
broken ends relies more on microhomology, and utilizes a set of protein components
including PARP1, CtBP-interacting protein (CtIP), ligase I and ligase III. Some of these
protein components are also used by HR during strand resection (40, 41). Also,
monitoring of the DNA repair process shows that A-NHEJ happens late in the DSB
repair, and serves as a backup pathway when NHEJ failed in initial attempts.
If DNA DSB happens in one of the tandem repeats on a chromosome, the
complementary sequences on either side of the breakage could be revealed though
extensive unwinding or end resection (34, 42, 43). After strand annealing between these
two tandem repeat sequences, the single strand overhangs/flaps are cleaved off, and then
the strand ligation mediates the fusion of the two tandem repeats. SSA also uses
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homology to repair DSB, but unlike HR, SSA mediated repair and sequence deletion are
independent of Rad51.
Break induced repair (BIR) rescues a DSB event even when one side of a broken
DNA molecule is lost after DNA damage, which is not cued by aforementioned pathways
(44). BIR may use a nearby sister chromatid as template to accurately restore the broken
chromosome: RAD51 directs the DNA single strand overhang to invade and establish a
replication fork on the sister chromatid (Figure 1.4). Unlike semi-conservative DNA
replication, BIR moves the replication fork through sliding of the D-loop, while the
synthesis of lagging strand is carried out using the newly synthesized leading strand as
template (45).Though BIR saves cells from deleterious loss of chromosome, it will
produce chromosomal fusion or translocation if an improper template was chosen.
SSA, A-NHEJ and BIR are error prone pathways bringing profound changes to
local DNA sequence and chromosomal structure. LOH, sequence deletion, chromosomal
fusion and translocation are known outcomes if cells adapt these pathways. Since
aforementioned repair pathways bring different risks to the genome, choice of pathway to
counteract DSB is critical to the benefits of the host cells. These pathways are likely
attempted in an order for the best of the cells, which may differ because of different cell
lines, cell cycle or genetic background.
NHEJ is a prominent pathway to repair DSBs in all phases of cell cycle, and
usually acts swiftly to fix the lethal DNA lesion. NHEJ does not need extensive resection
and prolonged DNA synthesis; nucleotide cleavage and/or addition is sufficient to rejoin
the broken DNA. If complementary ends still exist after DSBs, precise ligation of the
broken fragments would dominate the ligation events. When the cells failed in this
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Figure 1.4 Break induced replication model (BIR).
BIR fixes DSB by re-synthesizing the lost DNA fragment. The DNA sequence of broken
molecule is in black while sequence of template DNA is in gray. Newly synthesized DNA
strand is drawn with dashed line, while the grey or black color represents the identity of
the sequence. The arrowheads indicate the 3’ end and the direction of DNA synthesis.
Adapted from Donnianni et al. 2013 (45).
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particular attempt, they would turn to error-prone NHEJ, HR or other alternative events
for repair (32).
HR in somatic cells relies on recombinase Rad51, which is only detectable in
G2/S phase, due to cell cycle dependent transcription (46, 47). In the meantime, sister
chromatids provide the nearby homologous template for efficient recombination (19).
Apparently, without the critical recombinase Rad51 for strand invasion and exchange,
and without a nearby template, homologous paring and exchange between two sequences
are not the preferred pathway for repair. When both NHEJ and HR are available to
compete, the CtIP, recruited by MRE11, stimulates end resection and channels the repair
toward HR. CtIP’s activity relies on CDK-dependent phosphorylation (48, 49), and
interestingly, RecQ4, one of the RecQ helicase facilitates CtIP’s recruitment at the DSB
site (15) while another RecQ helicase, WRN, suppresses the recruitment of CtIP and
MRE11, propelling DSB repair through NHEJ without extensive end resection (41).
If initial attempts through NHEJ or HR failed, extensive resection and degradation
may reveal remote homology or microhomology for re-ligation, so SSA or A-NHEJ
would follow afterward. In NHEJ deficient cells, the repair pathway turns to A-NHEJ,
which uses microhomology and ligase III to mediate the end rejoining (50, 51).
As stated in previous paragraphs, recombination mediators and interacting
partners not only participate in DSB repair but also shift the repair toward different
pathways and recombination products. RecQ4, one of the RecQ helicase, has been
associated with DSB repair. Patients with defective RecQ4 have Rothmund Thomson
syndrome, which was characterized with poikiloderma, cataracts, predisposition to
osteosarcoma, and accelerated aging. It is of great importance to explore RecQ4’s
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function in DSB repair since the RecQ4 deficient cells show several typical signs of
genome instability. Experiments were conducted on RecQ4 helicases by analyzing DSBinduced recombinants after siRNA knockdown in human fibroblast cells. Increase of gene
conversion events was observed in RecQ4 deficient cells, opposite to the impact BLM
deficiency brought. Moreover, BLM deficiency failed to increase crossover events in
RecQ4 deficient cells while it dramatically boosted crossover events in wild type cells.
Our results showed that RecQ4 and BLM shift the final products of HR toward opposite
directions, indicating agonistic roles they may play in HR. Since crossover is potentially
deleterious outcome in DSB repair, current genetic study provides preliminary data and
evidence to understand RecQ4’s impact on the genome stability, and these results warrant
further mechanistic studies.
Another potential risk of HR lies in template selection. HR maintains the genome
stability in somatic cells by cuing DNA breakage from radiation, genome toxic chemicals
or endogenous cell stress (8, 29). However, if the Rad51 coated DNA overhang invades a
non-allelic template sequence, and retrieves the incorrect DNA sequence, mutation and
malfunction are imaginable (52). Sporadically, recombination between non-allelic
sequences causes genetic diseases and contributes to cancer development (30, 52). When
DNA recombination happens between imperfectly matching sequences (synonymous
with diverged sequences and homeologous sequences), the restored DNA molecule would
have certain DNA sequence replaced by that of the DNA template. These recombination
events with a homeologous conversion tract are thus called homeologous recombination
events (HeR events) (53–56). Due to HeR’s deleterious consequences to gene function
and genome stability, a lot of research have been done to address the mechanism how
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cells avoid DNA recombination between diverged sequences. It has been confirmed in
multiple model organisms that functional DNA mismatch repair (MMR) is needed to
prevent recombination events between diverged sequence, however, at which stage the
MMR intervenes the homeologous recombination and the detailed mechanism is not well
known and still in debate (54, 57–59).
Pursuing the previous findings in our laboratory (53, 55), a systematic research
has been done to explore the mechanism how mammalian cells exclude highly diverged
sequences from DNA recombination, and the results are presented in current dissertation.
New substrates were constructed to have different lengths of diverged sequences
surrounded by perfect homology. Both spontaneous recombinants and DSB recombinants
from new substrates were collected and analyzed. The obtained data clearly demonstrates
that HeR events are common when sufficient homology for recombination locates on
both sides of the homeologous sequences. Additionally, strand exchange between
homeologous sequences is supported by evidence of heteroduplex DNA intermediate
after MSH2 knockdown. These results argue that DNA recombination does not target and
reject genetic exchange between highly diverged sequences in these new substrates.
Though MMR prevents recombination from happening between imperfectly matching
sequences, our results added to current paradigm that in certain circumstances, MMR
does not impede the exchange between diverged sequences, but facilitates it by
converting mismatched nucleotides to the recombination template. Moreover, our results
revealed the relaxed homology requirement of DSB-induced recombination, which
demonstrates the higher risk of HeR events during DNA damage and repair.
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CHAPTER 2 RECOVERY AND ANALYSIS OF SPONTANEOUS AND
DSB-INDUCED RECOMBINANTS IN MOUSE LTK- CELLS
HR is able to faithfully repair a damaged DNA molecule. It directs the DSB ends
of the broken DNA to its homologous template, synthesizes the lost DNA sequence and
restores the broken region seamlessly. However, improper choice of recombination
template may bring HeR events: If the broken DNA sequence pairs with another nonallelic DNA sequence and gets synthesized depending on a wrong template, it will likely
bring mutations and malfunction to the involved genes.
Our research focuses on the risk of homologous recombination between nonallelic, evolutionarily related fragments with high sequence divergence. These events
may convert the DNA sequence of one fragment to the other, and sometimes they even
recombine these two DNA molecules within the diverged sequence creating reciprocal
crossovers. These events are collectively called homeologous recombination (HeR), since
the HR took diverged sequences (homeologous sequences) as substrates. Many reports
confirmed HeR events between non-allelic sequences in germ-line cells or somatic cells
(52, 60). HeR events did happen between members of a gene family since they both share
substantial homology and reside in nearby locations. HeR events also happened between
highly diverged and physically separated repeat sequences like Alu sequences. One type
of hereditary nonpolyposis colorectal cancer (HNPCC) was caused by chromosomal
rearrangement between two Alu sequences (60). In addition, tens of thousands of
degenerative pseudogenes in mammalian cells still have adequate homology to
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recombine with their parent genes (61–63). All these HeR events between non-allelic
substrates may bring fatal mutations to functional genes, produce chromosomal deletions
or duplications, or even generate severe gross rearrangement by splicing non-homologous
chromosomes. Studying the HeR events between these substrates allows us to understand
the tight regulation cells maintain to achieve reparation rather than impairment.
Previous studies demonstrated that HR scrutinizes potential templates and only
allows efficient exchange between perfectly matching sequences (64). The strict
exclusion of diverged sequences during HR relies on DNA mismatch repair (MMR).
Horizontal gene transfer (HGT) between closely related bacteria species elevates
significantly when the recipient cells are deficient in MMR (54, 65). In yeast, active
MMR prevents HR from happening between diverged sequences as well (59, 66–68).
Systematic studies have been carried out in Saccharomyces cerevisiae comparing HeR
events in wild type and MMR deficient cells: MMR reduces HeR events up to 30-fold as
the sequence divergence increases from 0% to 9%, while beyond 9%, the rarity of HeR
events is likely a combination of the 30-fold reduction enforced by MMR and weak
interaction between highly diverged sequences (66). In mouse cells, a single nucleotide
mismatching could reduce the spontaneous recombination 30-fold (26). In mammalian
cells, HeR events between 1% to 1.5% diverged sequences increase 7 to 10-fold after
ablation of MSH2 (3, 69). Beside MMR, other protein factors also contribute to the
prevention of HeR events, probably by unwinding the potential mismatched heteroduplex
DNA (hDNA) intermediate in the HeR process. Yeast Sgs1 helicase is vital to the
rejection of HeR events (68), and recent results in our laboratory show that RecQ helicase
BLM, the mammalian homolog of Sgs1, suppresses HeR events in human cells as well
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(70). In vitro experiments show that BLM and MSH2 cooperate in detecting strand
annealing between diverged DNA sequences and peeling them apart, therefore, aborting
the strand invasion (56). The end resection and strand invasion toward homeologous
sequence may be attempted multiple times before the DNA repair is redirected to
alternative pathways.
A series of research projects have been carried out in our laboratory to investigate
HeR events between highly diverged sequences in mammalian cells, and some
representative substrates are illustrated in Figure 2.1. These recombination substrates
were designed to collect recombination events involving diverged DNA sequences
originally from herpes simplex virus: the DNA sequences of type 1 and type 2 herpes
simplex virus thymidine kinase (HSV-1 TK and HSV-2 TK) share 80% homology, similar
to that between highly diverged Alu sequences or other repetitive elements (53, 55).
Spontaneous recombination between HSV-1 TK and HSV-2 TK sequences was not
recovered in our previous experiments using the pHOME substrate, and the
recombination frequency was estimated to be lower than 10-9 (event per cell division)
(26, 55). When it comes to the recombination between HSV-1 TK recipient sequence and
hybrid donor sequence of HSV-1 TK and HSV-2 TK (pHYB21A or pHYB12-8), the
spontaneous recombination frequencies are at 10-8, similar that with HSV-1 TK region of
aforementioned donors (53). In these experiments on pHYB21A and pHYB12-8, only 1
out of 81 recombinant clones shows a conversion tract in the HSV-1 TK recipient toward
HSV-2 TK sequence, a signature of HeR events. Exchange between homeologous
sequence became common only in recombination substrate pHYB121, which carries
HSV-1 TK recipient and hybrid donor composed of HSV-1 TK, HSV-2 TK and HSV-1
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Figure 2.1 Alignment of recipients and donors from selected recombination substrates.
The structures of donors and recipients used in previous experiments are shown above,
and the alignment reveals the position of endonuclease recognition sites (XhoI or I-SceI)
within recipients relative to the donor’s sequence.
The white rectangles represent DNA sequences of HSV-1 TK and the striped rectangles
represent HSV-2 TK sequences. The I-SceI or XhoI site in recipient is marked by a tilted
partial circle and solid line. And the dash line runs across these donors to show the
nucleotide position where recipients hold the oligonucleotides insertion harboring the
recognition site of either XhoI or I-SceI. Arrangement of recipient and donor after
chromosomal integration is shown below the alignment.
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TK sequence. In this case, 11 out of 39 recombination events have gene conversions in
HSV1-TK recipient, and the conversion tracts always include all the nucleotide
mismatches between HSV-1 TK recipient and hybrid donor.
Considering the recombination events from pHYB21A and pHYB12-8, the
spontaneous recombination events preferentially occur between perfectly matching
sequences and avoid nearby homeologous sequences. The exchange between
homeologous sequence during spontaneous recombination is barely allowed unless
homology lies on both sides of the homeologous sequence, as shown by pHYB121.
Therefore, apparently perfect homology is required at both the initiation and resolution
site during HR. To further evaluate the supervision against homeologous sequences
during HR, increasing lengths of homeologous sequence were engineered in new
substrates to reveal how exchange between homeologous sequences is processed during
spontaneous recombination. If the “homology” rule is enforced at both initiation and
resolution, the recombination events in new substrates would be similar to that of
pHYB121, even though they have different lengths of homeologous sequence inside the
donor. Moreover, the proposed experiments help to clarify whether the homeologous
sequences in the hybrid donors impede HR to achieve the genetic exchange between
them, and whether they are actually targeted by aforementioned mechanism for rejection
or destruction.
All three new substrates carry a full length HSV-1 TK recipient and a hybrid
donor composed of HSV-1 TK, HSV-2 TK and HSV-1 TK sequences. Donors of these
substrates differ in the length of the HSV-2 TK sequence, and their upstream and
downstream HSV-1 TK sequences exceed the minimal efficient processing segment
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(MEPS, approximate 200 bp in mouse cells) required for efficient recombination (26, 71,
72). Spontaneous recombination between donor and recipient may remove the I-SceI
insertion from HSV-1 TK recipient, thus restore the function of the viral thymidine
kinase. These recombination events enable host cells to survive and form resistant clones
in culture medium containing HAT.
Analysis of these recombinants will reveal how clusters of mismatches affect
strand exchange between DNA molecules during spontaneous recombination. If HR
vigorously rejects homeologous sequences, the HeR recombination frequency or the
proportion of HeR recombinants would decrease when the substrate has a longer
homeologous region. Meanwhile, nucleotide mismatches between the donor and recipient
allow us to examine the border of recombination events, so it is possible to see whether
spontaneous recombination starts and ends exclusively in the homologous region,
converting all mismatched nucleotides.
Ionizing radiation, reactive oxygen species, and other genome toxic chemicals
cause DNA double-strand breaks (DSBs) directly or indirectly (9, 29). In proliferating
cells, HR is a vital pathway to repair DNA DSBs and saves cells from cell cycle stalling.
However, if not harnessed, HR may conduct genetic exchange between non-allelic DNA
sequences, and some even generate chromosomal translocation or fusion. DNA
recombination between highly diverged sequences, so called homeologous recombination
(HeR), was also observed in mouse Ltk- cells during DSB repair (55). These HeR events
happened between thymidine kinase sequences of type 1 and type 2 herpes simplex virus,
and their frequencies are 600-fold less than HR events (53). The sequence exchange
between homeologous region during DSB repair occurs more if DSBs provoked HR in a
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nearby homology: The HeR frequency between HSV-1 TK recipient and hybrid donor
composed of HSV-1 TK and HSV-2 TK sequences is 3 times more than HeR events
between pure homeologous sequences.
As described in previous paragraphs and in Figure 2.1, HeR event between
homeologous sequences was not recovered during spontaneous recombination (55, 73).
Even half of the homeologous donor was replaced with homologous sequence to boost
initiation of HR (pHYB21A or pHYB12-8), exchange between homeologous sequences
is still a rare event (53). Spontaneous recombination prefers perfect homology to start and
end, thus it either manages to incorporates all mismatched nucleotides in conversion tract
once encountering homeologous sequence, or simply return to the initiation site for
resolution without converting any nucleotide if homology is not available on the other
side of the homeologous sequence (53). However, in DSB induced HR between HSV-1
TK and hybrid donor composed of HSV-1 TK and HSV-2 TK sequences, genetic
exchange frequently propagates into nearby homeologous region, converting some
mismatched nucleotides (55). Therefore, the homology requirement for resolution
appeared to be somewhat relaxed in proximity to a DSB during DSB repair. To test this
hypothesis, experiments were designed to examine whether DSB induced HR events
frequently get resolved in the middle of the homeologous region when homologous
region is available on both sides. Transferring of mismatched nucleotides from donor to
recipient will reveal the range of homeologous exchange. After comparing the choices of
resolution site, difference in homology requirement between DSBs induced HR and
spontaneous recombination could be obtained.
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To learn how HR processes homeologous sequences during DSB repair,
endonuclease I-SceI was transiently expressed in selected cell lines. After the I-SceI
introduced DSB gets repaired through HR, NHEJ or other alternative pathways, the host
cell may gain a functional thymidine kinase and form a recombinant clone in HAT
selection. Experiments were carried out on the same selected cell lines examined for
spontaneous recombination, which have different lengths of homeology in the donor (55).
Therefore, the comparison between DSB repair recombinants and spontaneous
recombinants may reveal whether exchange between homeologous sequences might be
processed differently during DSB repair. The HeR events and conversion tracts in these
cell lines may answer the following questions: whether the homology requirement in
resolution is indeed relaxed during DSB induced recombination, whether the
homeologous region poses an obstacle to HR in conducting sequence exchange between
them, and whether strand exchange with substantial mismatches is targeted for rejection
or destruction. For example, if there is vigorous rejection of the homeologous sequence,
clone frequency or proportion of HeR recombinants should decrease in cell lines carrying
a longer homeologous region in their substrates.
Materials and Methods:
Construction of substrate: The backbones of new substrates are from vector
pJS-1(72). Three substrates, pLD1, pHYB121, pJSBam8 were developed from pJS-1 in
previous experiments (53, 55), and they are used directly to build new pBWW substrates
(Figure 2.2 to Figure 2.5). pJSBam8 has a 2.5 Kb HSV1-TK gene inserted at the unique
BamHI site of pJS-1, and the gene sequence has been rendered nonfunctional by 8bp
oligonucleotides insertion containing XhoI I site at nucleotide position 1215. The
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Figure 2.2 Workflow to construct substrate pBWW1.
Plasmids, primers and restriction sites in use are drawn and labeled in figure. The white
bars in donors and recipient are HSV-1 TK sequences, while the solid bars in donors are
HSV-2 TK sequences. pBWW1 has 33 mismatches between donor and recipient, and it
was used to build 3 other recombination substrates examined in current studies.
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Figure 2.3 Workflow to construct substrate pBWW33.
Plasmids, primers and restriction sites in use are drawn and labeled in figure. The white
bars in donors and recipient are HSV-1 TK sequences, while the solid bars in donors are
HSV-2 TK sequences. pBWW33 has 33 mismatches between donor and I-SceI site
containing recipient, and it was used in subsequent recombination experiments.
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Figure 2.4 Workflow to construct substrate pBWW25.
Plasmids, primers and restriction sites in use are drawn and labeled in figure. The white
bars in donors and recipient are HSV-1 TK sequences, while the solid bars in donors are
HSV-2 TK sequences. pBWW25 has 25 mismatches between donor and recipient, and it
was used in subsequent recombination experiments.
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Figure 2.5 Workflow to construct substrate pBWW16.
Plasmids, primers and restriction sites in use are drawn and labeled in figure. The white
bars in donors and recipient are HSV-1 TK sequences, while the solid bars in donors are
HSV-2 TK sequences. pBWW16 has 16 mismatches between donor and recipient, and it
was used in subsequent recombination experiments.
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nucleotides in HSV1-TK are numbered the same as in the Wagner’s paper hereafter (74).
pHYB121 has the same nonfunctional HSV-1 TK recipient inserted at BamHI site as
substrate pJSBam8, but it also has a hybrid donor inserted at the unique HindIII site. The
hybrid donor of pHYB121 is composed of continuous HSV-1 TK, HSV-2 TK and HSV-1
TK sequences: nucleotides 848-1096 of HSV-1 TK sequence followed by nucleotides
1097-1167 of HSV-2 TK sequence followed by nucleotides 1168-1459 of HSV-1 TK
sequence. pLD1 also has a 2.5 Kb HSV-1 TK sequence at the same BamHI site, but
unlike pHYB121 and pJSBam8, a 30bp oligonucleotide was inserted at position 1215 of
the tk gene introducing an I-SceI site. pLD1 has a hybrid donor of HSV-1 TK and HSV-2
TK sequence inserted at the unique HindIII site, which was excised and discarded during
substrate construction. pTK1 has the original full length HSV-1 TK sequence at its
unique BamHI site and it was used as a PCR template. One recombinant from substrate
pLD1, pLD1-3-6-3-5, has a recombined HSV-1 TK recipient with nucleotides 968-1167
replaced by HSV-2 Tk sequence, so its recipient has 33 different nucleotides compared
with the original HSV-1 TK sequence.
At the beginning, the hybrid donor of pBWW33 was amplified from cell line
pLD1-3-6-3-5’s genomic DNA using AW130 (5’ATT ATC TAA GCT TAG CCA CGG
AAG TCC GCC TGG 3’ which contains HindIII recognition site and matches HSV1-TK
nucleotides 623-642) and AW93 (5’TGA TCA TAA GCT TAA GAC GTC CAA GGC
CCA GG 3’which contains HindIII recognition site and matches HSV1-TK nucleotides
1459-1441). The 0.8 Kb PCR product was cut by HindIII, purified using a MinElute Gel
Purification Kit (Qiagen) and ligated with the HindIII linearized pJSBam8 to produce
substrate pBWW1. Therefore, the pBWW1 has the hybrid donor, 0.8 Kb HSV1-TK
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sequence with 33 nucleotides changed to HSV-2 TK sequence, in addition to a XhoI site
disrupted HSV-1 TK recipient. The donor in pBWW1 was then excised and ligated into
the HindIII site of pLD1 to generate pBWW33.
The hybrid donor of pBWW25 was amplified from cell line pLD1-3-6-3-5‘s
genomic DNA and substrate pTK1 through three steps of PCR. Firstly, AW130 and
AW131(5’ GGC GAT AGG GTG CCG GTC GAA GAT GAG GG3’ which matches
HSV1-TK nucleotides 1016-988) were used to amplify HSV1-TK nucleotides 623 to
1016 from pTK1. Secondly, AW132 (5’CCC TCA TCT TCG ACC GGC ACC CTA TCG
CC3’ which matches HSV1-TK nucleotides 988-1016) and AW93 were used to amplify
HSV1-TK nucleotides 988-1459 from pLD1-3-6-3-5. Lastly, these two PCR fragments
were annealed using the overlapping HSV-1 TK nucleotides 988-1016 sequence, and then
extended before the last PCR amplification by AW130 and AW93. After final PCR
amplification, the complete donor fragment was cut by HindIII and purified as described
above. The donor of pBWW16 was excised from pHYB121 using HindIII, and it was
purified the same way as done to other donors. The previously made pBWW33 has the ISceI disrupted HSV-1 TK recipient and hybrid donor carrying 33 nucleotides from HSV2 TK sequence. The donor of pBWW33 was cut out by HindIII, and then the plasmid
backbone was ligated with these two newly prepared donor fragments to generate
pBWW25 and pBWW16 respectively.
Digested DNA fragments were separated on agarose gel, and then the target bands
were excised and purified using a MinElute Gel Purification Kit (Qiagen). Or, the
digested DNA fragments were separated by low melting point agarose gels and harvested
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through phenol extractions. PCR products were subjected to additional gel purification
before HindIII digestion if there were additional, nonspecific bands.
For each ligation reaction, 15ng donor fragment and 45 ng vector backbone were
mixed with 1 uL T4 ligase (NEB) in 20 uL 1X ligation buffer (NEB), and the ligation
reaction was kept at 16 ºC overnight. On the second day, 5 uL ligation solution was
introduced into alpha-Select chemically competent bacteria (Bioline) as instructed by the
supplier. Transformants were plated at different dilutions on LB media containing 40
ug/mL neomycin, and they were kept overnight at 37 ºC in incubator. Viable clones were
picked and cultured overnight in 5 mL LB medium, and 4 to 5 mL bacterial culture was
extracted for plasmid using Qiaprep Spin Miniprep Kit (Qiagen).
The donor insertion of pBWW33 was identified by HindIII digestion, and the size
of insertion was confirmed by PCR amplification of the whole insertion using AW53
(5’TTA GCT CCT TCG GTC CTC CG 3’ which matches vector pJS1 5094-5113) and
AW58 (5’CCA ACT TAC TTC TGA CAA CG 3’ which matches pJS1 5147-5128).
Sequencing of substrate pBWW33 using primers AW94 (5’TAA TAC GAC TCA CTA
TAG GGG GCT TCA TTC AGC TCC GGT TCC 3’ which matches pJS1 5023-5044)
confirmed the orientation of the donor insertion. For substrate pBWW16, AW94 and
AW93 will amplify the correct donor insertion, while AW94 and AW92 (5’ ATT ATC
TAA GCT TGA TAT CGG CCG GGG ACG CGG 3’ which matches HSV1-TK 848-867)
amplify the reversed donor insertion. The donor of pBWW16 was amplified using AW94
and AW58 (5’CCA ACT TAC TTC TGA CAA CG 3’ which matches pJS1 5147-5128)
and sequenced before use. Finally, I-SceI digested substrates were checked on agarose gel
to make sure they have intact recognition site of I-SceI within HSV1-TK recipient.

31

Cell culture: Mouse Ltk- cell line and its derivative cell lines were cultured in
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine
serum (FBS), minimal essential medium nonessential amino acids and 50 ug of
gentamicin. All cells were incubated at 37 ºC with 5% CO2.
Cell line establishment: Mouse Ltk- cells were transfected with each substrate
through electroporation, and the cells with chromosomal integration of the substrate were
selected using G418. Five million cells were pelleted in a 15 mL conical tube, washed
one time by 5 mL PBS and then suspended in 775 uL PBS. The ClaI linearized substrate
(2.5 ug in 25 uL digestion buffer) was added into the cell suspension to make it 800 uL
before electroporation. The electroporation was carried out in a cuvette with 0.4 cm gap
width at 1000 volts and 25 microfarads, and then the time constant was always 0.4
milliseconds. Right after electroporation, all the cells were transferred into a T175 flask
and they were cultured for 2 days before G418 selection. Two days later, the cells were
trypsinized, and 100,000 cells were plated in each T75 flask with 200 ug/mL G418.
Syringe transfection (75) was attempted one time on pBWW33. Linearized pBWW33
(1.25 ug) was mixed with 0.5 million cells in 1mL culture medium, and then the cell
suspension was taken into a 1ml syringe. All cells were forced through 30-gauge needle 4
times (8 strokes including the first transfer) to allow plasmid penetrating cell membrane.
After the procedure, all cells were plated into 10 T75 flasks. On the next day, G418 was
added into the culture medium at 200 ug/ml. The G418 selection usually took 11 to 14
days before resistant clones grew up.
G418 resistant clones were picked and cultured separately in a 24 well plate. After
2 weeks, all cells in a well were trypsinized and transferred in one T25 flask. Upon
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confluence, cells of each flask were separated into two T25 flasks: cells in one flask were
frozen and stored at -80ºC, while the cells in second flask were used to prepare genomic
DNA.
Genomic DNA of these clones were extracted as described before (73), and their
concentrations were measured by spectrophotometer. For Southern blot, 8 ug genomic
DNA was digested by HindIII or BamHI, separated on agarose gel and transferred onto
nitrocellulose. Meanwhile, 10 pg digested substrate was loaded aside to display the intact
donor or recipient, and their signals are equivalent to a single copy integration in mice
genome. Full length HSV-1 TK sequence was used to synthesize probe, which hybridizes
with recipient and donors (76). Cell lines were chosen for further experiments if they
have intact donor and recipient, and their signal indicate a single copy integration of the
substrate.
Collect spontaneous homeologous and homologous recombinants: Fluctuation
test was carried out on each cell line to collect spontaneous recombinants as described
before (77). In fluctuation test, 10 subclones were grown up in parallel. Initially, 100 cells
were seeded per well in 24 well plate to start a subclone. Once confluent, the cells from
each well were trypsinized and transferred into T25 flask. They were subsequently
transferred into T75 flask, and then two T175 flasks, where the cells grew up to
approximate 40 million. Finally, for each subclone, cells from the 2 T175 flasks were
trypsinized and plated in HAT selection. Maximal 10 million cells were plated in a T175
flask with 30 mL 1 X HAT medium to achieve effective selection as well as proper clone
density. HAT resistant clones usually became visible 2 to 3 weeks afterward, and then
they were picked and cultured for sequence analysis as described before.
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Calculation of clone frequency, homologous recombination frequency and
homeologous recombination frequency: In fluctuation test, the clone frequency was
calculated for each subclone by dividing the number of HAT resistant clones by the
number of cells subjected to HAT selection. Then, the clone frequencies of 10 subclones
were averaged to generate the clone frequency of the cell line. Similarly, the HR
frequencies of the 10 subclones were calculated separately, and then they were averaged
for the cell line. For each subclone, the HR frequency was calculated by multiplying
clone frequency of the subclone with the proportion of HR clones in analyzed clones.
HeR frequencies were calculated for each subclone separately the same as HR events,
and they were averaged to generate HeR frequency of the cell line. If there were other
events, like the reactivation of mouse thymidine kinase pseudogene, these events were
still counted in clone frequency, therefore, the spontaneous recombination frequency
would be different from the clone frequency and calculated separately case by case.
PCR amplification and sequencing: All PCR amplifications were performed
using GE’s illustra Puretaq Ready-To-Go PCR Beads as instructed by the supplier. The
dried PCR bead was dissolved in 25 uL reaction solution containing DNA template and
50 ng of each primer. And this 25 uL reconstituted PCR mixture was overlaid with
mineral oil to prevent evaporation in following thermal-cycling.
PCR amplification of HSV-1 TK sequence used following “Touchdown” protocol:
The initial denaturation starts at 95ºC for 5 minutes. In the first 12 cycles, the 1 minute
annealing step starts at 72ºC and then the temperature drops 2ºC after every two cycles
until it reaches 62ºC; the elongation takes 3 minutes at 72ºC, and the denaturation takes 1
minute at 95ºC. In next 24 cycles, annealing takes 1 minute at 60ºC, elongation takes 3
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minutes at 72ºC and denaturation takes 1 minute at 95ºC. Final elongation step takes 10
minutes at 72ºC.
To analyze collected recombinants, the HSV-1 TK recipient sequence was
amplified by primer pair AW85 and AW133 or primer pair AW100 and AW133 from 500
ng genomic DNA using touchdown protocol. These two primer pairs amplify 1.4Kb or
1.1Kb sequences from the HSV1-TK recipient, and both products include the nucleotides
968-1126 of HSV-1 TK sequence, which would be altered by these recombination events.
To prepare these PCR products for sequencing, 10 uL PCR solution was treated by EXOI
and SAP (NEB) for 15 minutes at 37ºC, and then the mixture was incubated at 80ºC for
15 minutes to deactivate the added enzymes. Samples were sequenced using T7 promoter
primer at the core facility in University of South Carolina or at ETON Bioscience Inc.
Analysis of spontaneous homeologous and homologous recombinants: All
alignments were carried out using SciEdCentral software to compare recombinant DNA
sequences with reference sequences (HSV-2 TK sequence and HSV-1 TK recipient
sequence).
Transfection by electroporation: To collect DSB repair recombinants, the
plasmid pSce was electroporated into cells to introduce a DSB in the recipient at the ISceI site. Before electroporation, cells were cultured in T75 flasks until their number
exceeded 5X106. On the day of transfection, cells in T75 flasks were trypsinized, resuspended in culture medium and counted on a hemocytometer. For each transfection, 5
X106 cells were transferred into a 15 mL conical tube, and centrifuged at 300 x g for 3
minutes. The cells pellet was washed using 5 mL phosphate buffered saline (PBS), and
then centrifuged again as described above. The newly pelleted cells were re-suspended in
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800 uL PBS before electroporation. For each electroporation, 20 ug pSce plasmid was
first added to the cuvette, and then 800 uL cells suspension. The DNA and cells were
mixed in the cuvette by pipetting several times. All electroporation experiments were
performed using a Bio-Rad Gene Pulser set to 750 volts and 25 uF. The actual time
constant of these electroporation experiments was always 0.4 ms.
Immediately after electroporation, cells were transferred into a 15 mL conical
tube containing 4.2 mL culture medium to obtain a final concentration of 1X106
cells/mL. A small portion of the electroporated cells was removed to measure plating
efficiency as described in next paragraph, while the rest cells were plated into 3 T75
flasks for subsequent HAT selection.
Measurement of plating efficiency: To obtain plating efficiency, 100
electroporated cells were transferred into each one of the two T25 flasks and cultured for
two weeks. The clone numbers in these two flasks were averaged and then divided by
100 to give plating efficiency of the experiment.
Selection and culture of recombinant clone: The electroporated cells were
separated into three T75 flasks. The cells were cultured in 15 mL media for 2 days before
being fed with HAT selection media. About 2 weeks after selection, discrete clones
formed in T75 flasks, and they were randomly picked for further analysis (55). The HAT
resistant clones in T75 flasks were counted to calculate clone frequency. The total clone
number in three flasks was divided by 5X106, and then divided by plating efficiency to
generate clone frequency.
Southern blot: The genomic DNA of selected recombinants was digested by
BamHI and HindIII, and then separated through electrophoresis for Southern blot.
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Moreover, HindIII digestion was used to check the junction fragment in some
recombinants that were suspected to carry more than one copy of substrate.
Subcloning of cells: To obtain subclones of an existing cell line, the cells were
diluted to 100 cells/mL Then, 0.5 mL diluted cell suspension was transferred into a T75
flask together with 15mL media and incubated for 2 weeks. Discrete cell clones formed
in the T75 were picked and cultured separately for later analysis.
Results:
Structure of substrates: Three new substrates all have a full length HSV-1 TK
recipient and a hybrid donor made of HSV1-TK and HSV2-TK sequences. The HSV-1
TK recipient in three substrates is the same and it has 30bp insertion at position 1215: the
nucleotides are numbered the same as in the Wagner’s paper (74). This 30 bp nucleotide
insertion contains the recognition site of endonuclease I-SceI, and destroys the thymidine
kinase’s function encoded by the recipient. Donors in these substrates range from 612 bp
to 837 bp, and they are hybrid donors composed of continuous HSV-1 TK, HSV-2 TK
and HSV-1 TK sequences. All the donors have upstream HSV-1 TK sequences between
250 bp and 380 bp, then HSV-2 TK sequences between 60 bp and 200 bp, and finally the
same downstream HSV-1 TK sequence of around 300 bp. When the HSV-1 TK recipient
is aligned to these three hybrid donors (Figure 2.6), the I-SceI insertion site always
locates against the downstream HSV-1 TK sequences of these donors, and about 50 bp
away from the border of HSV-2 TK sequences. The HSV-2 TK sequences in these
substrates are 60 bp, 153 bp and 199 bp respectively, and they carry 16, 25 and 33
nucleotide mismatches compared with the HSV-1 TK recipient (Figure 2.7). These
substrates are named pBWW16, pBWW25 and pBWW33 after the number of
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Figure 2.6 Alignment of donors and recipients from pBWW plasmids.
The structures of donors and recipients used in current experiments are shown above, and
the alignment reveals the location of recipient’s I-SceI recognition site, relative to the
donor’s sequence. The white rectangles represent HSV-1 TK sequences and the striped
rectangles represent HSV-2 TK sequences. Previously constructed substrate pHR99 has
similar structure, while it carries a HSV1-TK donor slightly longer than the rest donors.
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Figure 2.7 Alignment of recipient and donor sequences in substrate pBWW33 to show
mismatched nucleotides.
Compared with donor, the recipient has 30 bp oligonucleotide insertion including an 18
bp recognition site of I-SceI (underlined). Totally 33 mismatched nucleotides (indicated
by the *) exist between donor and recipient, and they are numbered from M1 to M33
depending on their closeness to the I-SceI site. The labeling of mismatched nucleotides is
opposite to the nucleotide sequence of tk: the first mismatched nucleotide is the remotest
from I-SceI, thus labeled as M33 while the last mismatched nucleotide is labeled as M1.
Mismatched nucleotides M16 and M25 are labeled here since they are first mismatched
nucleotides in substrate pBWW16 and pBWW25. Below the DNA sequence, the
nucleotides are numbered with “^” the same as in the Wagner’s (74).
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mismatched nucleotides in their hybrid donors. These substrates were linearized by
endonuclease ClaI before transfection, and Figure 2.8 shows the restriction map of these
substrates. To check the completeness of these tandem repeats after genome integration,
endonuclease BamHI and HindIII were used separately to digest genomic DNA for
Southern blot.
Construction of plasmids: pBWW1 and pBWW33 were constructed by Bryan
Wehrenberg and Barbara Waldman. pBWW1 plasmid with correct insertion and sequence
were confirmed through PCR (Figure 2.9) and DNA sequencing. AW53 and AW58
amplified the whole insertion at HindIII site of the substrate, and these 0.9 Kb PCR
products indicate one copy of donor insertion. Plasmids of 7 bacterial clones pBWW1-6
to pBWW1-12 were checked by PCR and DNA sequencing. Donor in pBWW1-8 has the
correct direction and sequence, so the plasmid was renamed as pBWW1 and used in
following experiments.
Substrate pBWW33 and pBWW25 were constructed by Bryan Wehrenberg and
Barbara Waldman, and their donors were examined and sequenced as described above.
To make substrate pBWW16, donor fragment and plasmid backbone were excised
by HindIII from pHYB121 and pBWW33, respectively. They were gel purified and
checked before ligation (Figure 2.10).
Correct pBWW16 plasmids were found through enzyme digestion (Figure 2.11)
and PCR amplification using primer pair AW53 and AW58 or AW53 and AW39 (Figure
2.12). The direction and sequence of donors were further examined through DNA
sequencing. Donor of pBWW16-2 has correct direction and sequence, so the plasmid was
renamed as pBWW16 and used in following experiments.
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Figure 2.8 Structure and restriction map of pBWW substrates.
Restriction map of pBWW substrates shows their structure after chromosomal
integration, and it also demonstrates the size of DNA fragments after HindIII or BamHI
digestion. The linearized substrate is about 9.1 Kb. They have a 0.6 Kb or a 0.8 Kb
hybrid donor flanked by HindIII sites, and a 2.5 Kb HSV-1 TK recipient flanked by
BamHI sites. The Neo cassette between donor and recipient is used for selection in
prokaryotic or eukaryotic cells.
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Figure 2.9 Identification of plasmid pBWW1 with 0.9 Kb donor insertion using primers
AW53 and AW58.
Lane 1 to 7, PCR product of pBWW1-6, 7, 8, 9, 10, 11 and 12.
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Figure 2.10 Fragments of donor and backbone were examined before ligation for plasmid
pBWW16.
Lane 1, 0.6 Kb donor. Lane 2, 8.2 Kb plasmid backbone of pBWW33.
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Figure 2.11 Identification of plasmid pBWW16 with 0.6 Kb donor insertion.
Lane 1 to 8, HindIII digestion of plasmids from clone pBWW16-1 to pBWW16-8.
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Figure 2.12 Direction of donor insertions in plasmid pBWW16 was confirmed by PCR.
Top: Lane 1 and 10, PCR product of negative control; lane 2-9, PCR product from clones
pBWW16-1 to pBWW16-8 using primer pair AW53 and AW58; Lane 11 to 18, PCR
product from clones pBWW16-1 to pBWW16-8 using AW53 and AW39. Bottom:
schema of the PCR strategy. Plasmids of pBWW16-1,2,3,4,8 have the insertion in correct
direction and they were further sequenced for accuracy.
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Substrates pBWW33, pBWW25 and pBWW16 were cut by I-SceI and examined
on gel. The digestion of pBWW16 shows it is linearized by endonuclease I-SceI (Figure
2.13).
Establishing cell lines: Substrates pBWW33, pBWW25 and pBWW16 were
linearized by digestion with ClaI (Figure 2.2 to 2.5) before transfection. The mouse Ltkcells were transfected with each substrate separately through electroporation, and then the
treated cells were selected by G418 for stable integration of the substrate. Syringe
transfection was only carried out on substrate pBWW33 once, and the treated cells were
subjected to the same G418 selection. G418 resistant clones from both methods were
screened by Southern blot to find cell lines with a single copy integration of each
substrate.
Screening cell lines with single copy integration of substrate: Genomic DNA
from each clone was digested using HindIII or BamHI, and loaded together with the
corresponding digestion of the substrate for Southern blotting. In HindIII digestion, the
cell line with intact substrate should show a DNA fragment lining up with the donor of
the substrate, and a junction fragment larger than the non-donor fragment of the digested
substrate. Similarly, in BamHI digestion, the cell line should have a 2.5Kb fragment
lining up with the recipient of the substrate, and a junction fragment larger than the nonrecipient fragment of the digested substrate. All cell lines in use were checked by both
digestions to make sure they have intact donor and recipient as well as only one junction
fragment. The copy number in cell lines was also estimated by comparing signals of
genomic DNA and the plasmid control.
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Figure 2.13 I-SceI successfully linearized pBWW16.
Lane 1, pBWW16 plasmid. Lane 2, I-SceI digested pBWW16 plasmid
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Southern blotting was carried out on pBWW25 stably transfected cell lines by
Bryan Wehrenberg and Barbara Waldman, and the results were recorded in Bryan
Wehrenberg’s undergraduate Honors thesis entitled “Homeologous Recombination in
Mammalian Cells”. Southern blot results of pBWW33 and pBWW16 were described in
this chapter, and the selected Southern blot images of pBWW33 and pBWW16 stably
transfected cell lines are shown in Figure 2.14, Figure 2.15, Figure 2.16 and Figure 2.17.
The HSV-1 TK probe recognizes the HSV-1 TK sequence in the recipient as well as that
in the hybrid donors. Cell lines were chosen for future experiments only when they had
intact donor and recipient bands, and one junction fragment of proper size. These donor
or recipient bands in selected cell lines are generally lighter than peers, so they have
better chance to have single copy integration of the substrate.
For each substrate, more than 2 cell lines with single copy integration were found.
The Southern blot results of selected cell lines pBWW33-48, pBWW33-67, pBWW16-2
and pBWW16-6 were labeled in these figures (Figure 2.14 to Figure 2.17).
Spontaneous recombination frequency and HeR frequency of examined cell
lines: Fluctuation tests were performed on selected cell lines, and the statistics and clone
frequencies are shown in Table 2.1 to Table 2.5. One additional fluctuation test was
carried out on cell lines pBWW33-67 and pBWW33-48, which have 33 mismatched
nucleotides between donor and recipient sequences.
The obtained spontaneous recombination frequencies from examined cell lines
range from 2.33X10-8 to 5.38X10-7, while their HeR frequency ranges from 1.54X10-8 to
1.83X10-7. In contrast, the homologous substrate pHR99 has recombination frequency at
5.72X10-7 with no HeR events.
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Figure 2.14 Identification of pBWW33 cell lines with correct plasmid integration through
BamHI digestion.
The size and copy number of recipient were screened as described above. Lane 1, BamHI
digested plasmid pBWW33. Lane 2 to 13, BamHI digested genomic DNA from
pBWW33 stably integrated cell lines. pBWW33-67 (lane 3) and pBWW33-48 (lane 9)
were chosen for following experiments. The sizes of selected DNA fragments are labeled
on the right side: 6.6 Kb lines up with one fragment from HindIII digested lambda DNA,
while 2.5 Kb lines up with the fragment of recipient.
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Figure 2.15 Identification of pBWW33 cell lines with correct plasmid integration through
HindIII digestion.
The size and copy number of donor were examined as described above. Lane 1, HindIII
digested plasmid pBWW33. Lane 2 to 13, HindIII digested genomic DNA from
pBWW33 stably integrated cell lines. pBWW33-67 (lane 2) and pBWW33-48 (lane 4)
were chosen for recombination experiments. The sizes of selected DNA fragments are
labeled on the right side: 8.3 Kb and 0.9 Kb line up with these two fragments from
HindIII digested pBWW33 plasmid. In lane 1, 8.3 Kb fragment is visible and pointed by
a tiny black arrowhead, while the 0.9 Kb fragment is not visible with its location marked
on the right side.
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Figure 2.16 Identification of pBWW16 cell lines with correct plasmid integration through
BamHI digestion.
The size and copy number of recipient were examined. Lane 2, BamHI digested plasmid
pBWW16. Lane 1, 3 to 13, BamHI digested genomic DNA from pBWW16 stably
integrated cell lines. pBWW16-2 (lane 3) and pBWW16-6 (lane 5) were chosen for
recombination experiments. The sizes of selected DNA fragments are labeled on the right
side: 6.6 Kb lines up with one fragment from HindIII digested lambda DNA, while 2.5
Kb lines up with the fragment of recipient.
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Figure 2.17 Identification of pBWW16 cell lines with correct plasmid integration through
HindIII digestion.
The size and copy number of donor were examined for integration of intact substrate.
Lane 1, HindIII digested plasmid pBWW16. Lane 2 to 13, HindIII digested genomic
DNA from pBWW16 stably integrated cell lines. pBWW16-2 (lane 2) and pBWW16-6
(lane 4) were chosen for further experiments. The sizes of selected DNA fragments are
labeled on the right side: 8.3 Kb and 0.6 Kb line up with these two fragments from
HindIII digested pBWW16 plasmid
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Table 2.1 Spontaneous recombination frequencies and HeR frequencies in cell line
pBWW16-2 and pBWW16-6.

Cell line

Subclone

clone
frequency
(10-8)

pBWW16-2

1

0

0

0

Homeologous
recombination
frequency
(10-8)
0

2

0

0

0

0

3

6.62

3

0

0

4

3.64

2

0

0

5

5.00

1

0

0

6

0

0

0

0

7

3.33

1

1

3.33

8

0

0

0

0

9

46.22

10

0

0

10

18.07

6

4

12.05

23

5

# of colonies
analyzed

# of Homeologous
recombinants

Total
Avg. = 8.29
pBWW16-6

Avg. = 1.54

1

0

0

0

0

2

0

0

0

0

3

26.67

6

4

17.78

4

2.78

1

1

2.78

5

6.67

2

2

6.67

6

46.67

12

9

35.00

7

0

0

0

0

8

3.33

1

1

3.33

9

0

0

0

0

10

0

1*

0

0

23

17

Total
Avg. = 8.61

Avg. = 6.56

Substrate pBWW16 has 16 mismatched nucleotides between donor and recipient.
The clone frequency was calculated for each subclone by dividing the number of HAT
resistant clones by the number of cells subjected to HAT selection. Then, the clone
frequencies of 10 subclones were averaged to generate the clone frequency of the cell
line. Similarly, for each subclone, the HeR frequency was calculated by multiplying clone
frequency of the subclone with the proportion of HeR clones in analyzed clones, and then
they were averaged to generate HeR frequency of the cell line
* one HAT resistant clone of pBWW16-6 is not spontaneous recombinant as mentioned in
following discussion, and excluded from calculation of recombination frequency.
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Table 2.2 Spontaneous recombination frequencies and HeR frequencies in cell line
pBWW25-13 and pBWW25-16.

# of
colonies
analyzed

# of Homeologous
recombinants

Homeologous
recombination
frequency
(10-8)

Cell line

Subclone

clone
frequency
(10-8)

pBWW25-13

1

3.75

1

0

0

2

0

0

0

0

3

0

0

0

0

4

3.21

1

1

3.21

5

3.14

1

0

0

6

317

10

0

0

7

24

7

7

24

8

0

0

0

0

9

0

0

0

0

10

0

0

0

0

20

8

Total
Avg. = 35.11
pBWW25-16

Avg. = 2.72

1

127.91

1

0

0

2

62.07

3

1

20.69

3

7.19

1

1

7.19

4

11.49

2

0

0

5

17.01

3

0

0

6

117.12

1

1

117.12

7

27.59

2*

0

0

8

43.86

3

0

0

9

43.35

4

1

10.84

10

80.60

3

1

26.87

23

5

Total
Avg. = 53.82

Avg. = 18.27

Substrate pBWW25 has 25 mismatched nucleotides between donor and recipient.
The clone frequency and HeR frequency were calculated as stated in Table 2.1.
* One HAT resistant clone of pBWW25-16 is not spontaneous recombinant as mentioned
in following discussion, and excluded from calculation of recombination frequency.
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Table 2.3 Spontaneous recombination frequencies and HeR frequencies in cell line
pBWW33-48.

Cell line

# of
Exp

pBWW33-48

1

2

Subclone

Clone
frequency
(10-8)

# of Colonies
analyzed

# of
Homeologous
recombinants

Homeologous
recombination
frequency
(10-8)

1

0

0

0

0

2

8.00

0

0

0

3

0

0

0

0

4

0

0

0

0

5

7.81

1

1

7.81

6

7.52

1

1

7.52

7

0

0

0

0

8

0

0

0

0

9

0

0

0

0

10

0

0

0

0

11

0

0

0

0

1
2

0
0

0
0

0
0

0
0

3

0

0

0

0

4

0

0

0

0

5

0

0

0

0

6

4.67

1

0

0

7

7.69

0

0

0

8

0

0

0

0

9

31.25

4

4

31.25

10

66.27

10

1

6.63

17

7

Total
Avg. = 6.66

Avg. = 2.66

Substrate pBWW33 has 33 mismatched nucleotides between donor and recipient. The
clone frequency and HeR frequency were calculated as stated in Table 2.1. Two
fluctuation tests were carried out on pBWW33-48, and the clone frequency or HeR
frequency were calculated by averaging that of every subclone.
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Table 2.4 Spontaneous recombination frequencies and HeR frequencies in cell line
pBWW33-67.

Cell line

# of
Exp

pBWW33-67

1

2

Subclone

Clone
frequency
(10-8)

# of Colonies
analyzed

# of
Homeologous
recombinants

Homeologous
recombination
frequency
(10-8)

1

0

0

0

0

2

0

0

0

0

3

0

0

0

0

4

0

0

0

0

5

0

0

0

0

6

3.66

0

0

3.66

7

0

0

0

0

8

0

0

0

0

9

26.55

7

7

26.55

10

0

0

0

0

1

3.45

1

0

0

2

0.00

0

0

0

3

0.00

0

0

0

4

9.62

3**

3

9.62

5

0

0

0

0

6

0

0

0

0

7

4.12

5*

0

0

8

7.25

1

0

0

9

3.68

1

1

3.68

10

3.40

1

1

3.40

19

12

Total
Avg. = 3.09

Avg. = 2.35

Substrate pBWW33 has 33 mismatched nucleotides between donor and recipient. The
clone frequency and HeR frequency were calculated as stated in Table 2.1. Two
fluctuation tests were carried out on pBWW33-67, and the clone frequency or HeR
frequency were calculated by averaging that of each subclone.
* In subclone 7 of pBWW33-67 Experiment 2, 4 out of 5 HATR clones are not
spontaneous recombinants, so the recombination frequency is obtained through the
multiplying raw clone frequency and proportion of spontaneous recombinants.
** In subclone 4 of pBWW33-67 Experiment 2, all three analyzed recombinants have
original recipient as well as HeR recipient, which indicates one recombination event
happened in cells with substrate duplication (confirmed later in Chapter 3). Thus, for this
particular subclone, the clone frequency or homeologous recombination frequency
occurring to a single copy substrate should be half of the raw clone frequency.
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Table 2.5 Clone frequencies and spontaneous recombination frequencies in cell line
pHR99-4.
# of
Colonies
analyzed

# of Homologous
recombinants

Homologous
recombination
frequency
(10-8)

Cell line

Subclones

Clone
frequency
(10-8)

pHR99-4

1

285.71

2*

0

0

2

125.79

2*

1

62.89

3

59.32

2

2

59.32

4

196.36

0

0

0

5

107.62

2*

1

53.81

6

140.22

0

0

0

7

157.89

1*

0

0

8

204.78

0

0

0

9

144.74

0

0

0

10

401.22

1

1

401.22

10

5

Total
Avg. = 182.37

Avg. = 57.72

Cell line pHR99-4 has homologous substrate pHR99, which does not have mismatched
nucleotides between its donor and recipient.
Clone frequency was calculated for each subclone by dividing the number of HAT
resistant clones by the number of cells subjected to HAT selection. Then, the clone
frequencies of 10 subclones were averaged to generate the clone frequency of the cell
line. Similarly, for each subclone, the HR frequency was calculated by multiplying clone
frequency of the subclone with the proportion of HR clones in analyzed clones and they
were averaged to generate HR frequency of the cell line.
* In cell line pHR99-4, approximately half of clones are non-recombinant, therefore, the
spontaneous recombination frequency would be much different from the clone frequency
and calculated separately case by case.
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HeR recombination events and conversion tracts during spontaneous
recombination: For each cell line, 10 to 23 clones from fluctuation tests were analyzed,
and they were categorized based on their recipient sequences (Table 2.6). The vast
majority of these collected clones removed the I-SceI insertion and restored the recipient
to a continuous tk sequence, so they belong to spontaneous recombination events. If the
recipient does not have mismatched nucleotides converted to HSV-2 TK, the
recombination event is HR event, and listed in “recipient with no mismatch” in Table 2.6.
A recombination event is recognized as HeR event only when its recipient does have
mismatched nucleotides converted to HSV-2 TK sequence.
Among these HeR events, the restored recipients always acquired the mismatched
nucleotides at position 1167, the closest mismatched nucleotide to the I-SceI site. Starting
from there, the conversion tract extended continuously to the distal end regardless where
it ended. These HeR events are thus further categorized based on whether the recipient
acquired all the mismatched nucleotides from donor, and listed in “recipient with all
mismatches” or “recipient with fewer than all mismatches” in Table 2.6. The proportion
of HeR events was calculated as the percentile of HeR events within spontaneous
recombination events. In examined cell lines, it is common to see the conversion of
HSV-1 TK sequence to HSV-2 TK sequence, and proportion of the HeR events ranges
from 22% to 75%. Cell line with the least mismatched nucleotides between donor and
recipient does not have the highest proportion of HeR events. There were sporadic clones
survived HAT selection via reactivation of mice thymidine kinase pseudogene rather than
recombination within substrate (described later in Chapter 3), and these nonrecombinants were listed in “other events” for cell lines where they arose.
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Table 2.6 Recovered recombinant clones and their conversion tracts from spontaneous
recombination.

Analyzed
clones

Recipient
with all
mismatches

Recipient with
mismatches
(fewer than all)

Recipient with
no mismatch

Other
events

Fraction of
HeR

pBWW16-2

23

5

0

18

0

22%

pBWW16-6

23

17

0

5

1

77%

pBWW25-13

20

8

0

12

0

40%

pBWW25-16

23

4

1

17

1

23%

pBWW33-48

17

7

0

10

0

41%

pBWW33-67

19

9

0

3

7

75%

Total
or
Average

125

50

1

65

9

44%

Cell Lines

If the conversion tract includes all mismatches and fewer mismatches, the event is
categorized as HeR.
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All recipients in HeR events acquired all mismatched nucleotides from donor
except one obtained in cell line pBWW25-16: the recipient of clone pBWW25-16-4-27
only acquired the first 17 mismatched nucleotides out of total 25. The collected
recombinants in current research were given a name, which is a combination of cell line,
experiment and clone number, linked by dashes.
Clone frequency and HeR frequency in examined cell lines during DSB
repair: Transfection was carried out on cell line pBWW16-2, pBWW16-6, pBWW2513, pBWW25-16, pBWW33-48, pBWW33-67 and pHR99-4. pBWW16-2 and
pBWW16-6 are cell lines of substrate pBWW16, which has 16 mismatched nucleotides
between donor and recipient within the homeologous region. pBWW25-13 and
pBWW25-16 are cell lines carrying 25 mismatched nucleotides, while pBWW33-48 and
pBWW33-67 are cell lines carrying 33 mismatched nucleotides. To collect DSB-induced
recombinants of these cell lines, pSce was transiently expressed in these cell lines. After
I-SceI introduced a DSB into the recipient, the broken recipient sequence may be repaired
and regain functional thymidine kinase. If so, colonies would form in HAT selection.
Table 2.7 lists clone frequencies and HeR frequencies of pBWW cell lines during
DSB repair and Table 2.8 lists the clone frequency and HR frequency of pHR99-4 during
DSB repair. The clone frequency was calculated for every cell lines as described in
Materials and Methods, while the HeR frequency in pBWW cell lines is the product of
clone frequency and the proportion of HeR events.
In DSB repair, the clone frequency of pBWW cell lines ranges from 1.01X10-5 to
8.53X10-5. Since almost all the HAT resistant clones in these cell lines are recombinants
precisely removing the 30 bp insertion, the clone frequency is equivalent to the
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Table 2.7 Clone frequencies and HeR frequencies of pBWW cell lines in DSB repair.
Cell line

Expt.
Number

pBWW16-2

1

Clone
frequency
(10-5)
0.56

2

pBWW16-6

pBWW25-13

pBWW25-16

pBWW33-48

pBWW33-67

# of Colonies
analyzed

Homeologous
recombinants

12

1

Homeologous
recombination
frequency (10-6)
0.47

0.63

9

1

0.70

3

0.7

9

0

0.00

4

1.91

5

2

7.64

5

1.81

6

0

0.00

1

Avg.=1.12
2.57

14

5

Avg.=1.76
9.18

2

1.92

14

3

4.11

3

1.3

16

4

3.25

1

Avg.=1.93
0.23

6

2

Avg.=5.51
0.77

2

0.25

6

3

1.25

3

0.35

7

2

1.00

1

Avg.=0.28
6.49

16

1

Avg.=1.01
4.06

2

4.45

14

1

3.18

3

4.97

15

1

3.31

1

Avg.=5.30
5.78

15

1

Avg.=3.52
3.85

2

8.15

15

4

21.73

3

12.2

16

0

0.00

1

Avg.=8.71
0.92

16

4

Avg.=8.53
2.30

2

2.51

11

1

2.28

3

2.35

12

5

9.79

Avg.=1.93

Avg.=4.79

Electroporation of pSce was carried out at least 3 times on these pBWW cell lines. The
table shows clone frequency, analyzed clones, HeR recombinants and HeR frequency of
each experiment. For each experiment, the clone frequency was calculated by dividing
the number of HAT resistant clones by the product of 5 million cells and plating
efficiency. Then, all the clone frequencies were averaged to generate the clone frequency
of the cell line. Similarly, for each experiment, the HeR frequency was calculated by
multiplying clone frequency with the proportion of HeR clones in analyzed clones, and
then they were averaged to generate HeR frequency of the cell line.
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Table 2.8 Clone frequencies and HR frequencies of pHR99 during DSB repair.

Cell line

Expt.
Number

Clone
frequency
(10-5)

Colonies
analyzed

Homologous
recombinants

Homologous
recombination frequency
(10-6)

pHR99

1

3.31

5*

3

19.86

2

3.31

0

NA

NA

3

3.43

5*

0

0.00

Avg.=3.53

Avg.=9.93

Electroporation of pSce was repeated 3 times on pHR99-4 cell lines. The table shows
clone frequency, analyzed clones, HR recombinants and recombination frequency of each
experiment.
The clone frequency of pHR99 was calculated as in Table 2.7. Moreover, the HR
frequency was calculated by multiplying clone frequency of the subclone with the
proportion of HR clone, and then they were averaged for the cell line. Since there are
non-recombinants collected during DSB repair, the HR frequency would be much
different from the clone frequency.
* pHR99-4 has some HAT resistant clones carrying unchanged recipient, which indicate
events other than DSB repair (further investigated in Chapter 3). The recombination
frequency of pHR99-4 was corrected to the product of raw clone frequency and the
proportion of DSB repair recombinants.
NA, identity of colonies in experiment 2 are not clear since they were lost during cell
culture. Therefore, the homologous recombination frequency is not available.
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recombination frequencies and used synonymous with recombination frequency. As
shown in Table 2.7, longer homeologous sequence between donor and recipient does not
reduce the clone frequency of the host cell lines. For each cell line, clone frequency of
DSB repair is 9 times or more than that of spontaneous recombination (see Table 2.1 to
2.5), which agrees well with the fact that DSB boosts the DNA recombination between
tandem repeats. Therefore, the vast majority of the collected recombinants are product of
DSB repair rather than spontaneous recombination. The clone frequencies of pBWW cell
lines with hybrid donors are equivalent or higher than that of pHR99-4 with pure
homologous donor, however, their spontaneous recombination frequencies could be ten
times lower than that of pHR99-4.
Categorization of DSB repair recombinants: Recovered clones in DSB repair
experiments were categorized based on their recipient sequences. These recombination
events, which restored I-SceI disrupted region of recipient to original HSV-1 TK
sequence, were further divided according to the number of converted mismatched
nucleotides: recipient with all mismatches, with mismatches (fewer than all) and with no
mismatch. Those events that failed in restoring a continuous TK sequence were listed as
other events, and they are most likely NHEJ events. In Table 2.9, these clones in column
“recipient with all mismatches” and column “recipient with mismatches (fewer than all)”
are HeR recombinants.
Conversion tract in homeologous recombinants: In HeR events, all or part of
the mismatched nucleotides between homeologous sequences were transferred from
donor to recipient, and Table 2.10 lists those mismatched nucleotides that were
transferred in each HeR clone.
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Table 2.9 Recovered recombination clones and conversion tracts from DSB repair.

Cell Lines

Analyzed
clones

Recipient with
all mismatches

Recipient with
mismatches
(fewer than all)

Recipient
with no
mismatch

Other
events

Fraction
of HeR

pBWW16-2

40

4

0

34

2

10%

pBWW16-6

44

11

1

32

0

27%

pBWW25-13

19

6

1

11

1

37%

pBWW25-16

42

0

3

36

3

7%

pBWW33-48

47

4

1

42

0

11%

pBWW33-67

42

5

5

31

1

24%

Total
or
Average

234

30

11

186

7

19%
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Table 2.10 Conversion tracts in HeR recombinants from DSB repair.
Total
Mismatched
Nucleotides

Converted
Mismatched
Nucleotides

pBWW16-2

16

M1 to M16

pBWW16-2-1-7, pBWW16-2-2-2,
pBWW16-2-5-3, pBWW16-2-5-9

pBWW16-6

16

M1 to M16

pBWW16-6-1-5, pBWW16-6-1-7,
pBWW16-6-1-8, pBWW16-6-1-14,
pBWW16-6-1-16, pBWW16-6-2-1,
pBWW16-6-2-12, pBWW16-6-2-15,
pBWW16-6-3-1, pBWW16-6-3-11,
pBWW16-6-3-13

M1 to M12

pBWW16-6-3-16

M1 to M14

pBWW25-16-1-B2

M1 to M25

pBWW25-16-1-C1, pBWW25-16-2-A1,
pBWW25-16-2-C2, pBWW25-16-2-C3,
pBWW25-16-3-B1, pBWW25-16-3-C2

M3 to M14

pBWW25-16-1-11

M1 to M7

pBWW25-16-2-1

M1 to M2

pBWW25-16-3-15

M1 to M33

pBWW33-48-2-16, pBWW33-48-1-5,
pBWW33-48-2-2, pBWW33-48-2-6

M1 to M2

pBWW33-48-2-14

M1 to M33

pBWW33-67-1-1, pBWW33-67-2-10,
pBWW33-67-1-18, pBWW33-67-3-3,
pBWW33-67-3-12

M1 to M5

pBWW33-67-1-5

M1 to M16

pBWW33-67-1-19, pBWW33-67-3-13

M1 to M10

pBWW33-67-3-4

M1 to M2

pBWW33-67-3-11

Cell line

pBWW25-13

pBWW25-16

pBWW33-48

pBWW33-67

25

25

33

33

Clone

For convenience, these mismatched nucleotides were numbered in an order, moving
away from the I-SceI site, as follows: the mismatched nucleotide closest to I-SceI
recognition site is named as mismatched nucleotide 1 (M1), while the farthest one is
named as mismatched nucleotide 33 (M33). The name of each recombinant in this table
is a combination of cell line, experiment and clone number, linked by dashes.
65

These HeR recombinants restored the broken recipient back to continuous TK
sequence, and also had HSV-1 TK sequence converted to HSV-2 TK sequence. In
substrate pBWW16, pBWW25 and pBWW33, the homeologous region between donor
and recipient has 16, 25 and 33 mismatched nucleotides respectively, and the details of
these mismatched nucleotides are drawn in Figure 2.5.
HeR recombinants of six pBWW cell lines are listed in Table 2.10, and their
recipient had mismatched nucleotides changed from HSV-1 TK sequence to HSV-2 TK
sequences. Among recovered HeR events, the conversion tract almost always starts from
the M1, and extends continuously toward M33. This rule applies to 40 HeR events except
for pBWW25-16-1-11, which failed to convert the two mismatched nucleotides closest to
the I-SceI site. HeR events in five pBWW cell lines have conversion tract containing all
mismatched nucleotides as well as fewer mismatched nucleotides, while HeR events in
cell line pBWW16-2 only have conversion tract including all mismatched nucleotides.
Comparison of spontaneous recombinants and DSB repair recombinants:
For each examined cell line, 19 to 46 DSB induced recombinants were analyzed and gene
conversion of mismatched nucleotides are common across these pBWW cell lines. The
proportion of the HeR events in these cell lines ranges from 7% to 37%, however, cell
lines with the least mismatched nucleotides in substrate do not show the highest
proportion of HeR events. Comparing spontaneous recombination and DSB induced
recombination, there are two major trends regarding the proportion of HeR events. First,
in the same cell line, the proportion of HeR recombinants in spontaneous recombination
is always higher than that in DSB induced recombination. Take cell line pBWW33-67 for
example: the proportion of HeR recombinants in spontaneous recombination is 80%,
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which is much more than the 24% in DSB induced recombination. Second, a cell line
with higher HeR proportion in spontaneous recombination tends to have higher HeR
proportion in DSB induced recombination, too. For example, the proportion of HeR
recombinants in pBWW33-67 is 80% in spontaneous recombination and 24% in DSB
induced recombination, and they are higher than those 41% and 11% HeR events in
pBWW33-48.
In DSB induced recombination, the restored recipient almost always acquires the
mismatched nucleotide closest to I-SceI site (M1), and from there, the conversion tract
extends continuously to the distal end no matter where it ends. Totally 40 recovered HeR
events have continuous conversion tract beginning at M1, while the conversion tract in
one event started after M1. The HeR events are categorized into “recipient with all
mismatches” if all the mismatched nucleotides were transferred to recipient, or “recipient
with mismatches fewer than all” if not. As summarized earlier in the chapter, 53 out of 54
spontaneous recombinants have “all mismatches” transferred to recipient, while in DSB
induced recombination, 30 out of 41 recombinants have “all mismatches” transferred into
recipient. After reviewing the data, apparently more HeR events with “fewer than all”
mismatches appeared in DSB induced recombination compared with spontaneous
recombination. The Fisher’s exact test comparing HeR clones in these two sub-categories
between spontaneous recombination and DSBR generates a p-value of 3X10-4, which
shows a significant difference in HeR subtypes between these two events.
Duplication of substrate in cell line pBWW33-67: Sequencing results of 9
recombinants in cell line pBWW33-67 were confusing because almost all nucleotides
after position 1215 have two readings: double peaks suddenly show up in the sequencing

67

chromatogram around the I-SceI site. A closer look of the chromatogram suggested these
recombinants appears to have one original recipient and one altered recipient by DSB
repair. Thus, these recombinants may arise from cells with duplication of the integrated
substrate, and DSB repair only happened to one of the two copies. To learn the origin of
the duplication, subcloning of cell line pBWW33-67 was carried out to obtain discrete
subclones that only contain descendants from a single cell. All subclones are named by
their parental cell line, initial of “subclone” and clone number. For example, subclone
number 1 is called pBWW33-67S1. Copy number of substrate in these subclones was
checked by Southern blot.
Southern blot was carried out to check substrate’s copy number in 24 subclones of
pBWW33-67. Figure 2.18 examined the substrate's copy number in the first 12 subclones
of pBWW33-67. As exemplified in this figure, pBWW33-67S11 shows darker bands of
donor and recipient, which indicates duplication of the substrate in this subclone. Among
the remaining 12 subclones, another subclone, pBWW33-67S20, shows the same
duplication of the substrate (data not shown here). To learn more about the duplication,
HindIII digestion was used to cut the integrated plasmid into a 0.87 Kb donor fragment
and a junction fragment composed of plasmid sequence, 2.5Kb recipient and nearby
genomic sequence at integration site. Figure 2.19 demonstrates that after HindIII
digestion, the bands in normal subclones (lane 2 and lane 4) are the same as those in
subclones with duplicated substrate. Since junction fragments of these subclones are the
same as other cell lines, two copies of substrate in pBWW33-67S11 and pBWW3367S20 are most likely due to a DNA duplication event involving the integrated substrate,
rather than two separate substrate integration events. The duplication of substrate exists
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Figure 2.18 Duplication of the substrate happened in some subclones from cell line
pBWW33-67.
Lane P, HindIII and BamHI digested plasmid pBWW33; Lanes 1 to 12, HindIII and
BamHI digested genomic DNA from cell line pBWW33-67S1 to pBWW33-67S12.
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Figure 2.19 Junction fragments in cell line pBWW33-67S11 and pBWW33-67S20
remain the same after duplication of the substrate.
Lane 1, HindIII digested pBWW33-67S11; Lane 2, HindIII digested pBWW33-67S12;
Lane 3, HindIII digested pBWW33-67S20; Lane 4, HindIII digested pBWW33-67S21.
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in a small portion of the cell population, independent of electroporation, so it is probably
a product of a duplication event several generations after the integration of substrate.
Other examined cell lines did not show the duplication of substrate.
In the current analysis, these 9 unexpected recombinants from pBWW33-67 were
not listed in tables because they are a relatively small portion of the DSB induced
recombinants, and the duplication confounds analysis.
Discussion:
Type of spontaneous recombinants: In current work, the majority of
spontaneous recombination events are categorized into two groups: HR event and HeR
event. In addition to recombination events, other type of events did happen in fluctuation
tests: recipient in clone pBWW16-6-4-15 shows no sequence change, and the same thing
happened in cell line pBWW33-67. These events are most likely reactivation of mouse
thymidine kinase, and they were further investigated in Chapter 3.
Type of DSB-induced recombinants: DNA double-strand breaks in mammalian
cells are usually repaired through non-homologous end joining (NHEJ), homologous
recombination (HR) and single strand annealing (SSA) (30, 34, 78). Since the donor has
truncation at both 5’ and 3’ end, the SSA or crossover events between donor and recipient
cannot produce functional thymidine kinase. In the current experiments, recombinants
only came from gene conversion events between donor and recipient, as well as minor
NHEJ events (53, 55).
All collected recombinants are divided into 3 groups for clarity. HR and HeR
events are separated from NHEJ events based on whether repair of DSB restored the
broken DNA sequence back to a continuous tk sequence. HR events only restore the I-
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SceI disrupted region of recipient using HSV-1 TK sequence from the donor, therefore
the restored recipient loses the 30bp oligonucleotide insertion previously engineered into
its HSV-1 TK sequence. If the restored recipient sequence has mismatched nucleotides
converted to HSV-2 TK sequence besides losing the 30 bp insertion, the event is
recognized as HeR. In comparison, recipient sequences in NHEJ events lose base pairs at
DSB site, however, it is not precise excision of the 30 bp oligonucleotide insertion that
happened in HR events. Though NHEJ events may have chance to remove the 30 bp
insertion precisely like HR events, the probability and impact on current analysis are
minor: previous experiments show the pure NHEJ events happened at dramatically low
clone frequency, without providing a homologous donor for DSB repair.
High frequencies of HeR events were observed in pBWW substrates during
spontaneous recombination: Previously, we demonstrated that HR barely happens
between highly diverged sequences. Spontaneous recombination between HSV-1 TK
recipient and HSV-2 TK donor sequences was never recovered from previous
experiments using pHOME (55, 73). Use of a HSV-1 TK and HSV-2 TK hybrid sequence
as donor allowed recombination to happen between a tandem repeat, however, only 1 of
81 recombinants from pHYB21A and pHYB12-8 had conversion of HSV-1 TK recipient
to HSV2 TK sequence, far less than NHEJ or homologous recombination events that
occurred within HSV-1 TK sequence (53). Using a hybrid donor composed of HSV-1 TK,
HSV2 TK and HSV-1 TK sequences, the pHYB121 has recombination frequency
equivalent to previous substrates. However, in 11 out of 39 recombinants converted the
HSV-1 TK sequence of recipient to HSV-2 TK sequence, and the mismatched nucleotides
were transferred all at once (53). These events clearly show HR restored the HSV-1 TK
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recipient using the hybrid donor, and incorporated donor’s HSV-2 TK sequence into
recipient frequently if HSV1-TK sequences are on both sides of HSV2-TK sequence.
Recombination events from these previous substrates allow us to postulate that as long as
perfect homology is available on both sides, the homeologous region could be processed
by HR, and leave conversion tract on the recipient sequence.
In current work, the potential surveillance against exchange between
homeologous sequences was scrutinized extensively. Three new substrates have hybrid
donor composed of HSV-1 TK, HSV-2 TK and HSV-1 TK sequences, and their donors
differ in the length of HSV-2 TK sequences. Ranging from 60 bp to 199 bp, these HSV-2
TK sequences have 16, 25 or 33 mismatched nucleotides compared with HSV-1 TK
sequence. Two cell lines of each substrate were examined in fluctuation test (summarized
in Table 2.11): recombination frequencies of these substrates are around 10-8 and 10-7,
and they have HeR frequencies at 10-8 except pBWW25-16 is at 1.83X 10-7. Compared
with the HeR events between HSV-1 TK recipient and hybrid donor composed of HSV-1
TK and HSV-2 TK sequence (pHYB21A or pHYB12-8), HeR events happened within
these new substrates are substantial, and their clone frequency and proportion of HeR
events are similar to previous substrate pHYB121. The results confirmed that homology
on both sides of the homeology ensures the removal of the I-SceI insertion through HR as
well as facilitates HeR events.
Recombination and HeR events are not affected by length of homeologous
region in both types of recombination: Cell lines of substrate pBWW25 have average
recombination frequency at 4.38X10-7, close to 5.72X10-7 from cell line of pHR99, at
least 5 times more than other cell lines; while their average HeR frequency is
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Table 2.11 Comparison of clone frequencies, HeR frequencies and fractions between
spontaneous recombination and DSB-induced recombination.
Spontaneous Recombination

DSB-induced Recombination

Cell line

Recombination
frequency
(10-8)

HeR
frequency
(10-8)

HeR
fraction

Recombination
frequency
(10-5)

HeR
frequency
(10-6)

HeR
Fraction

pBWW33-48

6.66

2.66

41%

8.71

8.53

11%

pBWW33-67

3.09

2.35

80%

1.93

4.79

24%

pBWW25-13

35.11

2.72

40%

0.28

1.01

37%

pBWW25-16

52.44

18.3

23%

5.3

3.52

7%

pBWW16-2

8.29

1.54

22%

1.12

1.76

10%

pBWW16-6

8.61

6.56

77%

1.93

5.51

27%

pHR99-4

57.72

NA

NA

0.99

NA

NA

Cell line pHR99-4 has homologous donor and recipient, therefore, HeR frequency and
HeR fraction are not applicable to this cell line. Moreover, recombination frequencies of
pHR99-4 are dramatically different from its clone frequency since many HAT resistant
clones from it are not recombinants.
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1.05X10-7, at least 2 times more than that of other substrates. Cell lines of pBWW16 only
have slightly higher average clone frequency and HeR frequency than those in cell lines
of pBWW33. Spontaneous recombination frequencies of these 6 cell lines suggest
homeologous region does not necessarily bring down the clone frequency and HeR
frequency. Apparently, the scrutiny and abortion against the exchange between
homeologous sequences in examined cell lines are minor, compared with tens of folds
fastidious rejection against evenly distributed homeology (79). If the rejection is effective
within current substrates during spontaneous recombination, longer homeologous region
would incur stronger rejection and should be harder to penetrate than a shorter one.
To sum up, the data of spontaneous recombination does not support substantial
rejection against exchange between homeologous sequences, since no correlation was
found between HeR clone frequencies and the length of homeologous region neighboring
the I-SceI site. In contrast, mismatched hDNA in initiation stage faces vigorous scrutiny
and rejection shown by both in vitro and in vivo assays (56, 79).
In examined substrates, the homeology does not impede the spontaneous
recombination process upon successful initiation on either side. Spontaneous
recombination events in substrate with even longer homeologous region could be
explored in future, however, for examined substrates, no measurable impediment was
observed in genetic exchange between homeologous region at least up to 200 bp.
During DSB repair, the clone frequency and HeR frequency of the two cell lines
with the same substrate are not dramatically different from that of other cell lines. Oneway ANOVA comparing HeR clone frequencies in 3 substrates during DSB repair give a
p-value equals 0.2954, while the same test comparing clone frequencies in 3 substrates
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give a p-value equals 0.0624. The performed ANOVA tests failed to find significant
difference in frequencies between 3 examined substrates. Interestingly, the two cell lines
carrying the 33 mismatched nucleotides have the highest average clone frequency and
HeR frequency. In summary, during DSB repair, longer mismatched sequence does not
decrease HeR frequency or fraction of HeR events across examined cell lines. Data in the
current chapter failed to show fastidious rejection against genetic exchange between
homeologous sequences during DSB repair.
Higher spontaneous clone frequency and HeR frequency in pBWW25 cell lines
are likely due to its longer homology than the other two substrates. The donor of
pBWW25 has the same 300 bp downstream HSV-1 TK sequence as the other two
substrates, while it has 400 bp upstream HSV-1 TK sequence, about 100 bp longer than
the other two substrates. As demonstrated by Huang and other researchers (26, 71),
efficient recombination depends on availability of continuous uninterrupted homology,
and the recombination frequency is in linear relation with the length of homology once
the homology exceeds the MEPS. In these pBWW substrates, the homeologous sequence
inside donor reduced the continuous homology for HR, thus they have lower clone
frequency compared with substrate pHR99. The substantially longer homology of
substrate pBWW25 likely brought clone frequency higher than other pBWW substrates,
though the position of substrate integration may contribute to these higher frequencies as
well.
HeR events are common in both spontaneous recombination and DSB repair:
In Table 2.11, the proportion of spontaneous HeR recombinants ranges from 22% to 80%,
showing the mismatched nucleotides are easily transferred from donor to recipient.
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Similar to the observation in spontaneous recombination, analysis of DSB repair
recombinants supports that DSB provoked recombination frequently proceeds from the
homologous region into a homeologous region. When a DSB was introduced into HSV-1
TK recipient, 41 out of 227 recombination events have homeologous conversion tracts,
indicating frequent use of homeologous sequence during DSB repair. Among the
examined cell lines, 7% to 37% HeR events were found after DSB repair, so the genetic
exchange between homeologous sequences is a common phenomenon during DSB repair.
HeR events are not affected by length of homeologous region in both types of
recombination: In spontaneous recombination, recombination between sequences with
33 mismatched nucleotides has even higher proportion of HeR events, which contradicts
with the idea that cluster of mismatches triggers rejection and destruction. Otherwise,
longer homeologous sequence in pBWW33 would incur more rejection, and cause lower
proportion of HeR events compared with shorter ones.
Similar to the finding in spontaneous recombination, there is no obvious rejection
against homeologous exchange during DSB repair. For example, cell lines pBWW16-2
and pBWW16-6 have a substrate harboring the shortest homeologous region, but their
fractions of HeR events are not the highest among examined cell lines.
Trends in proportion of HeR events: Two trends in the proportion of HeR
events were described in results. First, the proportion of HeR events during DSB repair
has positive correlation with that in spontaneous recombination. A cell line with more
HeR events in spontaneous recombination is likely to have more HeR events during DSB
repair. So, the proportions of HeR events are probably determined by a combination of
multiple factors, including origin of recombination, genetic background, substrate’s
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integrated site and other unknown factors. Second, within the same cell line, the
proportion of HeR events in spontaneous recombination is always higher than that in
DSB repair. With the same genetic background, higher proportion of HeR in spontaneous
recombination does suggest different underlying mechanism from DSB induced
recombination. Examination of the substrates’ structure reveals that DSB provoked
recombination is most likely initiated in downstream HSV-1 TK sequence of donor, while
spontaneous recombination has another continuous homology, the upstream HSV-1 TK
sequence of donor, to start recombination events efficiently. The recombination events
initiated in upstream HSV-1 TK sequence and resolved in downstream HSV-1 TK
sequence only produce HeR recombinants, therefore, with these HeR events added to the
pool of HR and HeR events initiated in downstream HSV-1 TK sequence, the fraction of
HeR events in spontaneous recombination would surely be higher than in DSB repair.
Different homology preference of DSB repair: As postulated before, in
spontaneous recombination events, conversion tract rarely ends in homeologous region,
converting some of the mismatched nucleotides: out of 53 clones, only 1 clone has
conversion tract terminated in middle of homeologous region (Table 2.12). In the study
of DSB repair events, out of 41 identified HeR clones, 11 clones have conversion tract
ended in homeology, only converting part of these mismatched nucleotides between
donor and recipient. Comparing the location where conversion ends in two situations, the
Fisher’s exact test generates a p-value of 3X10-4, showing a dramatic difference between
spontaneous recombination and DSB induced recombination. Current data clearly
demonstrates that spontaneous recombination tends to resolve in the homologous region,
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Table 2.12 Transfer of mismatched nucleotides between donor and recipient differs in
spontaneous recombination and DSB-induced recombination.

Spontaneous Recombination
Number of
Mismatches
33

25

16

Cell line

DSB-induced Recombination

pBWW33-48

Fewer than all
mismatches
0

All
mismatches
7

Fewer than all
mismatches
1

All
mismatches
4

pBWW33-67

0

12

5

5

pBWW25-13

0

8

1

6

pBWW25-16

1

4

3

0

pBWW16-2

0

5

0

4

pBWW16-6

0

17

1

11

1

53

11

30

Total
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while DSB provoked recombination frequently resolves in middle of homeologous
region.
In a fluctuation test, a recombination event may generate many clones with the
same conversion tract, so to get an estimation of discrete events, these identical clones
arising from the same subclone are counted as one event. And the discrete events counted
in this way are named as minimal spontaneous recombination events, a conservative
estimation of real recombination events. If one counts the minimal spontaneous
recombination events, the number of these spontaneous events converting all mismatched
nucleotides is 21 while the number of spontaneous events converting part of mismatched
nucleotides is only 1. If minimal spontaneous recombination events are used instead of
actual recombinants number, a Fisher’s exact test comparing HeR events changing partial
or all mismatched nucleotides between spontaneous recombination and DSB repair
generates p-value of 0.0433. The new test is more stringent than previous one using
recombinants number. However, it still supports a significant difference between
spontaneous recombination and DSB induced recombination.
Probable mechanistic differences behind the two types of recombination and
their homology preference: Variances in mechanisms may cause the difference between
spontaneous recombination and DSB provoked HR in choosing the resolution site. DSBR
and SDSA models (Figure 1.1) provide satisfactory explanation of how cells repair DSB
in mitotic cells (7). SDSA is considered as a major and preferable pathway to generate
gene conversion events during mitosis (19). Different from DSBR, after strand invasion
and DNA synthesis, the newly synthesized strand anneals back to the other resected
broken end for ligation, which abrogates the second strand capture and double strand HJs
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steps. SDSA tends to generate recombinants with unidirectional conversion tracts
although occasionally it does allow two strand invasion and bidirectional conversion
tracts (69). Moreover, without forming HJs, SDSA won not mediate crossover events
between donor and recipient, which are only achieved by HJs resolution in DSBR model
(7). Crossovers are not collected or discussed in the current experiments since crossover
within pBWW substrates only produces recombinants carrying a truncated tk gene, and
thus is unable to survive the HAT selection.
Spontaneous recombination may be due to repair of spontaneous occurring DSBs,
through either SDSA or DSBR pathway, as described above. Spontaneous recombination
may also start to restore the collapsed or stalled replication forks when the replication
machinery meet DNA lesions on parental strands (Figure 1.2). Moreover, template
switching or replication slippage may explain these obtained recombinants as well.
What remains to be explored is the underlying mechanism of relaxed homology
requirement during DSB repair. Probably, DSB repair experiments collected
recombinants repairing the homeologous sequence near a DSB, while the genetic
exchange in collected spontaneous recombinants likely started from an unknown site
some distance away. Or, the difference lies in how HR resolves the exchange between
participating molecules: HJs need to be resolved during DNA recombination restoring
replication forks while as a predominant pathway in DSB repair, SDSA does not employ
HJ intermediate. More discussion and efforts to investigate the difference in homology
requirement between spontaneous recombination and DSB-induced recombination are
continued in Chapter 4.
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CHAPTER 3 DNA MISMATCH REPAIR’S ROLE IN SPONTANEOUS
AND DSB-INDUCED RECOMBINATION
DNA mismatch repair (MMR) is a critical pathway to maintain the genome’s
fidelity during cell proliferation (58). When cells produce descendants through
continuous divisions, their genomes need to be replicated timely and correctly. The major
DNA polymerase employed in DNA replication is faithful due to a proofreading
mechanism, and the errors occur at 1 in every 100,000,000 nucleotides (80). Though the
risk is low, it cannot be neglected considering size of the genome and repetitive cell
divisions. Moreover, when cells are threatened by endogenous or exogenous stresses,
normal replication could be stalled by altered DNA structures. In these situations, other
error-prone translesion polymerases may replace the high-fidelity polymerase, and carry
on DNA synthesis with a dramatically high error rate. Sometimes, the translesion
polymerases may even synthesize random DNA sequence to overcome temporary lesions
(81, 82). If not fixed properly, these mutations which arise from DNA replication will
accumulate and cause gradual deterioration of the genome. MMR is the major strategy
cells adopt to combat replicative errors. MMR deficiency in bacteria, as demonstrated by
many mutants, will cause high mutation rates in these strains, and deficiency of MMR
elevates spontaneous mutations in human cells as well (83). MMR deficiency associates
with vast majority of the human cancers and actually leads to cancer directly as shown in
certain hereditary nonpolyposis colorectal cancer (HNPCC) (60).
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MMR recognizes the DNA mismatches introduced by replicative errors, makes
incision on one of the mismatched DNA strands, degrades and re-synthesizes the excised
strand under the guidance of the complementary strand (84, 85). During MMR, the newly
synthesized strand is always chosen for degradation, therefore, cells restore the
mismatched DNA sequence back to the original parental sequence (86). In gram-negative
bacteria, transient hemimethylation allows MMR to recognize and destroy newly
synthesized strand and keep the methylated strand as template. In other bacteria and
eukaryotes, further investigation is needed to reveal how MMR targets the newly
synthesized DNA strand for degradation. Some reports suggest that temporary nicks
occurring on newly synthesized strands will signal the MMR for destruction while others
show the asymmetric orientation of replicative machinery may assist MMR to find the
newly synthesized target strand.
In bacteria, MMR has three major components working cooperatively to
recognize and repair mismatched nucleotides. MutS family members perform their
function as a dimer: they detect the distortion in DNA double helix caused by
mismatched nucleotides, and signal for downstream effectors (57). MutLs and MutHs
will form complex with the MutS dimer and recruit endonuclease, DNA helicase, and
exonuclease for strand degradation. In eukaryotes, there are two types of MutS complex:
Msh2/Msh6 detects base substitution and small loops while Msh2/Msh3 screens for small
loops or larger loops.
MMR has been proposed to play more than one roles in HR (54). MMR may
target and repair nucleotide mismatches in heteroduplex DNA (hDNA) left by HR events.
At several steps of HR, the hDNA intermediates are formed through annealing DNA
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strands from two homologous sequences. After HR resolved these two DNA sequences, a
stretch of foreign strand might be left in one DNA molecule as hDNA. These
mismatched nucleotides within hDNA would be the obvious target of MMR. Repair of
the hDNA by MMR either restores the original DNA sequence or converts it to the
template sequence. Second, MMR scrutinizes the strand paring between HR substrates
and prevents recombination between diverged sequences as discussed in Chapter 3. In
yeast, without functional MMR, the frequency of HeR events between diverged
sequences will raise 100 times to that between identical sequences (66). Although the
mechanism and protein components involved in rejection are still in debate, the rejection
occurs as early as strand invasion and D-loop formation (57, 87).
As shown in the previous chapter, in either spontaneous recombination or DSB
induced recombination, it is common to see nucleotide mismatches transferred from
hybrid donor sequence to HSV1-TK recipient sequences. However, the generation of
these HeR events is not clear. First, the homeologous sequence may be lost during the
earlier steps in breakage, end resection and degradation before the strand invasion. So the
restored recipients with HSV2-TK sequence are solely products of DNA gap repair,
which re-synthesized the lost DNA according to its homologous template. Second, as
described in Chapter 1, the hDNA annealing homeologous sequences could form during
initial strand invasion or HJs migration, so after HJ resolution, MMR may repair
nucleotide mismatches either toward HSV2-TK sequence (HeR events) or HSV1-TK
sequence (HR). Third, in SDSA pathway, resected HSV-1 TK DNA strand and newly
synthesized HSV2-TK strand may anneal and ligate with each other with help from
nearby homologous sequences, while MMR fixes the mismatched nucleotides afterward.
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Abrogation of MMR was achieved in selected cell line pBWW33-67 by stably
transfection of MSH2 shRNA. Through analysis of the recombinants in absence of
MMR, it is possible to reveal the molecular intermediate of HeR events and help to piece
together the process for previously observed HeR events. At the same time, comparing
the HeR frequency before and after MSH2 knockdown, it is possible to see whether
MMR prevents HeR events from happening within pBWW substrates. Moreover, it is
also possible to see whether MMR affects the resolution site of DNA recombination.
Materials and Methods:
Stable knockdown of MSH2 in cell lines pBWW33-67: To make experimental
and control cell lines for the MSH2 knockdown experiment, cell line pBWW33-67 was
transfected with MSH2 shRNA#3 (target sequence is 5’ CCG GCC CGG CAA TCT TTC
TCA GTT TCT CGA GAA ACT GAG AAA GAT TGC CGG GTT TTT G 3’ for mouse
Msh2 gene) or Control shRNA#1 (non human or mouse shRNA, target sequence is 5’
CCG GCA ACA AGA TGA AGA GCA CCA ACT CGA GTT GGT GCT CTT CAT
CTT GTT GTT TTT 3’). MSH2 shRNA #3, TRCN0000042493, was obtained from the
MISSION TRC shRNA bacterial glycerol stock library (Sigma), while Control shRNA
#1, SHC002, is one of the MISSION shRNA Control Vectors from Sigma. pBWW33-67
cells were plated in 35 mm dishes, and one day later, 0.8 ug shRNA plasmid was
prepared and transfected into cells using Qiagen Effectene as instructed by the supplier.
Two days after the transfection, the cells were trypsinized and about 2 million cells were
plated in one T75 flask for puromycin selection at 5 ug/mL. Two weeks later, puromycin
resistant colonies from the shRNA transfections were picked, cultured and stored
separately.
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6-Thioguanine (6-TG) resistance test: To check 6-TG's effect on obtained cell
lines, 100 cells were plated in each T25 flask. The flasks were refilled with media
containing different concentrations of 6-TG on the second day and then changed back to
regular media on the third day. After 14 days, viable colonies were stained with
Methylene blue and counted as described before. The colonies number in 6-TG treated
flask was divided by that in control flask to give survival rate for each cell line. To screen
the obtained cell lines, 4 uM 6-TG was used in the first round of tests. Selected cell lines
were subjected to a second round of tests to estimate of their resistance, and the 6-TG
concentrations include 0.5 uM, 2 uM, 4 uM and 8 uM.
Preparation of protein sample: To exact soluble protein samples, cells were
trypsinized and suspended in 5 mL culture media. The cell suspension in a 15 mL conical
tube was centrifuged at 300 x g for 3 minutes, and then the pelleted cells were washed
with 1.5 mL ice cold PBS and transferred into a 1.5 mL Eppendorf tube. After the second
centrifugation at 1,500 x g for 3 minutes, the newly pelleted cells were mixed with 30 uL
lysis buffer (RIPA buffer: 50 nM Tris-HCl, 150 nM NaCl, 1 mM EDTA, 0.1% SDS, 1%
deoxycholate and 1% Triton x-100, PH 7.4, mixed 1/10 v/v proteinase inhibitor cocktail,
Sigma Cat. P8340). The cell clumps were broken up through repetitive pipetting, and the
cell lysis was incubated on ice for 30 minutes. All obtained protein samples were stored
at -80˚C until use. Before western blotting, the thawed cell lysis was centrifuged at
10,000 x g for 10 minutes at 4˚C, and the supernatant was transferred into a new tube.
Protein electrophoresis and transferring: Protein samples were freshly
prepared before electrophoresis: 30 ug protein sample was mixed with 6 X SDS sample
buffer (300 mM Tris-HCl, 600 mM DTT, 12% SDS, 30% Glycerol and 0.06%
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Bromophenol blue, pH 6.8) and additional lysis buffer to reach the same final volume
across samples. The sample mixture was incubated at 95˚C for 5 minutes, and then
briefly spun down.
All protein samples were separated on 8% polyacrylamide gels in 1 X SDS
running buffer (25 mM Tris base, 192 mM Glycine and 0.1% SDS). For one gel, the
current was set at 15 mA while samples moved in the 4% stacking gel and then switched
to 19 mA after samples entered the 8% separating gel. The electrophoresis was stopped
once the 37 KD protein marker approached the end of the separating gel.
The 1 x transfer buffer (25 mM Tris base, 192 mM Glycine, 0.1% SDS and 20%
methanol) was prepared in advance and cooled at 4˚C before use. After the
electrophoresis ended, the gel was disassembled from the cassette and the stacking gel
was cut off from the separating gel. The separating gel was soaked in 1 x transfer buffer
and shaken slowly for 15 minutes. During the time, the nitrocellulose membrane
Amersham Hybond ECL from GE was wet with deionized water as instructed by the
supplier, and then soaked in 1 x transfer buffer together with filter paper, and the foam
filter pad.
The transfer “sandwich” was assembled in following order: black plate, filter pad,
filter paper, gel, membrane, filter paper, filter pad and white plate. Bubbles between
layers were gently driven out by a rolling test tube across the “sandwich”. The transfer
“sandwich” was put into the electrode assembly and then inserted into the tank with 1 x
transfer buffer. The protein transferring was carried out at 100 volts for 90 minutes unless
specified separately. During the transferring, the tank was incubated in an ice water bath,
and an ice cooling pad was kept in the tank as well.
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Western blot: After transferring, the membrane was washed briefly in 1 X Trisbuffered saline (TBS), and incubated in blocking buffer (5% non-fat milk and 0.1%
Tween-20 in TBS) for 1 hour at room temperature. Primary antibody was diluted
empirically in 10 mL blocking buffer, and the overnight incubation of the membrane was
carried out in a suitable petri dish with slow agitation at 4˚C. On the second day, the
membrane was rinsed briefly in wash buffer before three consecutive washing steps. The
membrane was washed with slow agitation for 5 minutes each time in 100 mL wash
buffer and the washing buffer is TBS with 0.1% Tween-20 (0.1% TBST) unless
otherwise specified.
Secondary antibody was diluted empirically in 10 mL blocking buffer, and the
incubation was set at room temperature for 1 hour with slow agitation. After incubation
with the antibody, three washing steps were carried out as described before except the
last wash took 10 minutes.
The detection was performed using Amersham’s ECL Select as instructed by the
supplier. Equal volume of solution A and solution B were mixed, and then the
membranes were immersed in the mixture for 5 minutes in the dark. The membrane was
drained of excessive liquid and wrapped in Saran wrap for chemiluminescent detection.
Western blot detecting MSH2 expression: expression of MSH2 in selected cell
lines was examined through western blot using MSH2 antibody from NOVUS (Cat# NB
100-621). The western blot process was described above and the differences in loading
and blotting were listed below. For electrophoresis, 30 ug Protein sample of selected cell
lines was separated on 8% polyacrylamide gel, and then transferred onto Amersham
Hybond ECL nitrocellulose at 400 mA for 90 minutes. The membrane was cut through
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75KD to separate MSH2 and β-tubulin for subsequent immune-blotting. MSH2 primary
antibody was applied at 1:15,000 in Tris buffered saline (TBS) with 3% non fat milk
(NFM), and the secondary antibody (Goat polyclonal antibody to Rabbit IgG, HRP
conjugated from NOVUS, Cat# NB 730-H) was added at 1: 100,000 in TBS with 3%
NFM. For β-tubulin, the primary antibody (mouse monoclonal antibody from SANTA
CRUZ, Cat# sc-5274) was applied at 1: 10,000 in 0.1% TBST with 5% NFM and the
secondary antibody (goat anti-mouse IgG-HRP, Cat# sc-2005) was applied at 1: 10,000
in 0.1% TBST with 5% NFM as well. For both proteins, the primary antibody was
incubated overnight at 4°C, and secondary antibody was incubated at room temperature
for 45 minutes. The washing buffer for MSH2 was TBS with 0.05% Tween-20 (0.05%
TBST), while 0.1% TBST was used for tubulin. Three washes were performed after each
incubation for 5 minutes. Finally, the membranes were developed using Amersham ECL
Select Western Blotting Detection Reagent (GE).
Collection and analysis of spontaneous recombination through fluctuation
test: To collect spontaneous recombinants in pBWW33-67 derivative cell lines, 10
subclones were cultured from 100 cells up to 40 million cells before HAT selection, as
described in Chapter 2.
Collection and analysis of spontaneous recombination through modified
fluctuation test: A modified fluctuation test was attempted on pBWW33-67 to collect
the recombination clones containing all descendants of a spontaneous recombination
event. Each subclone was cultured from 100 cells up to 4 million cells in the modified
test, and then these 4 million cells were separated into 4 T175 flasks. The cells in each
T175 flask were grown for another 3 days before subjected to HAT selection without
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counting and re-plating. Recombinant clones were collected and analyzed as described
before.
Collect and analyze DSB repair recombinants: To collect DSB provoked
recombinants of pBWW33-67 derivative cell lines, the electroporation and HAT
selection were done as described in Chapter 3.
PCR amplification and sequencing: The PCR and sequencing procedures were
described in Chapter 2. Moreover, nucleotide callings at every mismatched postilion (M1
to M33) were checked manually on the chromatograms when conversion occurred to
recipient, in order to see whether nucleotides of donor and recipient both appear at each
mismatched position.
Subcloning: To separate different cell populations within a DSB repair
recombinant, subclones of existing cell lines were obtained as described in Chapter 2.
The recipient sequences in newly established subclones were amplified, sequenced and
compared with their parental recombinant.
Drug resistance tests on tk function: To check the function of tk in selected cell
lines, the cells were tested with Trifluorothymidine (TFT) and Gancyclovir (GCV).
100,000 cells were plated into each T25 flask, and 4 hours later, these flasks were refed
with media containing 5 ug/uL TFT or 10 uM/uL GCV. After 3 days, the cells in these
flasks were examined under the microscope at day 3 and day 6.
RNA extraction: RNA from selected cell lines was extracted using Qiagen
Rneasy Mini Kit as instructed by the supplier. About 3 million cells in a T25 flask were
trypsinized, collected and lysed with supplied buffer. The cell lysate was homogenized by
passing through a blunt 20-gauge needle at least 5 times.
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RT-PCR and sequencing: qScripts XLT One-Step RT-PCR Kit was used with
primer pair AW109 (5’ TAA TAC GAC TCA CTA TAG GGA AGT AGC ACA GGC
GGC ACA C 3’, downstream primer matches the seventh exon of mouse TK sequence)
and AW100 (5’ GAT TTA GGT GAC ACT ATA GGC TGC CAT GAG CTA CAT
CAA TC 3’, upstream primer matches the first exon of mouse TK sequence) to amplify
the mRNA transcripts of mouse thymidine kinase. The RT-PCR was carried out in a final
volume of 25 uL with 500 ng sample RNA and 400 nM each primer. The RT-PCR begins
with cDNA synthesis at 48ºC for 20 minutes, and then the initial denaturation at 94ºC
takes 3 minutes. The subsequent 32 PCR cycles include 20 seconds denaturation at 94ºC,
1 minute annealing at 55ºC and 90 seconds elongation at 72ºC. The final elongation step
is done at 72ºC for 10 minutes.
These RT-PCR products were separated on 0.8% agarose gel and the 612 bp
target band in these samples was cut out for PCR amplification. The excised gel piece
was frozen overnight, and then centrifuged at 16,100 x g for 3 minutes to pellet the
agarose gel. The second PCR with AW109 and AW110 was carried out as described in
Chapter 2 using 1 uL of the resulting supernatant.
PCR amplification of mouse thymidine kinase pseudogene: The mouse
thymidine kinase pseudogene in selected cell lines was amplified using AW109 and
AW100 as described in Chapter 2. Their sequences were aligned to the reference mouse
tk sequence to check for any nucleotide change.
Results:
Establishing cell lines used in MSH2 knockdown experiments: Twelve stably
transfected cell lines were obtained from control shRNA transfections performed on
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pBWW33-67, while another 12 stably transfected cell lines were obtained from MSH2
shRNA transfections. These cell lines were named for their parent cell line, initial of
experiment group and clone numbers. The cell lines with integration of control shRNA
were named from pBWW33-67C1 to pBWW33-67C12, while the cell lines carrying
MSH2 shRNA were named from pBWW33-67M2 to pBWW33-67M13.
Selecting cell lines for recombination assays: To initially screen for MMRdeficient cell lines and control cell lines, all established cell lines were subjected to
survival test in 4uM 6-TG, whose genotoxicity is mediated by MMR (88). As listed in
Table 3.1, half of the stable cell lines from MSH2 shRNA transfections have 21% or
higher survival rate, showing substantial resistance to 6-TG. In contrast, almost all cell
lines from control shRNA transfections were sensitive to 6-TG just like the parental cell
line pBWW33-67. Only one clone pBWW33-67C2 has a 14% survival rate, but this is
still lower than aforementioned 6-TG resistant clones from MSH2 shRNA transfection.
pBWW33-67M13 and pBWW33-67M11 have the highest survival rates, so they were
selected for western blot analysis together with control cell lines pBWW33-67C6 and
pBWW33-67C8, which were sensitive to 6-TG just like the parental cell line. These four
cell lines were subjected to a second round of 6-TG testing at different concentrations to
better estimate their MMR functionality, and the results are listed in Table 3.2.
Western blot in Figure 3.1 shows expression of MSH2 in selected cell lines, and
about 6 to 10-fold reductions were observed in MSH2 knockdown cell lines, compared
with parental cell line or control cell lines. The MSH2 expression in pBWW33-67M5,
pBWW33-67M11 and pBWW33-67M13 reduced dramatically while its expression in
pBWW33-67C6 and pBWW33-67C8 did not. Interestingly, the MSH2 expression in
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Table 3.1 Preliminary 6-TG resistance test on 22 stable cell lines carrying control shRNA
or MSH2 shRNA .

Experimental
groups

Cell Lines

# of colonies
in 0uM 6-TG

# of colonies
in 4uM 6-TG

Survival Rate

Parental

pBWW33-67

89

1

1%

Control shRNA

pBWW33-67C1

NA

NA

NA

pBWW33-67C2

81

11

14%

pBWW33-67C3

NA

NA

NA

pBWW33-67C4

80

1

1%

pBWW33-67C5

82

0

0%

pBWW33-67C6

74

1

1%

pBWW33-67C7

63

0

0%

pBWW33-67C8

32

0

0%

pBWW33-67C9

55

1

2%

pBWW33-67C10

41

1

2%

pBWW33-67C11

41

0

0%

pBWW33-67C12

71

0

0%

pBWW33-67M2

63

0

0%

pBWW33-67M3

67

0

0%

pBWW33-67M4

55

2

4%

pBWW33-67M5

52

30

58%

pBWW33-67M6

61

0

0%

pBWW33-67M7

103

22

21%

pBWW33-67M8

49

1

2%

pBWW33-67M9

65

5

8%

pBWW33-67M10

70

28

40%

pBWW33-67M11

75

96

128%

pBWW33-67M12

66

31

47%

pBWW33-67M13

75

61

81%

MSH2 shRNA

Number of colonies in 4 uM 6-TG was divided by number of colonies in 0 uM 6-TG to
generate the survival rate for each cell line in last column.
NA: Two cell lines were lost during cell culture, not available for 6-TG test.
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Figure 3.1 Expression of MSH2 in cell line pBWW33-67 and its derivative cell lines
from control or experimental group.
Lane 1, pBWW33-67C2; Lane 2, pBWW33-67C6; Lane 3, pBWW33-67C8; Lane 4,
pBWW33-67M2; Lane 5, pBWW33-67M3; Lane 6, pBWW33-67M5; Lane 7,
pBWW33-67M11; Lane 8, pBWW33-67M13 and Lane 9, pBWW33-67C2.
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Table 3.2 Detailed 6-TG resistance test on 5 selected cell lines.
Experiment

Cell Lines

0.5uM 6TG

1

pBWW33-67

84%

2%

3%

10%

pBWW33-67C6
pBWW33-67C8

61%
54%

3%
4%

4%
2%

15%
7%

pBWW33-67M11
pBWW33-67M13

101%
141%

99%
138%

55%
117%

25%
79%

pBWW33-67

54%

2%

4%

2%

pBWW33-67M13

99%

81%

96%

58%

2

2uM 6TG

4uM 6TG

8uM 6TG

Two replicates were carried out for each 6-TG concentration in the second test, and their
average colony number was divided by that in media only to generate survival rate. Cell
line pBWW33-67M13 had survival rates over 100% in the first trial, so it was tested
again together with parental cell line.
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these cell lines has negative correlation with their resistance to 6-TG: the higher MSH2
expression in a cell line, the more sensitive it is to 6-TG. pBWW33-67M13 has lowest
expression of MSH2 on the western blot but has highest survival rate in 6-TG media.
Combining the 6-TG test and Western blot results, the cell lines pBWW33-67M11,
pBWW33-67M13, pBWW33-67C6 and pbww33-67C8 are good candidates for
recombination experiments. Finally, pBWW33-67M13 and two other two control cell
lines, pBWW33-67C6 and pBWW33-67C8 were chosen for further recombination
experiments.
Collection and analysis of spontaneous recombination and DSB induced
recombination: Fluctuation tests were carried out on selected cell lines pBWW33-67M13,
pBWW33-67C6 and pBWW33-67C8, and their clone frequency, analyzed clones and HeR
frequency are listed in Table 3.3. DSB repair experiments were carried out on selected cell
lines 3 to 5 times to collect recombinants of DSB repair, and their clone frequency,
analyzed clones and HeR frequency are listed in Table 3.4.
Equivalent recombination frequency in MSH2 knockdown cells: For each
pBWW33-67 derivative cell line, 12 to 22 clones from spontaneous recombination
experiment were examined, and 20 to 63 clones from DSB repair were examined.
pBWW33-67 and its derivative cell lines have similar spontaneous recombination
frequencies at 10-8 and HeR events around 10-8. pBWW33-67M13 has a spontaneous clone
frequency of 5.71X10-8 and HeR frequency of 3.37X10-8, pBWW33-67C6 has spontaneous
clone frequency of 5.95X10-8 and HeR frequency of 0.82X10-8, and pBWW33-67C8 has a
spontaneous clone frequency of 3.22X10-8 and HeR frequency of 3.22X10-8.
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Table 3.3 Spontaneous recombination frequencies of cell lines in MSH2 knockdown
experiment.

Cell line

Subclone

pBWW33-67M13

1
2
3
4
5
6
7
8
9
10
Total

Clone
frequency
-8
(10 )

# of
Colonies
analyzed

# of
Homeologous
recombinants

4.17
0
3.64
0
12.30
19.84
0
2.50
0
14.63

2*
0
0
0
3
9*
0
3*
0
8*
25

0
0
0
0
1
8
0
0
0
4
13

Avg.=5.71
pBWW33-67C6

1
2
3
4
5
6
7
8
9
10
Total

0
13.97
0
0
5.09
25.82
6.60
0
4.67
3.33

Avg.=3.37
0
4
0
0
2
11
2
0
2
1
22

0
0
0
0
1
0
0
0
1
1
3

Avg.=5.95
pBWW33-67C8

1
2
3
4
5
6
7
8
9
10
Total

Homeologous
recombination
frequency
-8
(10 )
0
0
0
0
4.10
19.84
0
0
0
9.76

0
0
0
0
2.54
0
0
0
2.34
3.33
Avg.=0.82

5.26
0
0
0
0
26.94
0
0
0
0

2
0
0
0
0
1
0
0
0
0
3

Avg.=3.22

2
0
0
0
0
1
0
0
0
0
3

5.26
0
0
0
0
26.94
0
0
0
0
Avg.=3.22

*Some HAT resistant clones of pBWW33-67M13 survived selection because of
reactivated mouse tk pseudogene rather than recombination between HSV TK sequences,
so the recombination frequency was adjusted as the product of raw clone frequency and
proportion of recombination events.
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Table 3.4 DSB-induced recombination frequencies of cell lines in MSH2 knockdown
experiment.

Cell line

Expt
#

Expt.
Number

Clone
frequency
(10-5)

# of
colonies
analyzed

# of
homeologous
recombinants

Homeologous
recombination
frequency (10-5)

pBWW33-67M13

1

1

4.77

18

9

2.39

2

6.14

5

2

2.46

3

5.18

15

4

1.38

1

2.7

14

4

0.77

2

4.24

14

6

1.82

2

Avg.=4.61
pBWW33-67C6

1

2

Avg.=1.76

1

0

0

0

0

2

0.91

4

1

0.23

3

0.53

6

2

0.18

1

0.29

5

0

0

2

0.29

6

1

0.05

Avg.=0.40
pBWW33-67C8

1

Avg.=0.10

1

9.26

6

0

0

2

6.6

6

2

2.20

3

5.38

8

3

2.02

Avg.=7.08
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Avg.=1.41

Clone frequencies of DSB repair in these cell lines are around 10-5 except for cell
line pBWW33-67C6 in the control group, which has an especially low clone frequency of
4X10-6. pBWW33-67M13 has a clone frequency of 4.61X10-5 and HeR frequency of
1.73X10-5, pBWW33-67C6 has a clone frequency of 0.4X10-5 and HeR frequency of
0.1X10-5.
Similar conversion tract of spontaneous recombinants in MSH2 Knockdown
cells: The spontaneous HeR events in parental, control and MSH2 knockdown cell lines
have these 33 mismatched nucleotides in HSV-1 TK recipient converted to HSV2-TK
sequence all at once. In contrast, many DSB repair events only converted fewer than the
33 mismatched nucleotides to HSV2-TK sequence. The detail of conversion tract in DSB
repair is listed in Table 3.6.
Elevated proportion of HeR events in MSH2 knockdown cells during DSB
repair: The proportion of HeR events increased in MSH2 knockdown cell lines: the 39%
HeR events in pBWW33-67M13 cell lines is close to two times of that in parental cell line
and control cell lines (Table 3.5). However, clone frequency and HeR frequency of
pBWW33-67M13 are not different from that in parental or control cell lines (Table 3.4).
Unchanged proportion of HeR events in spontaneous recombination: For
spontaneous recombination, the proportion of HeR events in pBWW33-67M13 is 68%,
close to pBWW33-67 and pBWW33-67C8, but different from pBWW33-67C6, which has
the lowest proportion of HeR events in the 4 examined cell lines. The proportion of HeR
events in pBWW33-67C6 is about 4 times lower than other cell lines in spontaneous
recombination. The details of HeR events in experimental cell lines are listed in Table 3.5.
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Table 3.5 HeR events of spontaneous recombination and DSB repair in MSH2
knockdown experiment.
Recipient
with
mismatches
(fewer than
all)

Recipient
with no
mismatch

Other
events

HeR
Fraction

Recombination
events

Cell
Line

Analyzed
clones

Recipient
with all
mismatches

Spontaneous
recombination

P

15

12

0

3

0

80%

C6

22

3

0

19

0

14%

C8

3

3

0

0

0

100%

M13

19

13

0

6

0

68%

P

42

5

5

31

1

24%

C6

21

2

2

16

1

19%

C8

20

3

2

14

1

25%

M13

64

12

13

39

0

39%

DSB repair

Cell lines’ names are abbreviated in Table 3.5. P = parental cell line pBWW33-67, C6 =
control cell line pBWW33-67C6, C8 = control cell line pBWW33-67C8 and M13 =
MSH2 deficient cell line pBWW33-67M13.
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Table 3.6 Converted mismatched nucleotides in HeR recombinants from DSB repair.

Cell line
pBWW33-67M13

pBWW33-67C6

Clone

Coexistence of mismatched
nucleotides

pBWW33-67M13-1-1

M1 to M17

pBWW33-67M13-1-2

M1 to M33

pBWW33-67M13-1-6

M1 to M7

M1 to M7

pBWW33-67M13-1-7

M1 to M12

M1 to M12

pBWW33-67M13-1-8

M1 to M17

M1 to M17

pBWW33-67M13-1-9

M1 to M33

M1 to M33

pBWW33-67M13-1-11

M1 to M33

M17 to M33

pBWW33-67M13-1-13

M1 to M16

M1 to M16

pBWW33-67M13-1-16

M1 to M16

M6 to M16

pBWW33-67M13-2-7

M1 to M33

M1 to M33

pBWW33-67M13-2-9
pBWW33-67M13-3-3

M6 to M14 & M20

pBWW33-67M13-3-6

M1 to M33
M6 to M14 &
M17 &M20
M1 to M33

M1 to M16, M21 to M33

pBWW33-67M13-3-9

M1 to M16

M1 to M16

pBWW33-67M13-3-13

M1 to M33

M1 to M33

pBWW33-67M13-7-6

M6 to M17

M6 to M12

pBWW33-67M13-7-7

M1 to M33

pBWW33-67M13-7-10

M1 to M33

M29 to M33

pBWW33-67M13-7-16

M1 to M33

M1 to M33

pBWW33-67M13-8-4

M1 to M30

pBWW33-67M13-8-7

M1 to M12

M1 to M2

pBWW33-67M13-8-9

M1 to M5

M1 to M5

pBWW33-67M13-8-11

M1 to M33

M1 to M5, M21 to M33

pBWW33-67M13-8-14

M1 to M33

M1 to M33

pBWW33-67M13-8-15

M1 to M12

M1 to M12

pBWW33-67C6-2-12

M1 to M33

pBWW33-67C6-3-5

M1 to M12

pBWW33-67C6-3-7

M1 to M33
M1 to M5 & M13 to
M17
M1 to M33

pBWW33-67C6-5-10
pBWW33-67C8

Converted
Mismatched
Nucleotides

pBWW33-67C6-2-3
pBWW33-67C6-2-5

M1 to M5

pBWW33-67C6-3-1

M1 to M33

pBWW33-67C6-3-3

M1 to M22

pBWW33-67C6-3-6

M6 to M33
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Evidence of hDNA intermediates appeared after MSH2 knockdown: When
analyze DSB repair recombinants of pBWW33-67M13 cell line, the alignments show
discontinuous conversion tracts in recipient sequences where the identity of mismatched
nucleotides changed between HSV-1 TK and HSV-2 TK sequences repetitively. In the
chromatograms, almost all HeR events show double peaks at the positions of mismatched
nucleotides, and each peak represents a nucleotide of either donor or recipient. As a
result, coexistence of mismatched nucleotides causes the shifting of nucleotide calling
between donor and recipient in sequencing data. The coexistence of mismatched
nucleotides at each position demonstrates that the cell lines carry two set of sequence
information, conceivably from both donor strand and recipient strand of a hDNA
intermediate.
The chromatograms of previous recombinants were reviewed at this time and no
DSB repair recombinant shows double peaks like these from pBWW33-67M13. Only one
DSB repair recombinant, pBWW25-16-3-10, has mismatched nucleotides at M16 with
unknown reason. Another exception is one spontaneous HeR recombinant, pBWW16-25-9, which has double peaks for all mismatched nucleotides.
Table 3.6 lists the conversion of mismatched nucleotide in HeR recombinants
from cell line pBWW33-67M13, pBWW33-67C6 and pBWW33-67C8 during DSB
repair. Spontaneous HeR events are not listed in a table because they have all
mismatched nucleotides converted to HSV-2 TK sequence and they have no double peaks
at mismatched position in the sequencing chromatogram.
In addition to gene conversion details, coexistence of mismatched nucleotides is
labeled in a separate column. Conversion of mismatched nucleotide describes the
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nucleotide positions where the donor’s nucleotide is visible, while coexistence of
mismatched nucleotide demands the donor’s nucleotide as well as recipient’s nucleotide.
If the mismatched nucleotides are all from donor, they would be recorded in “converted
mismatched nucleotide” column, but not marked in “coexistence of mismatched
nucleotide” column.
Coexistence of mismatched nucleotides in DSB repair recombinant are
separated by subcloning: To learn more about the coexistence of mismatched
nucleotides in collected recombinants, 5 recombinants from pBWW33-67M13 were
subcloned to separate cell populations that may carry different set of nucleotides at the
mismatched positions. Sequencing results of their subclones are listed in Table 3.7.
pBWW33-67M13-1-13 and pBWW33-67M13-3-13 have continuous conversion
tract starting from M1, and the nucleotides of donor and recipient coexist at each
converted mismatched nucleotide position. They represent 12 out of the 20 HeR events
showing evidence of hDNA. Sequencing data of subclones from these two cell lines
shows that these recombinants are actually composed of two cell populations, which
carry either the donor’s HSV-2 TK sequence or recipient’s HSV-1 TK sequence in their
recipients.
Two cell lines have continuous conversion tracts starting from M1. However,
mismatched nucleotides of donor and recipient only coexist at some of the converted
mismatched nucleotide position. All 12 subclones of pBWW33-67M13-3-6 show donor’s
HSV-2 TK sequence, while all 6 subclones of pBWW33-67M13-1-16 show only HSV-1
TK sequence. Recovering one of the two cell populations is not satisfactory, however, it
does not contradict with current conclusion.
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Table 3.7 Separation of coexisted mismatched nucleotides was observed after subcloning
recombinants from pBWW33-67M13.
Converted
Mismatched
Nucleotides

Coexistence of
mismatched nucleotides

pBWW33-67M13-1-13

M1 to M16

M1 to M16

Mismatched nucleotides
in
Subclone
Subclone
type A
type B
D1 to D16
R1 to R33

pBWW33-67M13-3-13

M1 to M33

M1 to M33

D1 to D33

R1 to R33

pBWW33-67M13-1-16
pBWW33-67M13-3-3

M1 to M16
M6 to M14 &
M17 &M20
M1 to M33

M6 to M16
M6 to M14 & M20

NA
D17 to D20

R1 to R33
NA

M1 to M16, M21 to M33

D1 to D33

NA

Clone

pBWW33-67M13-3-6

The details of gene conversion tracts are listed after the recombinants, and the identities
of mismatched nucleotides in their subclones followed afterward. The mismatched
nucleotides of donor are labeled as D1 to D33, and the mismatched nucleotides of
recipient are labeled as R1 to R33.
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The last cell line pBWW33-67M13-3-3 has discontinuous conversion tract, and
nucleotides of donor and recipient only coexist at some of the converted nucleotide
positions. Surprisingly, all 7 recovered subclones carry the same partial HSV-2 TK
sequence and the conversion of nucleotides is different from DNA sequence of their
parental cell lines. It is not clear how this event with confusing sequence data happened
during DSB repair.
Collection of spontaneous recombinants containing all cells from one
recombination event: No spontaneous recombinant of pBWW33-67M13 was found
with double peaks in chromatograms. To find evidence for hDNA in spontaneous
recombination, further attempts were made to harvest a spontaneous recombination clone
representing a single recombination event.
A modified fluctuation test was carried out on pBWW33-67M13 twice, and all
recovered clones are listed in Table 3.8. Different from the previous fluctuation test, HAT
selection was carried out on approximate 40 million cells of each subclone without replating, and conceivably, all descendant cells from a recombination event form a discrete
clone. However, in modified fluctuation test, there was still no evidence of hDNA.
Recombinants recovered in a subclone tend to have the same type of events: 3 subclones
have all HR recombinants and 7 subclones have all HeR recombinants. Only subclone 9
in experiment 1 have both HR recombinant and HeR recombinant.
Reactivated mouse thymidine kinase pseudogene in non-recombinant clones:
HAT resistant clones with unaltered recipient had been found sporadically in Chapter 2,
but it was common for pBWW33-67M13 in spontaneous recombination. Nonrecombinant clones with a reactivated mouse thymidine kinase pseudogene were
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Table 3.8 Spontaneous recombinants collected from modified fluctuation test.
Experiment

Subclone

Recombinants
analyzed

Homeologous
Recombinants

1

1 to 6
7
8
9
10

0
2
2
3
0

0
0
2
1
0

2

1
2
3
4
5
6
7
8
9
10
11
12 to 17
18
19
20 to 24

0
2
0
1
0
2
0
1
1
0
1
0
1
1
0

0
2
0
0
0
2
0
0
1
0
1
0
1
1
0

Total

17

11

All recombinants from any subclone were harvested and examined. All HeR
recombinants in this chart have all 33 mismatched nucleotides converted to HSV-2 TK
sequence.
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observed in our laboratory before (first characterized by Jessica Burr Lea in her Master
Thesis titled “Influence of the DNA Long Inverted Repeat on Recombination in
Mammalian Cells”). Therefore, two drug resistant tests and RT-PCR were carried out to
confirm the identities of current non-recombinant clones (89, 90).
Trifluorothymidine (TFT) is toxic to all cells with functional thymidine kinase
while Ganciclovir (GCV) specifically targets cells with thymidine kinase of herpes
simplex virus. The non-recombinant clone, pBWW33-67M13-4-11, reached confluence
in GCV containing media but died out in TFT containing media, while control cell line
grew well in either TFT or GCV containing media. Figure 3.2 shows that the mouse TK
transcript was efficiently amplified in non-recombinant clones, but not from parental cell
lines.
RT-PCR targeting mouse TK gene as well as pseudogene was carried out on nonrecombinant clone pBWW33-67M13-4-11, parental cell line pBWW33-67M13 and
previous cell lines classified in Jessica Burr Lea’s master thesis. Lane 1 to 6 show RTPCR products of non-recombinant clones in presence or absence of reverse transcriptase,
while lane 7 to 9 show RT-PCR products of parental cell lines. Mouse TK sequence or
pseudogene sequence was successfully amplified from pBWW33-67M13-4-11 in
presence of reverse transcriptase while minor amplification happened in parental cell line
pBWW33-67M13. Similarly, previously classified non-recombinant clones, pJAVA3 5cSS-1a and pJAVA1 26E-O have the same 612 bp TK sequence amplified through RTPCR, while the parental cell lines JAVA1 26E and pJAVA3 5c do not.
Finally, the RT-PCR products of recombinant clone pBWW33-67M13-4-5, nonrecombinant clone pBWW33-67M13-4-11 and parental cell line pBWW33-67M13 in
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Figure 3.2 Mouse TK gene or pseudogene were successfully amplified through RT-PCR
from selected non-recombinant cell lines and parental cell lines.
Lane 1, pJAVA3 5c-SS-1a; Lane 2, pJAVA3 5c-SS-1a without reverse transcriptase; lane
3, pBWW33-67M13-4-11; lane 4, pBWW33-67M13-4-11 without reverse transcriptase;
lane 5, pJAVA1 26E-O; lane 6, pJAVA1 26E-O without reverse transcriptase; lane 7,
pJAVA1 26E; lane 8, pJAVA3 5c; lane 9, pBWW33-67M13; lane 10, pJAVA1 5c-VV-2a.
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pBWW33-67M13 experiment were excised, re-amplified and sequenced. These transcript
sequences were aligned to the mouse TK gene and its pseudogene to examine their
identity.
As shown in Figure 3.3, the 612 bp transcript sequences amplified from these cell
lines are mouse TK pseudogene because they carry all the 8 unique nucleotides from
mouse TK pseudogene. Meanwhile, these three transcripts have 14 additional mismatches
across the sequence compared with either reference mouse TK sequence. PCR and
sequencing the pseudogene’s genomic sequence in examined cell lines shows that most
new found mutations on transcript sequence are not found on the genome. Reviewing the
chromatogram of the transcripts’ sequences reveals that mixed reading occurs at these 14
mutation sites. These “mutations” in transcripts’ sequence is probably an artifact from
prolonged RT-PCR process.
Discussion:
Generation of homeologous conversion tract: To address the mechanism of
observed HeR events, experiments in the current chapter were designed to learn how
these mismatched nucleotides were incorporated into the recipient sequence during
recombination. In SDSA, newly synthesized recipient strand may take donor’s
mismatched nucleotides, anneal to the other resected recipient strand and form hDNA. In
DSBR model, hDNA may form during strand invasion, second strand capture, or HJs
migration that mediates strand exchange between donor and recipient. In both situations,
if MMR repair the hDNA toward the foreign sequence, the recipient would receive
homeologous conversion tract. Without MMR, the hDNA would be separated after DNA
replication, and one of the daughter cells gains homeologous conversion tract afterward.
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Figure 3.3 Amplified transcript sequences in selected cell lines were aligned to mouse TK gene and pseudogene.
M13, M13-4-11 and M13-4-5 are parental cell line, non-recombinant and recombinant respectively. Totally 8 mismatches exist
between mouse TK gene and its pseudogene within the sequencing area, and these mismatched nucleotides are marked with
“V”. Perfectly matching sequences were highlighted in the figure for clarity.

Therefore, mismatched hDNA formed during HR could be repaired or separated to
generate homeologous conversion tract.
Alternatively, excessive end resection and degradation may chew out the
homeologous sequence on the recipient, and the broken recipient gets converted through
DNA synthesis along the template strand. Thus, no mismatched hDNA is formed through
annealing diverged sequences during the process.
Experiments in the current chapter specifically ask whether these HeR events
possibly went through hDNA intermediate annealing homeologous sequences. If the
hDNA intermediates do exist, whether they always include the whole homeologous
region? Is it possible that the shorter conversion tracts are repair product of hDNA
intermediates annealing the whole homeologous region?
Establishment of MMR impaired cell line: To answer these questions above,
MSH2 in cell line pBWW33-67 was stably knockdown using shRNA. Then, spontaneous
recombination and DSB induced recombination in MMR deficient background were
examined and compared. Cell line pBWW33-67 was chosen for MSH2 knockdown
experiment since it has higher fraction of HeR events during DSB repair, and half of the
HeR events have few than all mismatched nucleotides converted. Alterations in
conversion tract would be easy to see if they occur.
Obtained cell lines were screened by Western blot and 6-TG experiments. The
chosen cell line of MSH2 knockdown group, pBWW33-67M13, has the lowest MSH2
expression, and highest survival rate in 6-TG experiments, indicating functional
deficiency in MMR. In contrast, the control cell lines pBWW33-67C6 and pBWW3367C8, with control shRNA integrated, have regular MSH2 expression, and they are

111

sensitive to 6-TG like the parental cell line. Data from these two experiments also shows
the MSH2 expression in examined cell lines has negative correlation with their resistance
to 6-TG, which agreed with the core role of MSH2 in MMR.
HeR recombinants of DSB repair in MSH2 deficient cells: Out of 25 HeR
recombinants of pBWW33-67M13 obtained from DSB repair experiments, 20
recombinants show double peaks at mismatched nucleotide position in sequencing
chromatogram. Coexistence of mismatched nucleotides in these HeR events implies that
hDNA intermediates formed between homeologous region segregates into two daughter
cells in MMR deficient cell, so these clones have mixed genetic information from both
donor and recipient.
To learn whether these 20 recombinants are mixed cell populations from hDNA
segregation events, subcloning was attempted on 5 selected cell lines. Two cell lines,
pBWW33-67M13-1-13 and pBWW33-67M13-3-13, have continuous conversion tract
and mixed nucleotides at every mismatched position. Subcloning of these two cell lines
successfully separates two cell populations: one have all the donor’s nucleotides at each
converted position while the other have all the recipient’s nucleotides. The result here
suggested these recombinants are likely products of hDNA intermediates, which are
separated into daughter cells instead of repaired by MMR. These two cell lines represent
12 out 20 HeR carrying mixed nucleotides.
pBWW33-67M13-3-6 and pBWW33-67M13-1-16 have continuous conversion
tracts and mixed nucleotides at some mismatched positions, representing 7 out of 20 HeR
carrying mixed nucleotides. Every examined subclones from these two cell lines have
sequence from one side, donor or recipient. The results agree with segregation of two
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strands with different identities, however, information of the other strand is not
visualized. It is not clear why the information of one strand was lost during subcloning.
Only for clone pBWW33-67M13-3-3, the result of subcloning is not compatible
with the sequencing data of its parental cell line. The recovered subclones have converted
nucleotides different from parental cell, new converted nucleotides appear while some
converted nucleotides from parental cell line disappears. The mystery of this particular
recombinant could not be explained by simple HR models, and remains unsolved.
Again, 20 out of 25 recombinants show double peaks in sequencing
chromatograms, suggesting segregation of hDNA intermediates encompassing
homeologous sequences. Therefore, the vast majority of HeR events involves formation
of hDNA intermediate. And the doubled percentage of HeR events after MSH2
knockdown implies that while hDNA intermediates in normal cells are repaired by MMR
toward either strand, the foreign strands in hDNA intermediates are always preserved and
visible in MMR deficient cells.
No change in clone frequencies after MSH2 knockdown while increase in
HeR frequency: After MSH2 knockdown, clone frequencies are not dramatically
different from that in parental and control cell lines. One-way ANOVA comparing
frequencies in parental, control and knockdown cell lines give a p-value equals 0.3942.
HeR frequencies look higher after MSH2 knockdown, while the same test give a p-value
equals 0.0508. Neither frequencies are statistically significant between tested groups.
No change in conversion tracts after MSH2 knockdown: 12 out of 25 HeR
events in pBWW33-67M13 have 33 mismatched nucleotides converted to HSV-2 TK
sequence, close to the 50% seen in parental cell line pBWW33-67. Unchanged ratio
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between partial and whole conversion tract after MSH2 knockdown suggested that MMR
does affect the length of conversion tract. Therefore, partial conversion tract is repair
product of hDNA intermediates annealing short homeologous sequences, while whole
conversion tract is product of hDNA intermediate annealing the complete homeologous
sequences.
Gene conversion tracts in MMR deficient cells support previous assumption that
HeR events with fewer converted mismatched nucleotides do resolve in middle of the
homeologous region. The alternative explanation that HeR events with fewer converted
mismatched nucleotides came from incomplete repair of 33 mismatched nucleotides, is
also barely feasible due to the mechanism of MMR: MMR always degrades hundreds or
thousands of nucleotides on one strand and re-synthesize it based on the other intact DNA
strand. It is unlikely that MMR switched the choice of strand within this 200 bp short
sequence. Also, if hDNA intermediates always include the entire homeologous sequence
but they are repaired differently, depletion of MSH2 will abrogate MMR and keep this
intermediate with all 33 mismatched nucleotides for later segregation. Thus, it was
predicted that in pBWW33-67M13, fraction of recombinants converting all mismatched
nucleotides would rise due to deficiency of MMR. However, we observed a slightly
decrease of these recombinants. To sum up, available evidences confirmed the existence
of hDNA intermediates that anneal the partial homeologous region proximal to I-SceI site
as well as that anneal the whole homeologous sequence.
The results in current chapter and previous two chapters clearly show the role
MMR plays in collected HeR events. For examined three substrates, HeR events are
common phenomenon in both spontaneous recombination and DSB-induced
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recombination, and increase of homeologous sequence does not dramatically decrease
either HeR frequency or proportion of HeR events. Moreover, MSH2 knockdown failed
to bring dramatic boost in HeR frequency, though it increased fraction of HeR events up
to 2-fold during DSB repair. Apparently, there is no vigorous rejection or destruction
toward the genetic exchange between homeologous sequences by MMR in examined cell
lines. It is possible that as long as nearby homology is available to initiate recombination,
homeologous sequence could participate in genetic exchange without noticeable
discrimination. Taken together, MMR does not target and eliminate genetic exchange
between homeologous sequences in these substrates, while it rather repairs the hDNA to
generate homeologous conversion tract, most likely half of the time. These results allow
us to say MMR does not impede recombination between homeologous sequences but
actually facilitates it between diverged sequences by converting hDNA leftover to
template sequence. Though against the intuition and current scheme for MMR, it is
reasonable for cells to allocate energy to reject improper recombination at the initiation
stage, rather than destroy any ongoing genetic exchange between diverged sequences.
No detection of hDNA during spontaneous recombination: In pBWW3367M13, 13 out of 19 spontaneous recombinants were products of HeR event. However,
none of them show double peaks at the position of mismatched nucleotides in
chromatography, which provided the evidence of hDNA intermediate during DSB repair.
In fluctuation test, cells were trypsinized and plated right before the HAT selection, so if
one recombination event generates two daughter cells carrying either strand of the hDNA
intermediate, they are probably separated by trypsinization and form discrete colonies in
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these flasks. Therefore, the fluctuation test was modified to collect clone that contains all
descendant cells of a recombination event.
Fluctuation test of pBWW33-67M13 has no more than 8 clones in one subclone.
If these clones were from a recombinant cell containing hDNA remnant, the recombinant
cell went through divisions up to three times before HAT selection. Since most subclones
grew up to about 40 million cells before HAT selection, the recombinant DNA product of
a recombination event most likely still resided in a single cell when the subclone had 4
million cells, if the recombination event already happened. Therefore, in modified
fluctuation test, each subclone was cultured up to 4 million cells. Then these 4 million
cell were plated sparsely, cultured for another 3 days before fed with HAT media for
selection. Ideally, offspring of the same recombinant cell will form a single recombinant
clone with mixed cell populations. In new experiments, 8 subclones generated HeR
events, but none shows direct evidence of hDNA segregation: double peaks in
sequencing chromatography. Only one subclone has both HeR and HR recombinants, a
sign of possible hDNA segregation, while the other 7 subclones only have HeR
recombinants. The percentile of hDNA segregation events is dramatically lower than that
in DSB repair. Fisher exact test comparing the ratio of hDNA segregation event versus
non-segregation events in spontaneous recombination and DSBR gives p-value equal
0.0012. Therefore, hDNA segregation dominates the HeR events of DSBR while it is
minor in spontaneous recombination. Currently, no direct evidence shows that
spontaneous recombinants go through hDNA intermediates annealing homeologous
sequences.
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Two possibilities remain for further exploration. First, as described in Chapter 3,
the hDNA intermediates actually formed between homeologous sequences, and they
included I-SceI site as well. Therefore, segregation of hDNA in subsequent cell division
produced one daughter cell carrying donor’s continuous TK strand and the other daughter
cell carrying I-SceI disrupted recipient strand. Since the latter daughter cell would perish
in HAT selection, only the first one was able to form pure HeR recombinant in
fluctuation test. Though in agreement with the mechanism of MMR and HR, the
speculation still need further investigation to see whether hDNA intermediates annealing
all the mismatches and I-SceI site are actually the precursors of collected HeR
recombinants. It is still possible that the spontaneous recombinants in current experiments
simply went through successive template switching during replication rather than hDNA
intermediate formed by strand exchange.
Reactivation of mouse thymidine kinase pseudogene in collected clones:
Many non-recombinant clones, mostly in fluctuation test of pBWW33-67M13, survived
HAT selection without nucleotide sequence change in HSV-1 TK recipient. It was
initially described in Jessica Burr Lea’s Master thesis that once a processed pseudogene
of mouse TK gene (91) is transcribed in high quantity, its expression can supply these
Ltk- cells with functional thymidine kinase. Data from two drug tests shows these newly
discovered non-recombinant clones did not grow in media with TFT, but reached
confluence in presence of GCV. These drug tests indicate active thymidine kinase in
these cells, but not of Herpes simplex virus origin (89, 90). The RT-PCR amplifying the
transcript of mouse TK gene as well as pseudogene shows successful amplification in
non-recombinant clones, but not in recombinant or parental cell lines. The transcript’s
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sequence in aforementioned clones have 8 nucleotides identical to mouse TK pseudogene
but not mouse TK gene. Meanwhile, all these three transcripts possess many mutations
different from either mouse TK gene or pseudogene. However, genomic sequence of the
mouse pseudogene in aforementioned three clones are almost the same as the reference
pseudogene sequence. The large amount of mutations in RT-PCR products are probably
artifact after prolonged amplification steps, or less likely, vigorous RNA editing of the
transcripts.
All these results suggested that the expression of mouse tk pseudogene arises
dramatically in non-recombinant clones, which supplied tk function in these cells rather
than the tk of herpes simplex virus in recombination substrates.
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CHAPTER 4 INVESTIGATION OF THE RELAXED HOMOLOGY
REQUIREMENT FOR RESOLUTION DURING DSB REPAIR
Holliday junction (HJ) refers to the cross-shaped, four-stranded DNA structure
after two DNA molecules swap one strand with each other during recombination (Figure
1.1). HJ was initially introduced to describe the exchange between homologous
chromosome: the HJ formed between two DNA molecules migrate to conduct strand
exchange between them until its resolution (20). This hypothesis captures the nature of
genetic exchange between homologous partners, and it is later on adopted in multiple
theoretical models to explain DNA recombination in various circumstances, such as
Meselson-Radding model, DSBR model and restoration of replication fork (7, 92). To
date, the existence and dynamic of HJ during recombination have been illustrated by
many genetic, cytological and molecular evidences in meiosis as well as mitosis (20, 44,
93, 94). The gene conversion events are most time unidirectional, either through gap
repair or by repair of asymmetric hDNA. Sometimes in meiosis, when sequence
divergence exists between the homologous partners, the HJ mediated strand exchange
may leave hDNA intermediate on both molecules with mismatched nucleotides, which
are repaired by MMR to produce reciprocal conversion tract (7). Without the MMR
responsible for the latter process, information from both strands will be visible after post
meiosis segregation of the hDNA (54, 95). Though HJs were found in mitosis at much
low frequency, it is conceivable that it can mediate similar strand exchange in mitotic
cells (93).
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While HJs are adopted in various models explaining usually rare mutual exchange
between homologous DNA sequences, SDSA serves as a prominent and simple way in
which the broken DNA utilize homologous partner for repair without altering the HR
template (Figure 1.1) (17, 18). Considering the recombination frequency and homology
requirement in these two types of recombination, strict homology requirement appears to
be required in resolution of HJ: it is likely that the resolution of HJs need significant
amount of homology to properly anneal the four strands for recognition and procession.
In contrast, the SDSA in mitosis may anneal strands with mismatched nucleotides,
showing sloppy choice in resolution site.
Alternatively, chromatin structure around DSB site is modified due to DNA
damage response (DDR), for example, the local phosphorylation of H2AX on chromatin
or other potential structural changes brought by DDR factors (1, 96). Therefore, the
homology requirement could be dramatically different from that proximal to a DSB
lesion. In another word, the homology requirement for resolution may be relaxed by
nearby DSB.
To validate aforementioned possibilities, it is critical to collect and analyze the
recombinant clones solely from HJs resolution. Analyzing existing recombination events
in prior chapters does not lead to an unequivocal answer. The cause of spontaneous
recombination is still debatable and it might be achieved through rescuing replication
fork or a two ends DSB; while DSB repair could take either SDSA or DSBR pathway.
After scrutinizing all possible pathways of HR, it is found that when dHJs resolution
occurs, the sequence of homologous template (donor) could be altered and converted to
recipient sequence. As demonstrated in Dr. Szostak’s DSBR model and his supportive
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data studying HR between gapped plasmid and chromosomal gene, this particular type of
events has been detected at low frequency in yeast mitotic cells (7, 97).
As shown in Chapter 2 and 3, when HR event started near a homeologous
sequence, the broken DNA received homeologous conversion tract through either gap
repair or repair of hDNA. Conversely, the HR template may gain mismatched hDNA by
taking recipient strand during HJs migration. If aforementioned HJ branch migration and
resolution in DSBR model do generate desired recombinant clones with altered donor,
the conversion tract on donor would present the footprint of branch migration between
initiation site and resolution site of HJ. If the HJs need adequate homology to resolve, the
conversion tract should always contain the whole homeologous region, the same as
observed in spontaneous recombination, while if DSB reduce the homology requirement
in resolution, the conversion tract on donor will have conversion tract contain partial
homeologous region as well as whole homeologous region.
In order to obtain recombinant clones from HJs resolution, and compare them
with previous results from pBWW substrates, new substrate was designed to recreate the
same condition for potential HR events (Figure 4.1). In previous chapters, the full length
HSV1-TK sequence was broken at the I-SceI site (nucleotide 1215), and the invasion was
primed by its broken ends toward a 0.8 Kb hybrid donor, which has HSV2-TK
homeologous sequence about 50 bp away from the invasion site (nucleotide 1215). In the
new design, though a 2.5 Kb full length tk gene serves as hybrid donor, and the I-SceI
site resides in the 0.8 Kb HSV1-TK recipient, after breakage, it is the same HSV1-TK
DNA ends invading a similar template with homeologous sequence about 50 bp from the
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invasion site. And most importantly, the HR events are driven by the same amount of
homology: nucleotide 623 to 1459 of HSV1-TK.
To demonstrate the similarity in HR events happening in pBWW33 and new
pLS4 substrate, their HSV-1 TK recipients are aligned to their hybrid donors respectively
(Figure 4.1): the I-SceI site in recipient is always aligned against the downstream HSV-1
TK sequence in hybrid donor, about 50 bp away from the border of HSV2-TK sequence.
In both substrates, HR events rely on the 0.8 Kb homology shared by donor and recipient.
The original 2.5 Kb HSV1-TK fragment was modified extensively to make the
hybrid donor for substrate pLS4. The donor would have mismatched nucleotides M33M8 of pBWW33 substrate, and then 5 point mutations afterward introducing a BamHI
recognition site and two stop codons. As a result, the hybrid donor has a cluster of 31
mismatched nucleotides about 50 bp upstream of the I-SceI insertion site (nucleotide
1215), compared with HSV1-TK recipient. In this arrangement, the invasion and repair
events would be almost the same as in substrate pBWW33, where the broken HSV1-TK
strands invade a 0.84 kb hybrid donor at a site 50 bp away from a cluster of 33
mismatched nucleotides.
For the new substrate pLS4, HR or NHEJ events ligating the broken recipient
would not necessarily bring HAT resistance to the host cells. Recombinant clone from
DSB repair will grow up only when the HR restore the broken recipient through dHJs
resolution, and the HSV2-TK sequences together with stop codons in 2.5 Kb hybrid
donor are converted to HSV1-TK recipient after repair of hDNA intermediate.
Sequencing the HR donors in this type of recombination events will reveal the conversion
tracts on participating HR donor, which in turn tells the range of HJs migration.
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Figure 4.1 Alignment of donor and recipient in substrate pBWW33 or pLS4.
Donor and recipient in pBWW33 and pLS4 are placed side by side to show the similarity
in recombination events happened between these two substrates.
The white rectangles represent HSV-1 TK sequences and the striped rectangles represent
HSV-2 TK sequences. The recombination events happened within pBWW33 and pLS4
are similar because they have hybrid donor and HSV1-TK recipient sharing the same
length of homology. The HSV2-TK sequence in donor of pLS4 starts from the same
position as in hybrid donor of pBWW33, and it possesses the same mismatched
nucleotides M33 to M8 in donor of pBWW33. The 5 additional mismatched nucleotides
introduced a BamHI site and 2 stop codons right after HSV2-TK sequence.
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Materials and Methods:
Structure of substrates: The new substrate pLS4 has a 2.5 Kb hybrid tk donor in
tandem with a truncated HSV1-TK recipient. The hybrid donor is full length HSV1-TK
sequence carrying a patch of HSV-2 TK sequence, an engineered BamHI recognition site
and two engineered stop codons in middle of its coding sequence (CDS); and expression
of donor’s encoded thymidine kinase is aborted by these two stop codons. The new
truncated recipient is made of 837 bp HSV-1 TK sequence (nucleotide 623-1459, the
same length and location as the hybrid donor of pBWW33), and it has 30 bp I-SceI
recognition site at the position 1215 (the same I-SceI insertion site as in recipient of
pBWW33). The positions of these nucleotides are all numbered the same as in the
Wagner’s paper, as described in Chapter 2 (74).
Substrate pLS4 was linearized by endonuclease ClaI before transfection, and the
restriction map of the linearized substrate is show in Figure 4.3. To check the
completeness of these tandem repeats after genome integration, endonuclease BamHI or
HindIII are used to digest genomic DNA for Southern blot.
Construction of substrate pLS4: The backbone of pLS4 is from pBWW16, and
HSV1-TK recipient and donor were amplified either from pTK1 (carry complete HSV-1
TK gene sequence), pBWW16, or previously obtained recombinants pBWW33-67-1-1
(nucleotide sequence 968-1167 in its HSV-1 TK recipient was substituted by HSV-2 TK
sequence). The cloning protocols were the same as described in Chapter 2 and the work
flow was described in following paragraphs.
At the beginning, pBWW16 was cut by HindIII, and its 8.2 Kb backbone was
purified and ligated to generate pLS2. To make pLS1, 0.87 Kb HSV1-TK recipient
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Figure 4.2 Mismatched nucleotides between recipient and donor of substrate pLS4.
Compared with donor, the recipient (top sequences) has 30 bp oligonucleotide insertion
including 18 bp I-SceI recognition site (underlined). Totally 31 mismatched nucleotides
exist between donor and recipient (marked with * in the alignment), and they are
numbered from m1 to m31 depending on their closeness to the I-SceI insertion site, the
same as they were labeled in pBWW33. The mismatched nucleotides m31 to m6 in pLS4
are correspondingly M33 to M8 in pBWW33. And 5 more different nucleotides, m1 to
m5, introduce BamHI site and two stop codons (all in bold, between nucleotide 1127 and
nucleotide 1155). Nucleotide positions are marked below the sequence with “^”, and
annotated in parentheses if they are corresponding to a mismatched nucleotide in
pBWW33 or pLS4.
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Figure 4.3 Structure and restriction map of substrate pLS4.
The linearized substrate is 9.1 Kb, and it has a 0.9 Kb HSV1-TK recipient flanked by
HindIII recognition site as well as a 2.5 Kb hybrid donor carrying two BamHI site. The
Neo cassette between the two repeats is for selection purposes in both prokaryotic cells
and eukaryotic cells.
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(623-1459) containing I-SceI insertion at position 1215 was amplified from pBWW16
using AW130 and AW93, and then the PCR product was cut by HindIII and purified for
ligation. Substrate pLS2 was cut by HindIII, treated by bacterial alkaline phosphatase
(BAP), gel purified and ligated with aforementioned 0.87 Kb recipient fragment to
generate pLS1. In subsequent cloning steps, the plasmid backbones were always treated
by SAP and gel purified for ligation with insertion fragment.
The 2.5kb full length hybrid donor was cloned into pLS plasmids through two
steps of PCR and ligation, during which HSV2-TK sequence, BamHI recognition site and
2 stop codons were introduced by PCR primers and selected templates.
First, 1.1Kb HSV1-TK sequence was amplified from pTK1 using AW146 (5’
CAG CCA GGA TCC TTC CGT AGG CCT GAC ACA TCG ACC G 3’, matches HSV1TK nucleotides 1132-1162) and AW147 (5’ AAG TAG GGA TCC AGA TCT CGA GCT
TGG CCG TGG TG 3’, matches the 3’ end of the 2.5Kb, BamHI flanked HSV1-TK
fragment). This fragment contains partial coding sequence of HSV1-TK and downstream
non-coding sequence. BamHI site and 2 stop codons were introduced at the 5’ end of the
fragment by primer AW146, while BglII was introduced at the 3’ end by primer 147. The
amplified PCR product was cut sequentially by BglII and BamHI, and then purified for
ligation with 6.6 Kb plasmid backbone from BamHI digested pLS1. The ligated pLS3 has
a 0.87 Kb I-SceI disrupted recipient and a 1.1 Kb HSV1-TK donor tail with 2 stop codons
in coding sequence. After ligation, the intact BamHI site at the 5’ end of the insertion is
followed by 2 stop codons while the BamHI site at the 3’ end was destroyed through the
re- ligation with BglII digested sticky end.
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Figure 4.4 Work flow to construct substrates pLS2.
Plasmids, primers and restriction sites in use are drawn and labeled accordingly in the
figure: the white bars in donors and recipient are HSV-1 TK sequences, while the solid
bars in these donors are HSV-2 TK sequences. Donor fragment in pBWW16 was excised
and the remaining plasmid was ligated to produce pLS2. pLS2 was then used to build
plasmid pLS1.
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Figure 4.5 Work flow to construct substrates pLS1.
A 0.9 Kb, PCR amplified recipient was inserted into the unique HindIII site of pLS2 to
produce plasmid pLS1, which was used to build plasmid pLS3.
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Figure 4.6 Work flow to construct substrates pLS3.
The plasmids were labeled the same way as in Figure 4.5. The 2.5 Kb TK fragment was
excised from pLS1 by BamHI, and a 1.1 Kb, PCR amplified donor’s downstream
fragment was inserted into the open BamHI site to produce plasmid pLS3, which was
used to build plasmid pLS4.
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Figure 4.7 Work flow to construct substrates pLS4.
The plasmids were labeled the same way as in Figure 4.5. A 1.4 Kb, PCR amplified
donor’s upstream fragment was inserted into the unique BamHI site of pLS3 to produce
plasmid pLS4. pLS4 is the recombination substrate used in subsequent DSB repair
experiments.
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Second, 1.4Kb HSV1-TK sequence containing promoter and partial coding
sequence was amplified from clone pBWW33-67-1-1 using AW52 (matches plasmid
backbone upstream of BamHI site) and AW148 (5’ CCG GAA GGA TCC CCA GGA
CCA GGT TCG TGC CGG 3’, matches HSV1-TK nucleotides 1131-1111). The PCR
product was cut by BamHI and purified for ligation with 7.7 Kb backbone from BamHI
digested pLS3. Therefore, the pLS4 has a 2.5 Kb hybrid donor with a stretch of HSV2TK sequence followed by 2 stop codons.
Cell culture: Mouse Ltk- cell line and its derivative cell lines are cultured as
described in Chapter 2.
Cell line establishment: Mouse Ltk- cells were transfected with pLS4 through
electroporation and the cells with stable substrate integration were selected using G418.
The electroporation, selection and screening process were the same as described in
Chapter 2. Cell lines were chosen for further experiments if they have intact tandem
repeats and the signal indicates a single copy integration of the substrate.
Collection of DSB repair recombinant clones: To collect DSB repair
recombinants, electroporation of selected cell lines with pSce plasmid and subsequent
HAT selection were carried out as described in Chapter 3. HAT resistant clones were
ready to pick after 2 -3 weeks in selection, and the clone frequencies or HeR clone
frequencies were calculated the same as in Chapter 3. These clones were picked and
cultured for sequence analysis as described in Chapter 2.
PCR amplification and sequencing: The PCR and sequencing procedures were
described in Chapter 2.
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Analysis of DSB repair recombinants: All alignments were carried out in
SciEdCentral to compare recombinant sequence with reference sequences (engineered
hybrid donor sequence and HSV-1 TK recipient sequence). Through alignment,
conversion of mismatched nucleotide from HSV2-TK to HSV1-TK sequence on donor
would be revealed. Moreover, nucleotide callings at every mismatched postilion (m1 to
m30) were checked manually in chromatography.
Results:
Construction of substrates: the HindIII flanked donor was removed from
pBWW16 to generate pLS2. Compared with pBWW16, new pLS2 is linearized by
HindIII without releasing 0.7 kb fragment. pLS2 was confirmed through HindIII
digestion in Figure 4.8.
After 0.9 kb I-SceI disrupted HSV1-TK recipient was amplified from pBWW16’s
recipient, it was then ligated into the unique HindIII site of pLS2. Figure 4.9 confirmed
successful insertions of 0.9 Kb HSV1-TK recipient in 4 pLS1 plasmid: successful
insertion was observed in pLS1-7 to pLS1-10 (Lane 3 to Lane 6). Recipient in pLS1-8
has the correct sequence and direction according to DNA sequencing data, therefore, the
plasmid was renamed as pLS1 and used in following experiments.
The downstream 1.1 kb HSV1-TK sequence was amplified from pTK1 and
inserted into the BamHI site of pLS1. If the PCR product was corrected inserted, new
plasmid will show a longer vector fragment, and a 1 kb plasmid fragment after ClaI and
BamHI double digestion, as shown in Lane 3 of Figure 4.10. Double digestion by ClaI
and BamHI revealed pLS3-16 clone has 1.1 Kb HSV1-TK insertion with right direction
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(see Figure 4.10). plasmid pLS3-16 was confirmed by sequencing and renamed as pLS3
for subsequent experiments.
At the last step, 1.4 kb upstream HSV1-TK sequence was amplified from a
recombinant clone carrying 33 mismatched nucleotides, and then inserted into the unique
BamHI site of pLS3. BamHI digestion was used to revealed pLS4 clones with correct 1.4
Kb HSV1-TK insertion (see Figure 5.11). Successful insertions were found in pLS4-5B,
pLS4-6B and pLS4-8B. After sequencing, plasmid pLS4-6B has the insertion with
correct sequence and direction and finally renamed as pLS4.
Establishing cell lines pLS4: pLS4 was linearized at the unique ClaI site before
transfection and the substrates was transfected into mouse Ltk- cells through
electroporation as described before. Totally 29 G418 resistant clone (pLS4-1 to pLS4-29)
were picked, cultured and screened on Southern blots for single copy integration of the
substrate.
Screening cell lines with single copy integration of substrate: Genomic DNA
from each clone was digested using HindIII or BamHI for Southern blot. In HindIII
digestion, the cell line with intact substrate should show a DNA fragment lining up with
the 0.9 Kb recipient, and a junction fragment larger than 6.9 Kb, the size of remaining
non-recipient fragment. Similarly, in BamHI digestion, the cell line should have a DNA
fragment lining up with a 1.4Kb donor fragment, and a junction fragment larger than 6.3
Kb. All cell lines in use were checked by both digestion to make sure they have intact
donor and recipient.
Selected Southern blot images of pLS4 stably transfected cell lines are shown in
Figure 4.12 and Figure 4.13. The HSV-1 TK probe recognizes the HSV-1 TK recipient as
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Figure 4.8 Identification of plasmid pLS2 through HindIII digestion.
Lane 1, HindIII digested pBWW16. Lane 2, HindIII digested pLS2. The 8.3 Kb and 0.7
Kb labels point to the backbone fragment and donor fragment of digested pBWW16.
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Figure 4.9 Plasmids pLS1 were confirmed with 0.9 Kb recipient insertion through
HindIII digestion.
Lane 1 to 7, HindIII digestion of plasmid from clone pLS1-5 to pLS1-11.
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Figure 4.10 Plasmid pLS3 with 1.1 Kb donor insertion was confirmed by BamHI and
ClaI double digestion.
Lane 1 to 8, double digested plasmid from clone pLS3-14 to pLS1-21.
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Figure 4.11 Plasmids pLS4 with 1.4 Kb donor insertion were confirmed by BamHI
digestion.
Lane 1 to 8, BamHI digestion of plasmid from clone pLS4-1B to pLS4-8B.
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Figure 4.12 Identification of pLS4 cell lines with correct substrate integration by HindIII
digestion.
The size of recipient was examined as described above. Lane 1 to 15, HindIII digested
genomic DNA of pLS4 stably integrated cell lines: pLS4-2 to pLS4-11, pLS18, pLS4-20,
plS4-21, pLS4-23 and pLS4-26. Cell lines pLS4-5 (lane 4), pLS4-7 (lane6) and pLS4-23
(lane 14) were chosen for following experiments.
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Figure 4.13 Identification of pLS4 cell lines with correct substrate integration by BamHI
digestion.
The size of donor fragment was screened as described above. Lane 1 to 14, BamHI
digested genomic DNA of pLS4 stably integrated cell lines: pLS4-3 to pLS4-11, pLS18,
pLS4-20, plS4-21, pLS4-23 and pLS4-26. Cell lines pLS4-5 (lane 3), pLS4-7 (lane5) and
pLS4-23 (lane 13) were chosen for following experiments.
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well as the hybrid donors. Cell lines were chosen for future experiments only when they
have intact donor and recipient fragments.
The Southern blot results of selected cell lines pLS4-5, pLS4-7, pLS4-23 were
labeled in these figures (Figure 4.12 and Figure 4.13). The plasmid digestions on these
blots were not as expected, and failed to indicate the correct molecular weight. Therefore,
the 6.6 kb MW maker was used to estimate the size of junction fragment. Junction
fragments in chosen cell lines were much larger than 6.6 kb, supposedly having intact
donor and recipient.
Collection of DSB repair recombination events: for each selected cell line, 4
electroporation experiments were initially attempted to collect DSBR recombinants. All
three cell lines have similar plating efficiency (around 30%) after electroporation, while
only pLS4-7 generated HAT resistant clones within 4 attempts. Totally, 23 resistant
clones were selected from roughly 20 million cells of pLS4-7 after I-SceI expression.
When electroporation was carried out on cell lines pLS4-5 and pLS4-23, 5 million
untreated cells were plated in HAT selection to check potential existed spontaneous
recombinant. No recombinant grew up in these selections either. Four mock
electroporation experiments were carried out later on for pLS4-7 cell line using 1 X TE
instead of pSce, while surprisingly, 83 resistant clones grew up in HAT selection from 20
million cells.
The hybrid donor sequences in pLS4-7 cell line, and 4 resistant clones from pSce
transfection were amplified and sequenced as before. The results show that they all carry
the original hybrid donor sequence with stop codons. So far, no induction of DSBR

141

recombinants was observed in examined cell lines and no desired DSBR recombinants
were recovered in performed experiments.
Discussion:
Designed substrate to collect recombinants from dHJs resolution: As
proposed in introduction, current recombination substrate was designed to collect only
recombinant clones from dHJs resolution. Analysis of this type of recombinant could tell
whether HJs resolution requires proper homology to resolve, and whether DSB affects
homology requirement of HJ resolution.
Ideally, if DSB-induced recombination have HJs established in nearby homology,
the HJ may anneal the homeologous sequences into mismatched hDNA. Upon
establishment, as long as HJs need proper homology to resolve, they have to resolve
outside the homeologous region and include the whole homeologous sequences in the
conversion tract.
Failure in recovery of desired DSBR recombinants: Because induction of DSB
induced recombinant clones was not observed across examined cell lines, the attempts
failed to collect recombinants solely from dHJs resolution during DSB repair.
Without obtaining conversion tracts on donor through Holliday junction
resolution, it remains unclear what relaxed homology requirement during DSB repair, the
nearby DSB or the pathway choice of SDSA.
Explanation and future direction: In meiosis, reciprocal conversion of two
participating DNA molecules were occasionally recovered after HR, while there are not
many reports studying the possible change in HR template in mitosis. In Dr. Orr-weaver
and Dr. Szostak’s original study on DSB-induced recombination between gapped plasmid
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and chromosome, 3 out of 72 recombination events possibly changed the chromosomal
donor after they repaired the gapped plasmid through gene conversion (98). However,
this phenomenon was barely reported in mitotic cells afterward even if periodically
observed.
The desired gene conversion events changing donor as well as the recipient DNA
are expected to occur at low frequency during mitosis. First, the predominant HR
pathway in DSB repair is assumed to be SDSA, and only a small fraction of HR would
progress into HJs intermediate (19). Second, Holliday junction dissolution could resolve
dHJs without altering donor (21), and then the rest events may diverge into crossover or
gene conversion events with even smaller probability.
MMR may reduce the chance to collect desired gene conversion events. Even HJ
migration and resolution do leave recipient’s DNA strand in donor, in the form of hDNA
intermediate, it may be restored back to original donor sequence. If the MMR prefers to
repair the hDNA intermediate toward the original sequence, it is even harder to recover
the gene conversion events on donor without intervention in MMR. Since it is
demonstrated that the deficiency of MMR does not alter the resolution site in
spontaneous recombination or DSB-induced recombination (Chapter 3), depleting MSH2
could be attempted next to preserve information from both strands of the hDNA
intermediate after HR. Ideally, after HJ resolution, hDNA intermediates left on donor are
not corrected by MMR, and their exogenous recipient strand would be preserved and
segregated to produce viable recombinants with conversion tract on donor sequence.
As discussed in introduction, the desired recombinants from HJ resolution are
probably too low to be detected in current experimental condition, and multiple rounds of
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electroporation may be needed to collect the expected recombinants. Second, if the MMR
prefers restoring donor’s hDNA toward its original sequences, the desired recombinants
are not recoverable in current condition. Depleting MSH2 may be attempted next to
reveal potential sequence change in donor brought by recipient through dHJs resolution.
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CHAPTER 5 RECQ4 AFFECTS THE PATHWAY CHOICE IN
HOMOLOGOUS RECOMBINATION DURING DSB REPAIR
RecQ4 helicase belongs to a conservative DNA helicase family which shares
homology with RecQ of bacteria (39, 99). There are five human RecQ like helicase,
while three of them, WRN, BLM and RecQ4 are directly linked to genetic diseases
characterized by genome instability, premature aging or cancer predisposition.
Deficiencies in RecQ helicases have such great impacts on genome maintenance that they
have been postulated to play roles in DNA replication, DSB-induced recombination and
telomeric maintenance. Current research and opinions on their functions are illustrated in
following paragraphs.
Werner syndrome arises from deficiency in RecQ helicase WRN, and the patients
show premature aging and cancer predisposition (39). WRN has multiple catalytic
activities on DNA, including 3’ to 5’ DNA helicase, DNA dependent ATPase, 5’ to 3’
exonuclease, and strand annealing. In vitro experiments show that WRN interacts with
DNA-PKcs and inhibits its function unless assembled with DNA and Ku70, while
conversely, DNA-PKcs also phosphorylates WRN in vitro and in vivo, though the impact
is not fully understood yet (65). Besides these direct interactions with NHEJ core
components, WRN has been proven critical in NHEJ events: WRN’s deficiency brings
more repair events with large deletions, indicating delayed NHEJ and a shift to A-NHEJ
(31, 100). A recent report revealed more details of WRN’s function and its effect on
NHEJ: study of NHEJ and A-NHEJ events in WRN deficient cells suggests that WRN
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promotes NHEJ, reduces A-NHEJ, and decreases the use of microhomology in end
joining. WRN’s catalytic activities, exonuclease and helicase are critical to NHEJ while
its solely presence inhibits A-NHEJ. Moreover, WRN significantly reduces CtIP’s
recruitment to DSB site, and inhibits progressive resection needed for HR and A-NHEJ
(41). Without WRN, the repair shifts toward A-NHEJ pathway, which promote telomere
fusion and chromosomal translocation. Consistent with existing reports, nearly half of
NHEJ events in WRN deficient cells collected in our laboratory have chromosomal
rearrangements, which were confirmed by Southern blot and cytological analysis
(unpublished data).
Bloom syndrome arises from mutations in BLM helicase, and BLM syndrome
patients have cancer predisposition in multiple tissues, while their cells have obvious
cytogenetic abnormality showing high frequency of SCE during mitosis (12, 13, 70).
Without proper function of BLM, crossover becomes preferred outcome of HR in BLM
deficient cells (70). As described before, crossover events in meiosis promote genetic
diversity and ensure correct separation of homologous chromosomes, however, when
somatic cells are forced to repair lethal DSB lesions, crossover is neither necessary nor
optimal outcome. In BLM deficient cells, elevated crossover between homologous
chromosome is conceivable, which may facilitate LOH and contribute to the development
of a wide spectrum of cancer (9, 101).
The similar roles BLM plays at two HR steps explain the bias toward crossover in
BLM deficient cells. First, BLM could unwind newly synthesized DNA strand from its
template, allowing it to anneal back to the other resected DNA strand for ligation (102,
103). Therefore, BLM directs HR events toward the SDSA pathway instead of a dHJs
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intermediate, which has great potency to generate crossover (16, 19). Similar to
aforementioned function, BLM may cooperate with MMR to prevent homeologous
invasion at this earlier step of HR. Sgs1 (yeast homolog of BLM) interacts with MMR’s
components, recognizes and efficiently unwinds strand annealing with mismatched
nucleotides during SSA (68), so at strand invasion step, similar mismatched hDNA
within D-loop intermediate is likely unwound the same way. Although helicase UvrD of
E.coli interacts with MutS-MutL and unwinds the hDNA containing nucleotide
mismatches in vitro (87), the choice of helicase in mammalian cells could be different
and still need further investigation.
Secondly, BLM propels convergent movement of dHJs to hemicatenated DNA,
with two DNA duplexes conjoining through a single-strand interlock, and then the
hemicatenated linkage gets resolved by decatenation instead of HJs resolution (21, 99).
Hemicatenated or catenated structure frequently arises in DNA replication or DNA
recombination, and it needs prompt unlocking for subsequent segregation (104). In yeast,
epistatic effect was observed between sgs1, topoisomerase IIIα and RIM1 in resolving
this particular replicative lesion, which confirmed sgs1’s participation in DNA
decatenation (105–107). In following up biochemical assays, the complex was
reconstituted to drive convergent branch migration of HJs along DNA substrates and
detach DNA molecules in catenation (104, 108, 109). Similarly in mammalian cells,
BLM mediates the convergent branch migration of dHJs to a single-strand interlock,
which is readily resolved by associated topoisomerase IIIa and RMI1-RIM2 (22),
therefore, BLM manages to reduce crossover events during HR.
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RecQ4 deficiency causes Rothmund-Thomson syndrome, and the patients have
skeletal abnormalities and predisposition to malignant tumors (110). Cytological
evidences show RecQ4 deficient cells have issues in genome stability and proper
segregation of chromosome (111). RecQ4 participates in telomeric maintenance, and
protects chromosomes from telomere erosion. RecQ4 is also assembled in initiation
complex for replication (112). Overexpression of RecQ4 has been found in prostate
cancer, and its expression level correlates with the tumor grade, while depletion in RecQ4
reduces the tumor growth and invasiveness (113).
Moreover, RecQ4 participates in DSB repair. RecQ4 moves to the repair loci
earlier than other RecQ helicase members (BLM or WRN) (110) and the recruitment
depends on MRE11 (15). RecQ4’s unwinding activity is vital for the 5’ end resection and
it also helps to recruit CtIP to the repair site (15). RecQ4 also shows high affinity to
branched DNA substrate, especially HJs structure, therefore, it could help to resolve
DNA intermediates during replication or recombination (114). In Arabidopsis, RecQ4 is
reported with anti-crossover activity in meiosis similar to Top3a or FANCM (115).
Though suggested with multiple functions, RecQ4’s role during DSB repair still
lack systematic studies. Limited studies on RecQ4 in DNA repair were conducted in
mammalian cells, especially possible impact on DSB repair outcome. A recent published
paper described the interaction and potential cooperation between BLM and RecQ4
supported by cytological evidence (116), In their paper, SCE events in control cells and
patient’s BLM deficient cells were briefly compared before and after RecQ4 knockdown.
Due to the chronic stress BLM deficient cells went through, potential genetic changes
make them not optional experimental system for further manipulation. The comparison of
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recombination events immediately after the protein depletion, as conducted in current
chapter, would be better to avoid potential distortion from genetic background. Moreover,
the use of substrate pLB4-11 could present changes in multiple pathways for DSB repair,
and also subtle details of HR. If RecQ4 plays roles in DSB repair and affects the repair
outcome, different composition of DNA recombination events would be expected in
RecQ4 deficient cells.
pLB4-11 cell line has a chromosomal integrated recombination substrate pLB4,
which was designed to collect all types of DSB repair events. As shown in Figure 6.1,
pLB4 has a 2.5 kb full length tk gene and a 3.9 kb tk-neo fusion gene in tandem, and they
serve as donor and recipient in a HR events. The 2 kb DNA sequence separating tandem
repeats contains hygromycin resistance gene, which was used in substrate integration. An
I-SceI recognition site was engineered into the tk-neo fusion gene, and these 22 bp
oligonucleotide insertion shift the reading frame, so the tk-neo gene only produces a
truncated thymidine kinase protein. Initially the downstream neo gene is not expressed
due to the shifted reading frame of tk gene, until a recombination event restores the
correct reading frame for the fusion gene.
When I-SceI introduce a DSB into the tk-neo fusion gene, cells have chance to
rejoin the two broken ends and sometimes, regain the original reading frame for the
fusion gene. Therefore, DSB repair events may allow host cells to survive G418
selection, and form clones for sequence analysis. Reading frame could be restored in
several ways. First, HR could direct the resected DNA overhang to the nearby
homologous template, the tk gene sequence of donor, and the broken recipient sequence
would get restored to a continuous HSV-1 TK sequence, allowing translation of tk-neo
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fusion gene. The crossover events between donor and recipient would be recovered as
well because the upstream donor has full length tk gene carrying intact promoter. Second,
some NHEJ events may restore the reading frame to correctly translate neo gene. When
the number of deleted nucleotides happens to be 3N+1 bp, the rejoined DNA sequence
will resume the original reading frame, and the produced tk-neo fusion protein still render
host cells G418 resistance even with polypeptide loss in tk region. Third, SSA may rejoin
the broken DNA molecule through long stretch of homology shared by the two tandem
repeats. These events cause fusion of the two tk sequences and loss of DNA sequence inbetween. For substrate pLB4, SSA events cause 2.4 Kb deletion and generate a 3.9 Kb
fusion fragment. Technically, the recombinant clones from SSA events are
indistinguishable from crossover events, since they both fuse the donor and recipient.
Restriction map in Figure 5.1 demonstrates the expected bands from endonuclease
digested pLB4, and changes brought by different recombination events. If digested by
BamHI, the original substrate or gene conversion product will show a 3.9 Kb recipient
fragment and a 4.5 Kb junction fragment containing donor and hygromycin resistance
gene. The NHEJ product have the same 4.5 kb junction fragment as original pLB4, while
the recipient fragment would be smaller than 3.9 kb due to sequence deletion (not
obvious with short deletion). The crossover or SSA events would fuse aforementioned
two fragments into a 3.9 Kb “recipient” fragment, the only visible band on the blot.
To unveil the details of recombination events, thymidine kinase gene sequences
from two different strains of type 1 herpes simplex virus were placed in pLB4. Totally
13 nucleotide polymorphisms exist between the tk genes in donor and recipient (see
Figure 5.2). These 13 nucleotides were numerated by their position along the tk sequence.
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Figure 5.1 Restriction map of substrate pLB4 and possible recombinants.
Recombination substrate pLB4 has two tandem repeats: the 3.9 Kb recipient of tk-neo
fusion gene and the 2.5 Kb donor of tk gene. Recognition site of I-SceI was inserted into
the tk sequence of the recipient. The 22 bp oligonucleotide insertion shifts the original
reading frame and aborts the function of downstream neo gene. The restriction map of the
gene conversion and crossover products is shown below. Adapted from Wang et al. 2016
(70).
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There are 4 mismatched nucleotides upstream of the I-SceI site: the first 3 mismatches
cluster together about 400 bp away from the I-SceI site while the last one located within
20 bp. The fifth nucleotide is 2 bp after the I-SceI site, and the rest 8 mismatches start
200 bp downstream of the I-SceI site, spanning around 400 bp. The nucleotide
polymorphism within tk-neo recipient helps to delineate NHEJ and HR events, because
HR may convert recipient’s nucleotide to donor at these positions.
Materials and Methods:
Transient knockdown of RecQ4, BLM or both in human fibroblast cell line
pLB4-11: Transfections of RecQ4 siRNA were carried out using Qiagen HiPerfect
Transfection Reagent following the supplier’s instructions. On the first day, 1.5 x105 cells
were plated in 35 mm dish with 2.3 mL culture media (а-MEM supplied with 10% FBS).
On the second day, 12 uL of 10 uM siRNA solution was mixed gently with 88 uL аMEM in 1.5 mL Eppendorf tube, and then with 12 uL HiPerfect Transfection Reagent.
The mixture was gently vortexed and kept at room temperature for 10 minutes to allow
formation of transfection complex. Afterward, the siRNA mixture was added drop-wisely
onto the cells, and the dish was gently swirled back and forth to ensure even distribution.
On the third day, the dish was refilled with fresh media 2-3 hours before the second
siRNA transfection. The transfection procedure was the same as performed a day before.
The calculated siRNA concentration is always 50 nM in RecQ4 knockdown experiments.
The double knockdown experiments employed the same procedure as described
for RecQ4 knockdown experiments, while the amount of siRNA was adjusted
accordingly. Control siRNA, BLM siRNA and RecQ4 siRNA were added at a final
concentration of 75 nM, 25 nM and 50 nM in corresponding experimental groups, while
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Figure 5.2 Mismatched nucleotides between donor and recipient in pLB4.
Totally 13 nucleotide mismatches were highlighted and numbered in the sequence
alignment. Bold font was used to show the 22 bp insertion with I-SceI recognition site
capitalized. Adapted from Wang et al. 2016 (70).
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in BLM and RecQ4 double knockdown group, two siRNA were added at the same
concentrations as in their own knockdown groups.
All mentioned siRNAs targeting RecQ4 or BLM with commercial name
FlexiTube siRNA, were bought from Qiagen. RecQ siRNA#2 (Cat. No SI00061852) and
RecQ siRNA#3 (Cat. No SI00061859) target RecQ4 transcript in human cells. BLM
siRNA#3 (Cat. No SI00000952) targets BLM transcript in human cells. A negative
control siRNA not targeting human transcripts was also purchased from Qiagen (Cat. No
1027310).
Recovery of DSB repair recombinant clones: To collect recombinant clones
from DSB repair, pSce was electroporated into cells 24 hours after the second siRNA
transfection. The cells were trypsinized from 35 mm dish, suspended in culture media
and then counted on a hemocytometer. For each experimental group, 2.5 x105 cells were
transferred into a 15 mL conical tube for electroporation while all the rest cells,
approximately 3.5-4.5 x105 cells, were cultured in T25 for another day before lyzed to
extract protein sample.
For transfection, the conical tubes containing 2.5 x105 cells were centrifuged at
300 X g for 3 minutes. After removing the supernatant, the pelleted cells were suspended
in 3 mL phosphate buffered saline (PBS), and then centrifuged as described above. The
newly pelleted cells were suspended in 300 uL PBS before electroporation. To start the
electroporation, 2.4 uL DNA solution containing 7.5 ug pSce plasmid, and then the 300
uL cells suspension were added into a cuvette with 0.4 mm gap width. The DNA and
cells were mixed together by pipetting 3 to 4 times. All electroporation experiments were
carried out using Bio-Rad Gene Pulser set to 700 volts and 25 uF. Immediately after
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electroporation, cells were transferred into a T25 with 5 mL culture medium, and they
were incubated for two days before G418 selection.
The G418 selections were carried out at 1000 ug/mL from previous experience,
and for an appropriate colony density, no more than 5 x104 cells were plated per T75
flask. Discrete colonies usually formed within 14 days and they were randomly picked
and cultured for further analysis.
Preparation of protein sample: The procedure to exact soluble protein samples
was the same as described in Chapter 4.
Protein electrophoresis and transferring: The procedure has been carried out
the same as described in Chapter 3. The transferring condition for BLM was described in
previous paragraph but the transferring was set at 450 mA for 90 minutes. The
transferring buffer for RecQ4 does not contain 0.1% SDS and the transferring was set
100 volts for 90 minutes.
RecQ4 deficient lymphocyte cell lines AG18465 from Coriell Institute for
Medical Research was used as negative control in western blotting, while BLM deficient
human fibroblast cells GM08505 was obtained from NIGMS.
Western blot: The Western blot procedure was described in details in Chapter 4.
The primary and secondary antibodies were both diluted at 1: 10, 000 to detect tubulin,
while they were diluted at 1: 500 and 1: 25, 000 for RecQ4, or diluted at 1: 8, 000 and 25,
000 for BLM. As instructed by the supplier, the blocking and incubation of RecQ4
primary antibody were carried out in TBS solution with 5% BSA instead of 0.1% TBST
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Calculation of clone frequency: After clone picking, all T75 flasks were stained
and the remaining clones were counted. For each experimental group, the total clone
number was divided by the cells number in G418 selection to obtain the clone frequency.
PCR amplification: The PCR procedures was described in Chapter 2. AW85 and
AW133 were used to amplify tk-neo sequence including the 13 nucleotide mismatches
between donor and recipient, so any nucleotide change within the area would be revealed
by DNA sequencing.
Sequencing and alignment: The sequencing procedure was described in Chapter
3. Nucleotide sequences from these recombinant clones were aligned to recipient
sequence and donor sequences for any nucleotide change using SciEdCentral.
Southern blot: The genomic DNA of these recombinant clones was digested by
BamHI, and then separated on 0.8% agarose gel for Southern blot. The procedure was the
same as described in Chapter 2.
Results:
Knockdown of RecQ4 in human fibroblast cell line pLB4-11: Successful
knockdown of RecQ4 was achieved in pLB4-11 cell line after two consecutive siRNA
transfections. Figure 5.3 shows the RecQ4 expression in the RecQ4 knockdown
experiment 1. Cellular RecQ4 expression in Mock (only treated with transfection reagent
but without siRNA) and control siRNA group is high while its expression is barely
detectable in RecQ4 siRNA #2 group and RecQ4 siRNA #3 group.
Figure 5.4 demonstrated that RecQ4 knockdown was performed successfully in
second experiment. Moreover, the lane 6 was loaded with 15 ug protein sample from
RecQ4 deficient cells and 15 ug protein sample from mock to mimic 50% RecQ4
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Figure 5.3 Knockdown of RecQ4 was achieved in RecQ4 knockdown experiment 1.
Protein extract (30ug) from following cells are shown in western blot: Lane 1, RecQ4
deficient cells; lane 2, control siRNA group; lane 3, Mock; lane 4, RecQ4 siRNA #2
group; lane 5, RecQ4 siRNA #3 group.
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Figure 5.4 Knockdown of RecQ4 was achieved in RecQ4 knockdown experiment 2.
Protein extract (30ug) from following cells are shown in western blot: Lane 1, RecQ4
deficient cells; lane 2, control siRNA group; lane 3, Mock; lane 4, RecQ4 siRNA #2
group; lane 5, RecQ4 siRNA #3 group; lane 6, mixture of 15ug protein sample from
RecQ4 deficient cell and Mock.
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expression. RecQ4 expression in both RecQ4 siRNA groups is obviously lower than the
last lane, and it is estimated that 75% knockdown efficiency was achieved in both RecQ4
knockdown groups.
Knockdown of RecQ4, BLM or Both in human fibroblast cell line pLB4-11:
Knockdown of RecQ4, BLM or both was achieved in pLB4-11 cell line before transient
expression of I-SceI. In first double knockdown experiment, as shown in Figure 5.5,
knockdown of RecQ4, BLM and both in pLB4-11 were achieved in corresponding
experimental groups. BLM and RecQ4 expression in parental cell line, untreated group
and control siRNA group are equivalent; expression of BLM is dramatically lower in
BLM siRNA group or RecQ4 and BLM double siRNA groups; and minor RecQ4
expression is seen in RecQ4 siRNA groups or RecQ4 and BLM double siRNA groups.
Tubulin served as internal control across these samples, and its image in Figure 5.5 came
from the blot of RecQ4. Detection of Tubulin was not stable after protein transferring
optimized for BLM (400 mA, 90 minutes with 0.1% SDS), however, stained acrylamide
gel or stained nitrocellulose membrane after transferring showed that protein loadings
were equal across samples (data not shown). RecQ4 and BLM expression in double
knockdown experiment 2 are shown in Figure 5.6. BLM and RecQ4 expression were
dramatically reduced in corresponding groups before induction of DNA DSB.
Collection of DSB-induced recombinant clones: To collect DSB-induced
recombinant clones from these experimental groups, I-SceI was transiently expressed in
cells through electroporation of pSce. After I-SceI introduced a DSB within the recipient,
the broken DNA sequence may be repaired through HR, SSA or NHEJ events. If the
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Figure 5.5 Knockdown of BLM and RecQ4 was confirmed in RecQ4 and BLM double
knockdown experiment 1.
Protein extract (30ug) from the following cells are shown in Western blot: Lane 1, cell
line pLB4-11; lane 2, untreated group; lane 3, control siRNA group; lane 4, BLM siRNA
group; lane 5, RecQ4 siRNA group; lane 6, RecQ4 and BLM double siRNA group; lane
7, BLM deficient cells in top panel while RecQ4 deficient cells in middle and low panel
The minor bands in RecQ4 panel are likely artifact due to intense signal of main bands.
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Figure 5.6 Knockdown of BLM and RecQ4 was confirmed in RecQ4 and BLM double
knockdown experiment 2.
Protein extract (30ug) from the following cells are shown in western blot: Lane 1,
untreated group; lane 2, control siRNA group; lane 3, RecQ4 siRNA group; lane 4, BLM
siRNA group; lane 5, RecQ4 and BLM double siRNA group; lane 6, BLM deficient cells
in top panel while RecQ4 deficient cells in middle and low panel. The minor bands in
RecQ4 panel are likely artifact during film exposure due to intense signal.
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DNA repair restores the correct reading frame for the tk-neo gene in recipient, the host
cell will become G418 resistant and form recombinant clone.
DSB-induced recombinant clones from different experimental groups were
recovered from two times of RecQ4 knockdown experiment and two times of RecQ 4 and
BLM knockdown experiments. The clone frequencies and clones analyzed for each
experimental group in each experiment are all listed in Table 5.1. Clone frequencies
observed in these experimental groups range from 1.74X10-3 to 1.10X10-2. In each
experiment, the clone frequencies across the experimental groups are close though cells
may have different genetic background. The clone frequencies after RecQ4 knockdown
are not different from those in control groups, with a p-value equals 0.413 from student’s
test, while BLM knockdown brings slightly higher clone frequencies than the rest groups.
Categorization of DSB repair recombinant clones: Recombinant clones from
DSB repair are categorized based on their recipient sequences. If the recipients are
restored to continuous HSV-1 TK sequence, losing the 22 bp oligonucleotide insertion,
these events are classified as HR. HR events also convert some of the 13 nucleotide
mismatches to donor, and left a conversion tract in recipient for each HR event. The HR
events are further separated into gene conversion and crossover events: crossover results
in the fusion of donor and recipient, in addition to aforementioned 22 bp deletion and
conversion of nucleotide.
If the recipient lost a stretch of nucleotide around the break site after end
rejoining, they are categorized as NHEJ events. NHEJ events do not have any nucleotide
mismatches converted to donor, and almost all NHEJ events have sequence deletions
other than the loss of 22 bp oligonucleotide in HR. Occasionally, there might be NHEJ
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Table 5.1 Clone frequencies and analyzed clones in knockdown experiments.
Experiment
RecQ4 knockdown

Expt #
1

2

RecQ4 and BLM
double knockdown

1

2

Experimental group
Control siRNA

Clone
frequency
(10-3)
1.74

Colonies
analyzed
58

Mock

3.73

55

RecQ4 siRNA #2

4.38

58

RecQ4 siRNA #3

2.76

51

Control siRNA

4.90

28

Mock

6.00

25

RecQ4 siRNA #2

4.38

27

RecQ4 siRNA #3

4.76

27

Untreated
Control siRNA

6.19
4.15

28
26

BLM siRNA

6.60

27

RecQ4 siRNA

4.30

30

RecQ4&BLM siRNA

5.11

25

Untreated

8.38

16

Control siRNA

7.89

14

BLM siRNA

10.97

19

RecQ4 siRNA

6.55

19

RecQ4&BLM siRNA

9.54

18

The clone frequencies were calculated as described in Materials and Methods.
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events precisely removing the 22 bp oligonucleotide insertion without conversion of
mismatches 5, which should be always converted in HR events due to its extremely
closeness to the DSB site.
There are also complicated events which could not be simply assigned to either
HR or NHEJ. Some sporadic events were found to be combinations of HR and NHEJ
repair. They converted nucleotide mismatches to donor, and they also lost oligonucleotide
other than the 22 bp engineered insertion.
Changes in DSB repair recombinant clones after RecQ4 knockdown: As
shown on top in Table 5.2, the majority of DSB repair recombinant clones in RecQ4
knockdown experiments are product of HR events, with nucleotide mismatches converted
to donor. NHEJ events compose about one third of all DSB repair events, either in control
cells or in RecQ4 knockdown cells: there are totally 118 HR events and 41 NHEJ events
recovered in control cells, while 102 HR events and 45 NHEJ events in RecQ4
knockdown cells.
The proportion of gene conversion in HR events changed after RecQ4
knockdown. With reduced RecQ4 expression, more recombinant clones of gene
conversion event appeared as the result. Polling data from two RecQ4 knockdown
experiments, the control groups have 53 gene conversion recombinant clones and 65
crossover recombinant clones, while RecQ4 knockdown cells have 60 gene conversion
recombinant clones and 43 crossover recombinant clones. After RecQ4 knockdown, the
increase of gene conversion events is substantial, however, the Fisher’s exact test
comparing the ratio between HR subtypes in control and RecQ4 knockdown cells gives
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Table 5.2 DSB repair recombinants in knockdown experiments.
Experiment
RecQ4

Expt
#
1

knockdown

2

RecQ4 and

1

BLM
knockdown

2

Experimental group
Control siRNA

Clone
analyzed
58

GC

CO

NHEJ

COMPLEX

19

25

11

3

Mock

55

14

19

19

3

RecQ4 siRNA #2

58

19

15

16

8

RecQ4 siRNA #3

51

20

16

11

4

Control siRNA

28

10

8

9

1

Mock

25

10

13

2

0

RecQ4 siRNA #2

27

9

6

9

3

RecQ4 siRNA #3

27

12

6

9

0

Untreated

28

8

12

6

2

Control siRNA

26

14

8

3

1

BLM siRNA

27

7

15

4

1

RecQ4 siRNA

30

13

10

7

0

RecQ4&BLM siRNA

25

12

9

3

1

Untreated
Control siRNA

16
14

6
7

7
4

2
2

1
1

BLM siRNA

19

5

14

0

0

RecQ4 siRNA

19

5

9

4

1

RecQ4&BLM siRNA

18

4

9

5

0

GC: gene conversion; CO: crossover; NHEJ: non-homologous end joining
Recombinant clones were grouped into NHEJ, HR or complex events based on their
recipient sequence as described before. If the events are combinations of NHEJ and HR,
or have other rare alterations of sequence, they are grouped as complex events.
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p=0.0590, which states the difference is probably close to, however, not statistically
significant.
Changes in DSB repair recombinant clones after BLM knockdown: in double
knockdown experiments, DSB repair recombinant clones were collected from untreated,
control, BLM knockdown, RecQ4 knockdown or BLM and RecQ4 double knockdown
cells. In BLM knockdown groups, vast majority of HR events are crossover. Fisher exact
test comparing HR subtypes before or after BLM knockdown gives p=0.0177, while the
same test comparing HR subtypes before or after BLM and RecQ4 double knockdown
gives p=0.6867.
Conversion tracts in gene conversion events: During gene conversion, all or
part of the 13 nucleotide mismatches were transferred from donor to recipient. Table 5.3
and 6.4 lists the transferring of donor’s nucleotides to recipient in these gene conversion
events. Short conversion tracts dominate in all experimental groups, and most of them
just converted mismatches 4 and 5, these two closest to I-SceI site. Some short
conversion tracts only converted mismatches 5. All short conversion tracts described
above are shorter than 600 bp (distance between mismatches 3 and 6). For each
experimental group, recombinant clones with the same conversion tract are listed in one
cell at the end of the chart.
The gene conversion tracts in RecQ4 and BLM double knockdown experiments
are listed in Table 5.4 and they were labeled the same way as in Table 5.3.
Donor’s mismatched nucleotides left in fusion sequence after crossover
events: In crossover events, fusion sequences always possess donor’s nucleotides before
the I-SceI, and beyond that, they may have more donor’s nucleotides until crossover
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Table 5.3 Gene conversion tracts in RecQ4 knockdown experiments.
Expt.
#
1

Experimental
group

Converted
nucleotides in GC
events
4, 5

Clone
number

4 to 11

1

Mock

5
4, 5

2
12

RM1BG, RM1BY
RM1D, RM1F, RM1I, RM1J, RM1O,
RM1Q, RM1BC, RM1BD, RM1BL,
RM1BQ, RM1BV, RM1CI

RecQ4
siRNA #2

5
4, 5

2
15

1 to 5

1

RR21T, RR21CD
RR21E, RR21F, RR21G, RR21Q, RR21U,
RR21W, RR21BA, RR21BC, RR21BE,
RR21BT, RR21BV, RR21BW, RR21BX,
RR21CA, RR21CE
RR21BI

1 to 12

1

RR21O

5
4, 5

2
14

1 to 5
4 to 8
1 to 12

2
1
1

RR31V, RR31BA
RR31E, RR31I, RR31L, RR31N, RR31R,
RR31T, RR31U, RR31W, RR31BE,
RR31BG, RR31BM, RR31BT, RR31CA,
RR31H
RR31Q, RR31BY
RR31A
RR31M

Control siRNA

4, 5

10

RC3W, RC3U, RC3T, RC3O, RC3J, RC3I,
RC3H, RC3BD, RC3B, RC3A

Mock

5
4, 5

2
6

4 to 11
4 to 12

1
1

RM3M, RM3BC
RM3X, RM3Z, RM3V, RM3S, RM3J,
RM3E
RM3D
RM3H

RecQ4
siRNA #2

5
4, 5
1 to 5

3
5
1

R23Z, R23J, R23BC
R23S, R23P, R23L, R23G, R23C
R23V

RecQ4
siRNA #3

5
4, 5

2
9

1 to 5

1

R33Q, R33C
R33N, R33M, R33L, R33K, R33J, R33I,
R33G, R33E, R33D
R33T

Control siRNA

RecQ4
siRNA #3

2

18
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Clone name
RC1J, RC1K, RC1O, RC1R, RC1S, RC1T,
RC1U, RC1BA, RC1BN, RC1BP, RC1BQ,
RC1BR, RC1BS, RC1BW, RC1CA,
RC1CC, RC1CD, RC1CI
RC1M

Table 5.4 Gene conversion tracts of DSB repair recombinants in RecQ4 and BLM double
knockdown experiments.
Expt
#
1

Experimental
group

Converted
nucleotides in
GC events

Clone
number

Untreated

4, 5

8

RBU1Y, RBU1R, RBU1Q, RBU1O,
RBU1N, RBU1F, RBU1D, RBU1A

Control siRNA

5
4, 5

1
11

4 to 10

2

RBC1O
RBC1C, RBC1D, RBC1H, RBC1I, RBC1N,
RBC1P, RBC1S, RBC1T, RBC1X, RBC1Y,
RBC1BD
RBC1BB, RBC1E

45
1 to 10
1 to 11
4 to 12

4
1
1
1

RBB1K, RBB1L, RBB1P, RBB1Z,
RBB1X
RBB1I
RBB1G

4, 5

11

1 to 5
4 to 12

1
1

RBR1BB, RBR1BC, RBR1BD, RBR1E,
RBR1J, RBR1K, RBR1L, RBR1Q, RBR1R,
RBR1S, RBR1X
RBR1O
RBR1W

5
4, 5

3
8

4 to 12

1

Untreated

4, 5

6

RBU3B, RBU3F, RBU3H, RBU3L, RBU3P,
RBU3T

Control siRNA

4, 5

6

4 to 7

1

RBC3B, RBC3F, RBC3K, RBC3M,
RBC3N, RBC3T
RBC3C

5
4, 5

1
4

RBB3K,
RBB3F, RBB3G, RBB3O, RBB3Q

RecQ4 siRNA

5
4, 5
3 to 10

1
3
1

RBR3J,
RBR3C, RBR3I, RBR3N
RBR3G

BLM&RecQ4
siRNA

5
4, 5

2
2

RBRB3I, RBRB3Q
RBRB3L, RBRB3R

BLM siRNA

RecQ4 siRNA

BLM&RecQ4
siRNA

2

BLM siRNA
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Clone name

RBRB1B, RBRB1BC, RBRB1D
RBRB1A, RBRB1BD, RBRB1H, RBRB1I,
RBRB1O, RBRB1R, RBRB1S, RBRB1Y
RBRB1C

occurs. The possession of donor’s mismatched nucleotides in crossover events is listed in
Table 5.5 and Table 5.6. The crossover events are categorized into multiple groups with
the same amount of donor’s mismatched nucleotide: for example, crossover events that
have donor’s nucleotide 1 to nucleotide 5 (right after I-SceI), and other crossover events
that have specific amount of donor’s nucleotides. The possession of donor’s mismatched
nucleotides in crossover events are not that different across experimental groups, and no
obvious correlation was found between the number of donor nucleotides and the genetic
background.
NHEJ events: The NHEJ events and their clone information are listed in Table
5.7 and Table 5.8. For each clone, deletion size and potential usage of microhomology
are described. The sequence deletions in NHEJ events range from 1 bp to 1018 bp, and
they are always 3N+1 bp in length, which restored the original reading frame for the tkneo fusion gene. Frequently, microhomology was utilized to rejoin the broken DNA ends
during NHEJ: if the broken ends of DNA go through end resection, short complementary
DNA sequences could be revealed on both side and they are able to anneal for end
rejoining. NHEJ events in pLB4-11 cells are not different from that in RecQ4 knockdown
conditions: they are minority in DSB repair events. NHEJ events in pLB4-11 cells tends
to be lower after BLM knockdown, however, it is not statistically significant compared
with that in control cells.
Discussion:
Types of DSB-induced recombination: NHEJ and HR are two prominent
pathways to repair DNA double-strand breaks in mammalian cells (30, 32, 34). In
agreement with previous reports, these two types of events comprise the vast majority of
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Table 5.5 Position of donor’s mismatched nucleotides in crossover events (RecQ4
knockdown experiments).

Expt #
1

Group
Control
siRNA

Donor's
nucleotide

Clone
number

Clone name

1 to 5

13

1 to 8

3

RC1V, RC1Y, RC1BC, RC1BG, RC1BH,
RC1BL, RC1BM, RC1BT, RC1BU, RC1BZ,
RC1CB, RC1CF, RC1CH
RC1BF, RC1BJ, RC1BK

1 to 9

1

RC1BX

1 to 10

1

RC1P

1 to 11

2

RC1E, RC1BD

1 to 12

3

RC1X, RC1CE, RC1Z

1 to 13

2

RC1N, RC1BO

Mock

1 to 5
1 to 8
1 to 8
1 to 9
1 to 10
1 to 11
1 to 12
1 to 13

3
1
1
2
5
1
4
2

RM1V, RM1Y, RM1CE
RM1CD
RM1BP
RM1CC, RM1BN
RM1E, RM1G, RM1S, RM1BF, RM1BX
RM1W
RM1X, RM1Z, RM1BM, RM1BT
RM1BI, RM1CB

RecQ4
siRNA #2

1 to 5

5

1 to 8
1 to 9
1 to 10
1 to 11
1 to 12
1 to 13

1
1
3
1
3
1

RR21V, RR21BH, RR21BR, RR21BS,
RR21BY
RR21R
RR21BO
RR21J, RR21BK, RR21H
RR21L
RR21N, RR21BG, RR21BQ
RR21P

1 to 5

5

1 to 7
1 to 9

1
3

RR31J, RR31Y, RR31BR, RR31BS,
RR31CH
RR31BZ
RR31B, RR31G, RR31BN

1 to 10
1 to 12
1 to 13

3
3
1

RR31P, RR31BH, RR31BP
RR31CD, RR31CI, RR31BO
RR31BU

RecQ4
siRNA #3
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Table 5.5 continued
Expt #
2

Group

Donor's
nucleotide

Clone
number

Control

1 to 5

3

RC3Y, RC3N, RC3E

siRNA

1 to 8

1

RC3C

1 to 10

1

RC3P

1 to 11

1

RC3D

1 to 12

1

RC3S

1 to 13

1

RC3BC

1 to 5

3

RM3Q, RM3G, RM3B

1 to 8

2

RM3P, RM3O

1 to 9

1

RM3W

1 to 10

1

RM3U

1 to 11

2

RM3I, RM3A

1 to 12

4

RM3BA, RM3Y, RM3N, RM3BB

RecQ4

1 to 8

1

R23H

siRNA #2

1 to 10

1

R23N

1 to 12

2

R23Q, R23BD

1 to 13

2

R23F, R23A

RecQ4

1 to 5

1

R33Z

siRNA #3

1 to 8

1

RR31O

1 to 9

2

R33B, R33H,

1 to 12

2

R33S, R33P

Mock
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Clone name

Table 5.6 Position of donor’s mismatched nucleotides in crossover events (RecQ4&BLM
knockdown experiments).
Expt #
1

Group

Donor's
nucleotide
1 to 5

Clone
number
3

1 to 9

1

RBU1B

1 to 10

2

RBU1J, RBU1X

1 to 11

1

RBU1T

1 to 12

4

RBU1BD, RBU1M, RBU1G, RBU1BC,

1 to 13

1

RBU1W

1 to 5

1

RBC1A

1 to 6

1

RBC1Q

1 to 9

1

RBC1B

1 to 10

3

RBC1F, RBC1G, RBC1K,

1 to 12

2

RBC1V, RBC1BC

1 to 5

3

RBB1BB, RBB1O, RBB1U

1 to 9

2

RBB1S, RBB1BD

1 to 10

4

RBB1E, RBB1Q, RBB1R, RBB1A

1 to 11

1

RBB1B

1 to 12

3

RBB1J, RBB1M, RBB1C

1 to 13

2

RBB1BC, RBB1D

1 to 5

6

1 to 8

1

RBR1P, RBR1A, RBR1C, RBR1G, RBR1N,
RBR1U
RBR1Y

1 to 9

2

RBR1BA, RBR1M

1 to 12

1

RBR1T

BLM&RecQ4

1 to 5

1

RBRB1V

siRNA

1 to 8

1

RBRB1T

1 to 10

2

RBRB1L, RBRB1U

1 to 11

1

RBRB1F

1 to 12

4

RBRB1X, RBRB1G, RBRB1J, RBRB1Q

Untreated

Control
siRNA

BLM siRNA

RecQ4
siRNA

Clone
RBU1Z, RBU1V, RBU1K

172

Table 5.6 continued
Expt #
2

Group

Donor's
nucleotide
1 to 5

Clone
number
3

1 to 10

1

RBU3S

1 to 12

2

RBU3G, RBU3J

1 to 13

1

RBU3N

Control

1 to 5

1

RBC3A,

siRNA

1 to 9

1

RBC3I

1 to 10

1

RBC3D

1 to 12

1

RBC3O

1 to 5

2

RBB3E, RBB3N

1 to 7

1

RBB3C

1 to 8

2

RBB3D, RBB3P

1 to 9

1

RBB3T

1 to 10

3

RBB3I, RBB3B, RBB3H

1 to 11

1

RBB3L

1 to 12

4

RBB3A, RBB3M, RBB3R, RBB3S

RecQ4

1 to 5

2

RBR3A, RBR3Q

siRNA

1 to 8

2

RBR3F, RBR3K

Untreated

BLM siRNA

BLM&RecQ4
siRNA

Clone
RBU3A, RBU3K, RBU3M

1 to 9

1

RBR3R

1 to 10

2

RBR3B, RBR3L

1 to 12

1

RBR3O

1 to 13

1

RBR3S

1 to 5

6

1 to 10

1

RBRB3F, RBRB3G, RBRB3H, RBRB3M,
RBRB3N, RBRB3S,
RBRB3E

1 to 12

2

RBRB3J, RBRB3O

173

Table 5.7 NHEJ events and clone information in RecQ4 knockdown experiments.
Expt #
1

Group

Deletion
size (bp)

Microhomology

Control siRNA

10
22
22
22
28
133
169
241
256
295

GG
AGCT
AGCT
A
GGG
CAGGGT
GCCGT
GC
G
TA

RC1I
RC1A
RC1G
RC1Q
RC1W
RC1CG
RC1L
RC1BE
RC1H
RC1BI

Mock

1
1
4
7
7
10
10
22
22
22
22
43
118
145
148
307
343
685
1018

A
A
A
A
G
GG
A
0
AGCT
AGCT
AGCT
GG
AGC
AACA
ACA
C
GCCC
ACG
C

RM1T
RM1CA
RM1CF
RM1BS
RM1BZ
RM1C
RM1BK
RM1H
RM1R
RM1BH
RM1BJ
RM1BW
RM1K
RM1L
RM1A
RM1BU
RM1BR
RM1BA
RM1CH
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Clone
name

Table 5.7 continued
Expt #
1

Group

Deletion
size (bp)

Microhomology

Clone
name

RecQ4 siRNA #2

1
1
1
1
4
10
10
22
22
22
22
25
133
157
244
427

A
A
G
A
0
GG
GG
AGCT
AGCT
AGCT
AGCT
G
A
C
GC
G

RR21A
RR21B
RR21BJ
RR21CC
RR21CB
RR21M
RR21S
RR21C
RR21I
RR21BD
RR21CF
RR21BM
RR21CG
RR21BZ
RR21D
RR21Z

RecQ4 siRNA #3

1
1
1
1
4
7
22
22
22
22
193

A
0
A
G
0
G
AGCT
AGCT
AGCT
AGCT
CAGG

RR31Z
RR31BF
RR31BQ
RR31CG
RR31O
RR31F
RR31D
RR31S
RR31BD
RR31BL
RR31BW
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Table 5.7 continued
Expt #
2

Group

Deletion
size (bp)

Microhomology

Control siRNA

4
4
10
10
22
76
145
271
400

0
0
GG
GG
AGCT
GGG
G
GAT
ATAGC

RC3X
RC3BB
RC3Q
RC3M
RC3Z
RC3V
RC3F
RC3L
RC3BA

Mock

19
286

GG
ATCG

RM3BD
RM3R

RecQ4 siRNA #2

1
4
4
22
28
37
64
389
607

A
0
0
AGCT
GGG
GC
GC
GCCG
GGGAT

R23T
R23D
R23BB
R23E
R23U
R23B
R23I
R23O
R23Y

RecQ4 siRNA #3

7
10
16
22
133
166
166
337
430

A
GG
G
AGG
CAGGGT
0
GA
C
G

R33W
R33U
R33BB
R33BC
R33Y
R33X
R33V
R33BD
R33F
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Clone
name

Table 5.8 NHEJ events and their clone information in RecQ4 and BLM double
knockdown experiments.
Expt #
1

Groups

Deletion
size (bp)
1
7
19
22
25
25
7
19
22
1
8
10
118
1
22
22
76
133
133
310
1
1
22
1
133
16
268
NA

Microhomology

RecQ4 siRNA

1
4
10
445

G
0
GG
CAT

RBR3E
RBR3H
RBR3D
RBR3M

BLM&RecQ4 siRNA

22
22
22
394
430

AGCT
A
AGCT
TG
TG

RBRB3A
RBRB3B
RBRB3T
RBRB3D
RBRB3K

Untreated

Control siRNA

BLM siRNA

RecQ4 siRNA

BLM&RecQ4 siRNA

2

Untreated
Control siRNA
BLM siRNA
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A
A
A
AGCT
G
G
A
GG
0
G
TAA
GG
0
A
AGCT
AGCT
GGG
A
CAGGGT
AC
G
G
A
A
CAGGGT
0
ATC
NA

Clone
name
RBU1C
RBU1S
RBU1U
RBU1L
RBU1P
RBU1H
RBC1L
RBC1M
RBC1U
RBB1W
RBB1Y
RBB1BA
RBB1V
RBR1F
RBR1B
RBR1I
RBR1D
RBR1V
RBR1Z
RBR1H
RBRB1M
RBRB1N
RBRB1BA
RBU3O
RBU3Q
RBC3J
RBC3E
NA

recovered DSB repair recombinant clones. As mentioned in introduction, SSA could
produce recombinant during DSB repair, which is indistinguishable from that of
crossover events.
In pLB4-11 cell line, NHEJ events survived G418 selection as long as they
rejoined the broken recipient sequence with 3N+1 bp deletion, which restore the original
reading frame for tk-neo fusion gene. According to the data presented here, NHEJ events
are only a small proportion of the recovered recombinant clones, the actual NHEJ events
are most likely 3 times higher. This estimation suggests that NHEJ events induced by the
break are roughly as many as HR events. NHEJ events do not convert the aforementioned
13 nucleotide mismatches, and the homologous donor does not serve the “template” role
in NHEJ events.
Different from NHEJ events, HR events restore the disrupted recipient back to a
continuous HSV-1 TK sequence through removing the 22 bp engineered insertion.
Moreover, donor’s unique nucleotides would be transferred into recipient sequence: the
mismatched nucleotide 5, 3 bp downstream the I-SceI, was always converted while the
rest mismatched nucleotides were converted to donor as the conversion tract move
further. The HR events were further divided into gene conversion events and crossover
events. Crossover events had donor sequence spliced to recipient sequence, causing 4.5
Kb fragment deletion between these two tandem repeats.
Crossover events fusing tandem repeats: Aforementioned crossover events
could be achieved by SSA: if the broken ends went through extensive unwinding and
resection, the donor strand would eventually have chance to anneal with recipient strand.
After flaps cleavage and ligation, the rejoined DNA molecule would have a fusion of
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donor and recipient, the same as crossover events generated by HR. It is unknown
whether recovered fusion events arise primarily from crossover or SSA, however, we
found an increase in crossover events after BLM knockdown, which agree well with
BLM’s roles in Holliday junction dissolution or D-loop rejection to prevent crossover,
but contradict with BLM’s roles in long-range resection (117) and strand annealing to
promote SSA (118).
Clone frequency not affected by RecQ4 knockdown: The DSB repair clone
frequencies are equivalent in control and RecQ4 knockdown groups in each experiment,
while variations in clone frequency were observed across experiments. In BLM
knockdown experiments, no obvious change in clone frequency was observed after BLM
knockdown or BLM and RecQ4 double knockdown.
No dramatic change in NHEJ events after RecQ4 knockdown: NHEJ events
comprise a small portion of recovered events, and their proportions in RecQ4 knockdown
groups are not dramatically different from that in control groups. They have sequence
deletion from several nucleotides to thousands of nucleotides, and the deletion sizes are
similar across experimental groups. Most NHEJ events rejoin the broken ends with
potential use of microhomology, while only 13 out of 122 NHEJ events rejoined the
broken ends without using short complementary ends.
Microhomology used in these events is generally short, from 1 to 6 nucleotides.
About half of the NHEJ events used microhomology with 2 or more nucleotides, about
one third used microhomology with 1 nucleotide, while the rest one sixth did not use
microhomology. No obvious difference in utilizing microhomology was observed across
experimental groups, and if any difference did exist, it does not correlate with genetic
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background of examined cells. Though knockdown of RecQ4 or BLM does not affect
NHEJ events, current data confirmed that NHEJ prefer to use terminal microhomology to
ligate two broken ends.
Ratio of gene conversion to crossover changed after RecQ4 knockdown: In
control groups, more crossover events were recovered than gene conversion events after
DSB repair (65 vs 53), while this trend was reversed after RecQ4 knockdown (43 vs 60).
The substantial difference between control cells and knockdown cells suggests the HR
outcome shift from crossover to gene conversion after RecQ4 knockdown. However, the
fisher exact test comparing these two HR subtypes between control and knockdown
groups does not support significant difference between these two conditions.
RecQ4 knockdown alleviate the effect of BLM deficiency on HR: In RecQ4
and BLM double knockdown experiments, the DSB repair in BLM knockdown cells
were examined as well as in RecQ4 and BLM double knockdown cells. BLM knockdown
increased the proportion of crossover events, supported by fisher exact test comparing
HR subtypes between BLM knockdown groups and control groups (p=0.0499). The same
observation has been reported in our recent publication (70). The ratio of HR subtypes
between other groups are not dramatically different. In RecQ4 and BLM double
knockdown cells, though RecQ4 deficiency failed to increase the gene conversion events,
it does abrogate potential increase of crossover event in BLM deficient cells. Since
RecQ4 depletion alleviates effect from BLM deficiency, RecQ4 likely acts against BLM
in HJ dissolution or D-loop rejection steps, which need further investigation.
Resolution site of crossover events is away from DSB: Most recovered gene
conversion events have mismatches 4 and 5 converted to donor, with maximal 700 bp
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conversion tract surrounding the break site. Some gene conversion events only converted
mismatch 5, which means maximal 200 bp conversion tract mostly downstream of the
break site.
In contrast, crossover events have more donor’s unique nucleotide downstream of
the I-SceI insertion site in their recombinant DNA sequences. Polling data from control
cells, 50 out 54 gene conversion events in control cells have conversion tract ended
between mismatches 5 and 6, only gaining one donor’s unique nucleotide after break site.
However, in 43 out of 62 crossover events, their recombinant DNA sequences have two
or more donor’s unique nucleotides after I-SceI site. Fisher exact test comparing the
resolution sites in gene conversion events and crossover events comes out statistically
significant (p=0.0001). The results suggest that the crossover events may went through
extensive strand exchange and DNA synthesis, so the area of genetic exchange tends to
be dramatically longer than that in gene conversion events.
Complex recombination events encountered in current experiments:
Sporadically, there are complex recombination events which cannot be simply grouped
into either HR or NHEJ events. There are totally 30 such events out of 551 examined
events across experiments and they are generally listed in Table 5.9.
Many complex recombinants have additional modifications on their DNA sequences
besides the repair at the DSB site. They might be a combination of NHEJ and HR event,
a combination of NHEJ and a secondary deletion event, or a combination of HR and a
secondary unknown sequence changing event. There are also other gross rearrangement
events that could not be identified through sequencing and southern blotting. All these
events demonstrated that during DSB repair, cells probably made multiple attempts to fix
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the lesion and adopted more than one pathway to save them from stalled cell cycle and
cell death.
Concluding Remarks:
HR protects genome stability by fixing severe DNA damage affecting both
strands of a DNA molecule, while occasionally it brings detrimental mutation, deletion or
duplication after recombining diverged DNA sequences. In the current dissertation,
recombination between diverged sequences has been examined using a new set of
recombination substrates, which have different lengths of homeologous sequences
between donor and recipient surrounded by perfect homology. The frequency and the
fraction of HeR events were compared among these substrates to reveal how the length of
homeologous sequences affects the HeR events between donor and recipient, or
conversely, how cells process these homeologous sequences during DNA recombination.
The obtained results clearly demonstrate that when aided by surrounding
homology, HeR events occur at significantly higher frequencies than that between purely
homeologous sequences, and they are common regardless of the length of homeologous
sequences. Additionally, recombinants’ DNA sequences after MSH2 knockdown
suggested hDNA as the recombination intermediate in these HeR recombinants of DSB
repair. Moreover, MMR depletion brought a minor boosting effect on HeR frequency in
cell line pBWW33-67, in contrast with its dramatic boost on recombination between
diverged sequences. Available data presented evidence supporting that cells carry out
recombination ignoring the mismatched nucleotides between donor and recipient as long
as enough homology is available on both side of the homeologous sequence to mediate
the recombination.
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Table 5.9 Complex recombination events collected in all experiments.
Clone
Number
RBU1I

1st event

RR21BF

NHEJ

RC1D

NHEJ

RC1B

NHEJ

RR31CC

NHEJ

RR21BL

NHEJ

RC1C

NHEJ

RR31BX

NHEJ

RR31BI

CO

RR31BK

CO

RR21CH

CO

RM1U

CO

RM1BO

CO

RBB1F

DEL&INS

RR21BU

DEL&INS

R23W

NHEJ

Event Details

2nd event

37 bp deletion with no
microhomology
993 bp deletion with
microhomology GCG
193 bp deletion with
microhomology CAGG
22 bp deletion with
microhomology AGG
10 bp deletion with no
microhomology
8 bp deletion with
microhomology TAA
8 bp deletion with
microhomology TAA
23 bp deletion with no
microhomology

CO with conversion tract to 3

NHEJ

with donor's nucleotide
from 1 to 11
with donor's nucleotide
from 1 to 12
with donor's nucleotide
from 1 to 12
with donor's nucleotide
from 1 to 5
with donor's nucleotide
from 1 to 11
24 bp deletion with 5 bp
insertion
602 bp deletion with 266
bp insertion
18 bp deletion

RBC3G

INS

2 bp insertion

Possibly 0.3 kb insertion in recipient
beyond 13 mismatched nucleotides
unknown sequence alteration at a second
location
Possibly 0.4 kb deletion in recipient
beyond 13 mismatched nucleotides
Possibly sequence alteration affecting the
terminal enzyme sites
Possibly 0.1 kb insertion in recipient
beyond 13 mismatched nucleotides
CO with conversion tract to 4 at an
upstream location
Possibly CO at location beyond 13
mismatched nucleotides
1 bp second deletion between mismatched
nucleotides 4 and 5
NA

RC3R

INS

137 bp insertion

NA

RR21Y

INS

11 bp insertion

NA

RBR3T

DEL&INS

2 bp deletion and 1 bp
insertion

NA

CO at location beyond 13 mismatched
nucleotides
GC with conversion tract to 3
GC with conversion tract to 4
a string of G to C mutation near NHEJ
467 bp deletion with microhomology AC
13 bp insertion near NHEJ
DEL&INS with 209 bp deletion and 207
bp insertion near NHEJ, 0.9 kb deletion
beyond 13 mismatched nucleotides in
recipient.
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Table 5.9 continued
Clone
Number
RBU3I

1st event

RBC1Z

DEL&INS

R23R

DEL&INS

RR21K

DEL&INS

RR21CI

DEL&INS

RBRB1K

UNKNOWN

RBU1E

UNKNOWN

RR21BN

UNKNOWN

RM1B

UNKNOWN

R23K

DEL0

DEL&INS

Event Details

2nd event

21 bp deletion and 2 bp
insertion
11 bp deletion and 13 bp
insertion
8 bp deletion and 1 bp
insertion
13 bp deletion and 6 bp
insertion
41 bp deletion and 4 bp
insertion
gross rearrangement

NA

gross rearrangement
affecting recipient
gross rearrangement
affecting recipient
gross rearrangement
affecting recipient
0 bp deletion in recipient

NA
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NA
NA
NA
NA
NA

NA
NA
NA

Existing data indicates that MMR vigorously inhibits recombination between
homeologous sequences and that MSH2-MSH6 interacts with hDNA within D-loop in
vitro. Data in this dissertation strongly suggested that MMR helps to terminate HeR
events at initiation step, while once invasion and synthesis established along the DNA
template, the strand exchange and recombination between nearby homeologous sequence
seem not a problem to the cells. This further sketch of HeR rejection mechanism does
have its own virtue since the rejection of homeologous recombination is better to be at an
earlier stage considering the long lasting, complicated procedure to achieve
recombination. Timely check and abortion of recombination between diverged sequences
greatly benefit for cells to combat a deadly lesion without wasting unnecessary time and
energy. To sum up, results and conclusion in this dissertation provide detailed genetic
evidence supporting homeologous tolerance at later stages of HR.
Our findings also have great significance in understanding HeR events
documented in rare medical conditions. The recombination events within these artificial,
chromosomally integrated substrates are conceivably similar to the recombination events
between evolutionarily related, diverged sequences in vivo, such as recombination
between Alu sequences or between members of a gene family. Our results highlighted the
risk of recombination between these repeats since they still share a significant amount of
homology. On the other side, from the evolution point of view, the results also showed
the recombinational exchange between slightly diverged sequence could be very active in
aforementioned favorable conditions, which probably contributes to the homogenization
of a gene family, termed as concerted evolution.
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Another important conclusion of the current research is that homology
requirements of spontaneous and DSB-induced recombination are dramatically different,
and DSB is sloppy in choosing resolution site. The results emphasize the high risk in
DSB repair, where HeR events are easily obtained even without assistance of homology
on both sides of the homeologous sequences. Currently, the mechanism underlying the
different homology requirements, whether SDSA or nearby DSB, during DSB repair
relaxed homology requirement, remains unknown; the desired HeR events resulting
solely from Holliday junction resolution are not yet recovered. If the products of this subpathway really exist and are able to be recovered in the future, they would provide
invaluable help to clarify the cause of relaxed homology requirements during DSB repair.
It remains necessary to conduct more DSB experiments or MSH2 depletion experiments
in order to recover the aforementioned recombination events. And meanwhile, in vitro
studies are also informative and valuable if they can determine whether Holliday
junctions could be efficiently resolved in a region of homeologous sequences.
Moreover, attempts have been carried out to see RecQ4’s function in DSB repair.
The recombination substrate pLB4 allows us to collect a broad spectrum of DNA repair
events, and check the details of sequence changes in recovered events. Agonistic roles of
BLM and RecQ4 were found in generating crossover events. Since RecQ4 joins the
replisome, unwinds DNA strands for DNA synthesis and has high affinity to Holliday
junctions, it is postulated that RecQ4 counteracts BLM in D-loop rejection or convergent
branch migration of Holliday junctions. There is a conflicting report stating RecQ4 and
BLM cooperate to reduce crossover events in studies on BLM patients’ cells. Therefore,
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more experiments, both in vitro and in vivo, are required to verify and pursue the current
results.
The work presented in this dissertation moves forward our understanding of the
mechanism and regulation of HR, and warrants further investment to answer these yetresolved and newly emerging questions. Better understanding of HR will inevitably
contribute to our knowledge about genome instability, carcinogenesis, and has potential
applications to improve human health.
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